Prostate Cancer (DBCOND0062462)

Identifiers

Synonyms
Cancer, Prostate / Prostate Ca / Prostatic Cancer / Cancer Prostate / Malignant Neoplasm of Prostate / Prostate Cancers / Cancer Of Prostate / Cancer of the Prostate / Prostatic neoplasms malignant / Prostate cancer / Prostate cancer NOS / Malignant tumor of prostate (disorder) / Carcinoma prostate / Carcinoma of prostate (disorder) / Prostate carcinoma / Prostatic carcinoma / Carcinoma prostatic / Primary malignant neoplasm of prostate (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Capromab pendetide
A monoclonal anti-prostate specific membrane antigen antibody used in imaging kits to target radioactive agents to malignant prostate tissue.
Choline C-11
An imaging agent used in positron emission tomography imaging for suspected recurrent prostate cancer and non-informative bone scintigraphy, computerized tomography, or magnetic resonance imaging.
No drug targets
Estradiol
An estrogenic steroid used to treat vasomotor symptoms of vulvar and vaginal atrophy in menopause, hypoestrogenism, prevention of postmenopausal osteoporosis, treatment of breast cancer, and advanced androgen-dependent carcinoma of the prostate.
Etoposide
A podophyllotoxin derivative used to treat testicular and small cell lung tumors.
Flotufolastat F-18
A radiopharmaceutical diagnostic agent used in PET imaging to visualize PSMA-positive lesions in men with prostate cancer with suspected metastasis or recurrence.
Fluciclovine (18F)
A radiolabelled L-leucine derivative used to image tumors, especially in the prostate.
Gallium Ga-68 gozetotide
A radiopharmaceutical agent used in the diagnosis of prostate-specific membrane antigen (PSMA) positive lesions in male patients during positron emission tomography.
Piflufolastat F 18
A radiopharmaceutical diagnostic agent used with PET to image PSMA-positive lesions for the diagnosis of metastatic or recurrent prostate cancer.
Uracil
An antineoplastic agent used in combination with tegafur to treat various cancers, including breast, prostate, and liver cancer.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03615599
Plant-based Diets and Risk of Cancer in the Adventist Health Study-2No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04726319
Family History App in Personalized MedicineNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT00385827
A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC)treatment2terminated
NCT00136487
Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancertreatment2 / 3completed
NCT03572387
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatmenttreatment2completed
NCT00633087
A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancertreatment1 / 2terminated
NCT04321187
Influence of Prostate Cancer Radiation on AgingNo drug interventionsNot AvailableNot Availablecompleted
NCT01320787
18-F-Fluoroacetate as PET Imaging Agentdiagnostic1withdrawn
NCT04718987
Potency pReservation In Prostate cAncer Patients Treated With UltraSound-guided Low-dose Rate BrachytherapyNo drug interventionspreventionNot Availablerecruiting
NCT05171387
Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancertreatment2active_not_recruiting
NCT05279287
Video Analysis of Errors and Technical Performance Within Minimally Invasive Surgery Short Title: Video Analysis in Minimally Invasive Surgery (VAMIS)No drug interventionsNot AvailableNot Availablerecruiting
NCT00798187
Efficacy of Cancer Support Programs: A Social Comparison Theory AnalysisNo drug interventionsNot AvailableNot Availableterminated
NCT02420587
AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)treatment2withdrawn
NCT01692587
Does Protein Restriction Inhibit Prostrate Cancer GrowthNo drug interventionsbasic_scienceNot Availablecompleted
NCT02680587
Stereotactic Body Radiation for Prostate OligometastasesNo drug interventionstreatment2completed
NCT05787587
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT01188187
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancertreatment3completed
NCT01286987
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumorstreatment1completed
NCT00828633
Health-Related Quality of Life in Gay Men With Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02620033
Impact of Yoga As Complementary Therapy in Patients Undergoing Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT00003633
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancertreatment1unknown_status
NCT03920033
Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT02623933
MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer PatientsNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01681433
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abirateronetreatment2terminated
NCT00937833
Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical SlingNo drug interventionspreventionNot Availablecompleted
NCT00519233
AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancertreatment1completed
NCT03029533
Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancertreatment1unknown_status
NCT02146833
SHIP (Selinexor in Hormone Insensitive Prostate Cancer)treatment2terminated
NCT00685633
Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancertreatment2withdrawn
NCT01513733
The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancertreatment1completed
NCT02243033
Phase II Laser Focal Therapy of Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03169933
Combined, Intensified and Modulated Adjuvant Therapy in Prostate CarcinomaNo drug interventionstreatmentNot Availablecompleted
NCT00002633
Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancertreatment3completed
NCT01643954
Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The JamesNo drug interventionsotherNot Availableactive_not_recruiting
NCT00780754
Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasiaprevention3completed
NCT03436654
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic AdenocarcinomaNo drug interventionstreatment2active_not_recruiting
NCT03740854
The Effects of Two Different Ventilation Strategies on Lung Ventilation: An Ultrasonographic Evaluation.No drug interventionsdiagnosticNot Availableunknown_status
NCT00087854
Study of Individualized Amonafide to Treat Prostate Cancertreatment1 / 2completed
NCT04249154
Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancertreatment2recruiting
NCT00242554
Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasestreatment4completed
NCT02111954
Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04115254
Stereotactic Magnetic Resonance Guided Radiation TherapyNo drug interventionstreatmentNot Availablesuspended
NCT00020254
Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancertreatment2completed
NCT02342054
Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate CancerNo drug interventionstreatment2unknown_status
NCT02275754
Redes III Patient Navigator Qol StudyNo drug interventionssupportive_careNot Availablecompleted
NCT00678054
Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)No drug interventionstreatment2completed
NCT03579654
Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active SurveillanceNo drug interventionstreatment2unknown_status
NCT04194554
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancertreatment1 / 2recruiting
NCT03062254
Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapybasic_science2completed
NCT04424654
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapytreatment2completed
NCT00134654
Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancertreatment2completed
NCT04302454
Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapytreatment3recruiting
NCT02895854
LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT03440554
Non-contrast MR Imaging for Whole Body Cancer Detection and CharacterizationNo drug interventionsdiagnosticNot Availableunknown_status
NCT01727154
Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-TNot AvailableNot Availableterminated
NCT06460454
PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) ProgressingNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01354951
Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate CancerNo drug interventionstreatment2terminated
NCT02391051
Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trialNo drug interventionstreatment2recruiting
NCT00734851
Multimodality Phase II Study in Prostate Cancertreatment2terminated
NCT06250751
Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate CaNo drug interventionssupportive_careNot Availablerecruiting
NCT04953351
MRI-Ultrasound Fusion or Cognitive Registration in MR-targeted Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT01902251
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patientsbasic_science1completed
NCT05886751
Randomized Trial of Trust in Online Videos About Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT03999151
Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)No drug interventionspreventionNot Availableactive_not_recruiting
NCT04478851
EXCEL: Exercise for Cancer to Enhance Living WellNo drug interventionssupportive_careNot Availablerecruiting
NCT03389451
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancerdiagnostic2 / 3completed
NCT03675451
PSMA Imaging of Localized Prostate Cancerdiagnostic2completed
NCT00507351
Ambulatory Cancer Pain Management: A Feasibility StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02362451
Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate CancerNo drug interventionstreatment2terminated
NCT01275651
Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With KetoconazoleNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06271551
Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapytreatment2not_yet_recruiting
NCT01834651
A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastasestreatment2completed
NCT03770351
Early Prostate Cancer: Predicting Treatment ResponseNo drug interventionsNot AvailableNot Availableunknown_status
NCT05596851
Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy.No drug interventionsNot AvailableNot Availablerecruiting
NCT00002651
SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancertreatment3completed
NCT05668351
Stereotactic Ablative Radiation Therapy for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00695851
Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.treatment1completed
NCT01492751
Effectiveness of Localized Prostate Cancer TreatmentsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03802851
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04889651
A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteerstreatment1completed
NCT02918253
HDR Focal: Feasibility StudyNo drug interventionstreatmentNot Availablerecruiting
NCT00246753
Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapytreatment2completed
NCT01717053
Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancertreatment2completed
NCT03650153
Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. TransperinealNo drug interventionsdiagnosticNot Availablecompleted
NCT01412853
Spectro-IRM and Evaluation Response to Prostatic RadiotherapyNo drug interventionsdiagnosticNot Availablecompleted
NCT02702453
True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their PartnersNo drug interventionssupportive_careNot Availablecompleted
NCT04089553
An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancertreatment2completed
NCT01366053
Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH AgonistsNo drug interventionsNot AvailableNot Availablecompleted
NCT04172753
Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-LinacNo drug interventionstreatmentNot Availablerecruiting
NCT05073653
A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT03724253
[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)No drug interventionsdiagnostic2terminated
NCT00714753
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT06014853
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjectstreatment1completed
NCT01533753
Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancertreatment2terminated
NCT04136353
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostatetreatment3active_not_recruiting
NCT01741753
BKM120+Abiraterone Acetate for Metastatic CRPCtreatment1terminated
NCT01835977
Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT00002677
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumorstreatment1completed
NCT03857477
The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05539677
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT05955677
Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and MetastasisNo drug interventionsdiagnostic0recruiting
NCT00030277
High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate CancerNo drug interventionstreatment1completed
NCT01717677
Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" RiskNo drug interventionstreatmentNot Availableterminated
NCT05239377
MiProstate - Information Hub for the Prostate Cancer Care FlowNo drug interventionsNot AvailableNot Availablecompleted
NCT00958477
A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancertreatment1completed
NCT00054977
Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumorstreatment1completed
NCT05056077
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)No drug interventionssupportive_careNot Availablerecruiting
NCT04794777
Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate CancerNo drug interventionstreatment3recruiting
NCT03808077
The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancertreatment2recruiting
NCT04146077
Active Surveillance for Low Risk Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05001477
Customized TULSA-PRO Ablation RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT03458247
Study of Dose Escalation of Abiraterone Actetate in Prostate Cancertreatment2completed
NCT06296147
Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate BiopsyNo drug interventionssupportive_careNot Availablerecruiting
NCT00270647
Physicians' Health Study IINo drug interventionspreventionNot Availablecompleted
NCT06385847
To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancerother2recruiting
NCT04281147
Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the BodyNot AvailableNot Availablecompleted
NCT01968447
Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With SugammadexNo drug interventionstreatmentNot Availablecompleted
NCT00151047
Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancertreatment2completed
NCT00305747
Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapytreatment1completed
NCT05323747
Prospective Evaluation of a Commercially Available Hydrogel SpacerNo drug interventionsNot AvailableNot Availablecompleted
NCT04320147
MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT02623647
A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00087347
Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast CancerNot AvailableNot Availablecompleted
NCT00041847
Gene-Environment Interaction in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02033447
Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in MenNo drug interventionsother0completed
NCT06565247
Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic ValidationNo drug interventionsdiagnostic3not_yet_recruiting
NCT02462447
Carbon-11 Labeled Sarcosine in Prostate CancerNot AvailableNot Availablecompleted
NCT05574647
Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT00005847
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT00004045
Chemotherapy in Treating Patients With Prostate Cancertreatment2completed
NCT03070145
Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT02135445
Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancertreatment2completed
NCT00078845
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumorssupportive_care2completed
NCT04340245
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-ProgressorsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00992745
A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancerdiagnostic1completed
NCT03386045
Optimal Prostate StudyNo drug interventionstreatmentNot Availablerecruiting
NCT04322045
Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer ScreeningNo drug interventionsscreeningNot Availableunknown_status
NCT00090545
A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancertreatment2completed
NCT03465345
Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patientstreatment1withdrawn
NCT00767845
Symptom Management in African-American Men With Localized Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03193645
Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With DegarelixNot AvailableNot Availablecompleted
NCT04489745
Stereotactic Body Radiotherapy (SBRT) for Localized Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT00052845
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT02451345
Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle ModelNo drug interventionsotherNot Availablecompleted
NCT06451445
A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00003045
Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00321698
Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancertreatment1 / 2terminated
NCT04995198
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment EffectivenessNo drug interventionsNot AvailableNot Availablerecruiting
NCT05079698
A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancertreatment1active_not_recruiting
NCT01171898
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)No drug interventionstreatment1 / 2active_not_recruiting
NCT05772598
Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard QuestionnairesNo drug interventionsNot AvailableNot Availablecompleted
NCT02886598
Safety and Efficacy of Firmagon® (Degarelix) for InjectionNot AvailableNot Availablecompleted
NCT02796898
Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate CancerNo drug interventionstreatment1 / 2completed
NCT01448798
Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.No drug interventionstreatmentNot Availableunknown_status
NCT01960998
Perioperative Post-Prostatectomy Incontinence Home Telehealth ProgramNo drug interventionstreatmentNot Availablecompleted
NCT00348998
Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancertreatment2unknown_status
NCT00511498
Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical ProstatectomyNot AvailableNot Availablecompleted
NCT04507698
INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate CancerNo drug interventionsbasic_scienceNot Availableunknown_status
NCT05762198
Comparing Water Vapour Thermal Therapy (Rezūm) and TURPNo drug interventionstreatmentNot Availablerecruiting
NCT03182998
Decision Aids to Improve Knowledge in Patients With Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT00887198
Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancertreatment3completed
NCT04558398
Impact of Exercise on Mitochondria in Cancer Patients.No drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT01710098
Treatment of Prostate Cancer With Firmagon®Not AvailableNot Availablecompleted
NCT05940298
Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8No drug interventionsdiagnostic1recruiting
NCT04220398
Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00244998
Fulvestrant in Treating Patients With Advanced Prostate Cancertreatment2completed
NCT02313298
Stereotactic Body Radiotherapy for Organ Confined Prostate CancerNo drug interventionstreatment2unknown_status
NCT03652298
Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and PartnersNo drug interventionsprevention2terminated
NCT02518698
Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare PopulationNot AvailableNot Availablecompleted
NCT05324098
Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation TherapyNo drug interventionshealth_services_researchNot Availablecompleted
NCT02324998
Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomyother1completed
NCT03810105
A Study of Olaparib and Durvalumab in Prostate Cancertreatment2terminated
NCT05129605
Prostate Cancer Genetic Risk Evaluation and Screening StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00751205
Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)treatment2completed
NCT01230905
Study to Monitor the Effects of Androgen Suppression Treatment on the HeartNo drug interventionsscreening4completed
NCT02302105
Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05764005
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot StudyNo drug interventionshealth_services_researchNot Availablecompleted
NCT00684905
Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapytreatment2completed
NCT03457805
Prostatic Artery Embolization in Advanced Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT06183905
Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer DetectionNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT01531205
Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSAtreatment2terminated
NCT01692405
Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the SampleNo drug interventionsdiagnosticNot Availablecompleted
NCT03381105
From PSA to Stockholm3: Study Part 1No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04536805
Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformintreatment1 / 2recruiting
NCT02543905
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT01160705
Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2Not AvailableNot Availablecompleted
NCT05328505
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT01303705
Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancertreatment1completed
NCT02993497
Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal AnesthesiaNo drug interventionssupportive_careNot Availablecompleted
NCT01753297
A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.treatment4completed
NCT01605097
High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic NoduleNo drug interventionstreatmentNot Availablecompleted
NCT03432897
BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genestreatment2terminated
NCT05163197
Transperineal Laser Ablation Treatment (TPLA) for Prostate Cancer (PCa) RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00433797
Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer PatientsNo drug interventionstreatment1 / 2completed
NCT02555397
Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate CancerNo drug interventionstreatment1unknown_status
NCT04832997
Micro-ultrasound for Prostate Cancer DiagnosisNo drug interventionsdiagnosticNot Availablerecruiting
NCT05644197
Multidisciplinary Care After ProstatectomyNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT05146297
Diversity and Inclusion in Research Underpinning Prevention and Therapy TrialsNo drug interventionshealth_services_researchNot Availablerecruiting
NCT00329797
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone TherapyNo drug interventionssupportive_care3completed
NCT04176497
PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot StudyNo drug interventionstreatment2active_not_recruiting
NCT03365297
Therapeutics in Active Prostate Cancer Surveillancetreatment2completed
NCT00035997
Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasistreatment4completed
NCT00853697
Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate CancerNo drug interventionstreatment2completed
NCT02499497
A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancersupportive_care2completed
NCT01144897
PET Acetate for Castrate-Resistant Prostate Cancer on ChemotherapyNo drug interventionsdiagnostic1completed
NCT00498797
E3-Hormone Refractory Prostrate Cancer Taxotere Combinationtreatment2completed
NCT02199197
Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancertreatment2completed
NCT06451497
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid TumorsNo drug interventionsother1recruiting
NCT05910697
Clinical Utility of MyProstateScore 2.0 P2No drug interventionsdiagnosticNot Availableterminated
NCT06408597
Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or CystectomyNo drug interventionssupportive_careNot Availablerecruiting
NCT04299997
Evaluation of the PI-RADS v2.1 Score Using Multiple ReadersNo drug interventionsNot AvailableNot Availablecompleted
NCT00003183
Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancertreatment1 / 2unknown_status
NCT01558583
Online Study of Colorectal Cancer and Prostate Cancer Screening Decision MakingNo drug interventionshealth_services_researchNot Availablecompleted
NCT06172283
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation TherapyNo drug interventionstreatmentNot Availablerecruiting
NCT04298983
Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancertreatment2active_not_recruiting
NCT00188383
Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomyeducational_counseling_training1 / 2unknown_status
NCT02163083
Detection of Lymphnodes Using ICG During RARPNo drug interventionspreventionNot Availablecompleted
NCT01331083
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancertreatment2completed
NCT02365883
Transrectal Photoacoustic Imaging of the ProstateNo drug interventionsNot AvailableNot Availableterminated
NCT04009083
Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)No drug interventionsdiagnosticNot Availablecompleted
NCT06052683
A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.No drug interventionstreatmentNot Availablerecruiting
NCT02759783
Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial OligometastasesNo drug interventionstreatment2 / 3active_not_recruiting
NCT02618161
Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life AssessmentNo drug interventionstreatmentNot Availablecompleted
NCT04742361
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate CancerNo drug interventionsdiagnostic3active_not_recruiting
NCT02917161
Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept StudyNo drug interventionstreatmentNot Availablecompleted
NCT02091661
Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate CancerNo drug interventionstreatment3suspended
NCT05899361
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of InterestNo drug interventionsdiagnosticNot Availablerecruiting
NCT01376661
Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational StudyNo drug interventionsNot AvailableNot Availableterminated
NCT03725761
Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapytreatment2active_not_recruiting
NCT05710861
Cost-utility of Focal HIFU vs ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT00379561
PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancertreatment1completed
NCT02706561
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer SurgeryNo drug interventionssupportive_careNot Availablerecruiting
NCT01325961
Medico-economic Evaluation Comparing Intensity-Modulated Radiation Therapy (IMRT) Performed by Helical Tomotherapy and Dynamic Arc Therapy in Prostate, Cervical and Anal Canal CancersNo drug interventionsotherNot Availablecompleted
NCT06575361
Comprehensive Evaluation of MRI-AI in Prostate Cancer DiagnosisNo drug interventionsdiagnosticNot Availablerecruiting
NCT01777061
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET ScanNot AvailableNot Availableno_longer_available
NCT01656161
Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancertreatment3completed
NCT01617161
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00453661
Cancer Prevention and Treatment Demonstration for Ethnic and Racial MinoritiesNo drug interventionsNot AvailableNot Availablecompleted
NCT00483561
Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapytreatment2terminated
NCT02425228
Prospective Assessment of Image Registration for the Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00564928
A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancertreatment2completed
NCT05079828
Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007No drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT01538628
SpaceOAR System Pivotal StudyNo drug interventionstreatment3completed
NCT03093428
Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPCtreatment2active_not_recruiting
NCT01478828
Pre-Prostatectomy Lovastatin on Prostate CancertreatmentNot Availableterminated
NCT05161728
PSMA Response in Metastasized Hormone Sensitive Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT02404428
Utilizing MRI to Study the Effect of Sulforaphane on Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT00103428
Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancertreatment1 / 2terminated
NCT04992728
Prostate Assessment With Restriction Spectrum Imaging (RSI) MRINo drug interventionsNot AvailableNot Availablerecruiting
NCT05588128
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyLNot AvailableNot Availablerecruiting
NCT03541928
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgerytreatment2unknown_status
NCT02149628
The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxideprevention4completed
NCT03447028
Effect of TyG Index on Outcomes of Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT00931528
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapysupportive_care3completed
NCT00005828
Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyNo drug interventionstreatment2completed
NCT05471128
MRI Fusion Biopsy vs. Micro-Ultrasound Guided BiopsyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02858128
WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05225428
Video Education With Result Dependent dIsclosureNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04081428
Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRTNo drug interventionsNot AvailableNot Availablerecruiting
NCT02643511
Hemiablative Focal Brachytherapy Pilot StudyNo drug interventionstreatment2recruiting
NCT03604211
SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution ExperienceNo drug interventionsNot AvailableNot Availablecompleted
NCT00698711
Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21treatment1completed
NCT02224911
Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01672411
Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00002511
Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate CancerNo drug interventionstreatment3completed
NCT03232411
Biobank for African American Prostate Cancer Research in FloridaNo drug interventionsNot AvailableNot Availablecompleted
NCT05188911
Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA TrialNot AvailableNot Availableunknown_status
NCT03513211
Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancertreatment1 / 2completed
NCT05381311
Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00963911
Validation of a Screening Tool in Geriatric OncologyNo drug interventionsscreeningNot Availablecompleted
NCT00450411
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation TherapyNo drug interventionstreatment2completed
NCT02919111
Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patientsdiagnostic2 / 3completed
NCT06193993
Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patientstreatment1active_not_recruiting
NCT06206993
Effects of Kieser Resistance Training Plus Kieser Pelvic Floor Training vs. Kieser Resistance Training Plus Traditional Pelvic Floor Exercise on Urinary Incontinence in Prostate Cancer Patients After Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT00193193
Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinomatreatment2completed
NCT01794793
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studiestreatment4completed
NCT05761093
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice ExperimentNo drug interventionsNot AvailableNot Availablerecruiting
NCT06177093
De-escalated Dose SBRT in Localized Prostate Cancer (DESTINATION-MRL)No drug interventionstreatmentNot Availablerecruiting
NCT04854993
Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted Prostatectomytreatment3completed
NCT01620593
Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancertreatment2completed
NCT02821793
Expectations and Priorities of Elderly Patients for a First Medical Treatment for CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05081193
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancertreatment2recruiting
NCT06141993
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical TrialsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03630393
Ultralow Versus Standard Pneumoperitoneum PressureNo drug interventionstreatmentNot Availableterminated
NCT03909893
A Study of Adaptive Radiation Therapy for Pelvic Genitourinary CancerNo drug interventionstreatmentNot Availablewithdrawn
NCT00176293
Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancertreatment2terminated
NCT00278993
Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapytreatment2completed
NCT00980993
Quantification of Respiratory-induced Prostate MotionNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00345293
Dendritic Cell Vaccine Study (DC/PC3) for Prostate CancerNo drug interventionstreatment1 / 2completed
NCT00016393
BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT01987193
Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)No drug interventionsNot AvailableNot Availableterminated
NCT02139371
Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission TomographyNo drug interventionsdiagnostic0completed
NCT02001571
A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Functiontreatment1completed
NCT00523471
Blood Test to Measure DNA Damage in BloodNo drug interventionsNot AvailableNot Availableterminated
NCT00006371
A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancertreatment2terminated
NCT03574571
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancertreatment3recruiting
NCT00342771
An Epidemiological Study of Genetic Risk Factors for Prostate Cancer in African-American and Caucasian MalesNo drug interventionsNot AvailableNot Availablecompleted
NCT02015871
An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancertreatment3completed
NCT02022371
Prostate Cancer Genomic HeterogeneityNo drug interventionsdiagnostic1 / 2completed
NCT02414971
Relationship of Mitochondrial Enzymes With Cancer Related FatigueNo drug interventionsNot AvailableNot Availablecompleted
NCT06435871
Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT01491971
Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancertreatment2completed
NCT03712371
Study of Chitosan for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer PatientsNo drug interventionstreatment1 / 2terminated
NCT02456571
CTC Immune CheckpointNo drug interventionsNot AvailableNot Availablecompleted
NCT00219271
Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancertreatment4completed
NCT00823771
A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy TreatmentNo drug interventionsNot AvailableNot Availableterminated
NCT00004071
Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancertreatment2 / 3completed
NCT00293371
Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancertreatment1 / 2terminated
NCT01083771
Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate CancerNo drug interventionspreventionNot Availablecompleted
NCT00223171
Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate CancersNo drug interventionstreatment3unknown_status
NCT00003871
PSA Vaccine Therapy in Treating Patients With Advanced Prostate CancerNo drug interventionstreatment2completed
NCT05766371
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancertreatment2recruiting
NCT01354171
Active Surveillance Magnetic Resonance Imaging StudyNo drug interventionsdiagnostic3unknown_status
NCT04745871
Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).No drug interventionsdiagnosticNot Availablerecruiting
NCT03315871
Combination Immunotherapy in Biochemically Recurrent Prostate Cancertreatment2active_not_recruiting
NCT05896371
A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapytreatment1 / 2not_yet_recruiting
NCT00553878
Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancerprevention2 / 3completed
NCT04296578
Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abirateronetreatment1withdrawn
NCT06429878
The Long Term Effect of MRI Before Radical Prostatectomy.No drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT02789878
Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancertreatment2completed
NCT03572478
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancertreatment1 / 2terminated
NCT03809078
68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancerdiagnostic2completed
NCT03196778
Low Dose Hemi-body Radiation For Recurrent Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00080678
Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastasestreatment2completed
NCT06505278
The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapytreatment2not_yet_recruiting
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsNo drug interventionstreatment2recruiting
NCT03253978
SPORT High-Risk Trial Evaluating SABR in Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00006078
Lycopene In Preventing of Prostate CancerNo drug interventionsprevention1completed
NCT00483678
Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their PartnersNo drug interventionsotherNot Availablecompleted
NCT02882178
Consensus Method to Evaluate the Conformity of Prescription of a ChemotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT05515978
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patientstreatment0recruiting
NCT02766478
Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancerprevention2terminated
NCT01905488
Perioperative Changes of Cognitive Function According to Jugular Vein Insufficiency in Robot-assisted ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT03525288
PSMA-PET Guided RadiotherapyNo drug interventionstreatment2 / 3active_not_recruiting
NCT05454488
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate CancerNo drug interventionstreatment2recruiting
NCT00110188
Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)treatment2completed
NCT04894188
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate CancertreatmentNot Availablerecruiting
NCT06563388
Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET TrialNo drug interventionstreatment3not_yet_recruiting
NCT06029088
Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04638088
Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by LaparotomyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00644488
A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate CancerNo drug interventionstreatment1completed
NCT01368588
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment3active_not_recruiting
NCT05679388
A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patientstreatment1recruiting
NCT02772588
AASUR in High Risk Prostate Cancertreatment2active_not_recruiting
NCT00667888
A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using HypofractionationNo drug interventionstreatment3unknown_status
NCT01510288
Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancertreatment1terminated
NCT05596188
Anxiety Before Non-cardiac Surgery in AdultsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00208988
A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer ScreeningNo drug interventionseducational_counseling_trainingNot Availablecompleted
NCT00605488
The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00127088
Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patientstreatment2suspended
NCT04350788
Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management ProgramNo drug interventionssupportive_careNot Availablecompleted
NCT00414388
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancertreatment1 / 2completed
NCT04287088
bpMRI and Risk Based Shared Clinical Decision Making in Prostate Cancer DiagnosisNo drug interventionsdiagnosticNot Availablerecruiting
NCT04037488
Changes in Body Composition With Patients Under Androgen Deprivation TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01553188
AMG 386 and Abiraterone for Advanced Prostate Cancertreatment2completed
NCT00258388
Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapytreatment2completed
NCT04831307
68Ga-HTK03149 for Use as a Diagnostic RadiopharmaceuticalNo drug interventionsotherNot Availableunknown_status
NCT03418207
The Accuracy of Modified TTMB in the Spatial Distribution of Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT04692207
Prostate Biopsies With Target Lesion on MRINo drug interventionsNot AvailableNot Availablecompleted
NCT02438007
A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPCtreatment3terminated
NCT02106507
ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetatetreatment1completed
NCT00924807
Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancertreatment1 / 2terminated
NCT06487507
Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)No drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT05295407
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate BiopsyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02328807
Focal Prostate Radio-Frequency AblationNo drug interventionstreatmentNot Availablecompleted
NCT00263107
Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction.No drug interventionsNot AvailableNot Availablecompleted
NCT00482807
Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancertreatment1completed
NCT03413007
Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective TrialNo drug interventionsNot AvailableNot Availableunknown_status
NCT00788307
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapytreatment1terminated
NCT05580107
MDPK67b in Patients With Prostate CancerNo drug interventionstreatment1recruiting
NCT06559007
Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male ParticipantsNo drug interventionstreatment1not_yet_recruiting
NCT04516707
Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGONo drug interventionsNot AvailableNot Availablecompleted
NCT00196807
Prostate Cancer Screening: Fostering Informed DecisionsNo drug interventionsscreening3completed
NCT00433407
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorstreatmentNot Availablecompleted
NCT03861507
Needle Localization During Prostate Brachytherapy Using Power Doppler UltrasoundNo drug interventionsdiagnosticNot Availablerecruiting
NCT00003607
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate CancerNo drug interventionstreatment3completed
NCT00003307
Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancertreatment2completed
NCT06334809
INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair AlterationsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00215709
Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancertreatment1completed
NCT01260909
Real-Time MV/kV Image Guided Radiation TherapyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04687709
To Investigate the Role of Gut Microbiome in ADT Related Metabolic Changes in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01045109
Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen.No drug interventionstreatment2completed
NCT04098809
Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic ProstatectomyNo drug interventionsotherNot Availablecompleted
NCT04552509
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05826509
SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancertreatment2recruiting
NCT02516709
Linear Source Registry for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03580109
Spa Therapy for Upper or Lower Limb LymphoedemaNo drug interventionsotherNot Availablerecruiting
NCT04581109
Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP)No drug interventionsdiagnosticNot Availableunknown_status
NCT02811809
Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancertreatment2withdrawn
NCT02200809
MR-guided Focal Laser Ablation of the ProstateNo drug interventionstreatmentNot Availablecompleted
NCT06047509
Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for GuidanceNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00063609
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapyprevention4completed
NCT02966509
Engagement of Patients With Advanced CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT04848909
Stereotactic Body Radiotherapy (SBRT) Post ProstatectomyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00049309
Low-Fat Diet and/or Flaxseed in Preventing Prostate CancerNo drug interventionstreatment2completed
NCT03264209
Smart After-Care in Patients With Prostate CancerNo drug interventionssupportive_careNot Availableunknown_status
NCT04262609
Faecal Incontinence in Prostate Cancer Survivors Treated Whith RadiotherapyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04534309
Behavioral Weight Loss Program for Cancer Survivors in MarylandNo drug interventionspreventionNot Availablecompleted
NCT02853409
Quality of Life of Patients With Locally Advanced and Metastatic Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00582556
Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapytreatment2completed
NCT06505356
Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association With Disease StageNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT00943956
Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancertreatment1completed
NCT03787056
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT03212456
Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General AnesthesiaNo drug interventionstreatmentNot Availableunknown_status
NCT00003256
Flavopiridol in Treating Patients With Recurrent Prostate Cancertreatment2completed
NCT04582656
Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT05458856
Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostatetreatment3completed
NCT04177056
Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain ReliefNo drug interventionstreatmentNot Availableunknown_status
NCT04732156
Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence SystemNo drug interventionsdiagnosticNot Availablerecruiting
NCT02702856
Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06003556
PSMA-Guided Ablation of the ProstateNo drug interventionsdiagnostic2recruiting
NCT04045756
Focal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00819156
Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancertreatment2completed
NCT02635256
Hypofractionated Radiosurgery for Localised Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00707356
Study of WST11 in Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT00014456
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT04400656
PROState Pathway Embedded Comparative TrialNo drug interventionsNot AvailableNot Availablecompleted
NCT00377156
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesNo drug interventionstreatment3completed
NCT04625556
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing MicrobiomeNo drug interventionsNot AvailableNot Availablerecruiting
NCT00577356
Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancertreatment2terminated
NCT06491056
Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)No drug interventionsNot AvailableNot Availablerecruiting
NCT01444456
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00664456
Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate CancerNo drug interventionstreatment3completed
NCT00134056
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapytreatment3completed
NCT00516256
CHESS: Human and Computer Mentors for Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00669656
Herbal Therapy for Treatment of Recurrent Prostate Cancertreatment2completed
NCT01762956
Pelvic Floor Muscles Training in Men Undergoing Radiotherapy for Prostate Cancer: Randomized Controlled TrialNo drug interventionspreventionNot Availableterminated
NCT03692585
Ethnographic Study of the Everyday Life of Men With Prostate Cancer, Focusing on Diet, Activities and Digital BehaviorNo drug interventionsNot AvailableNot Availablecompleted
NCT03315585
The Efficacy and Safety of Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Focal TherapyNo drug interventionstreatmentNot Availablecompleted
NCT01437085
A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed ImplantNo drug interventionsNot AvailableNot Availableunknown_status
NCT02971085
Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active SurveillanceNo drug interventionsNot AvailableNot Availablerecruiting
NCT03709485
Evaluation of Gut Microbiome in Patients With Prostate CancerNo drug interventionsbasic_scienceNot Availableunknown_status
NCT04186585
Recommended Dose Estimation of BP-C2other1recruiting
NCT00402285
Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT01937585
Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA MenNo drug interventionspreventionNot Availablecompleted
NCT00841685
The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and ProstateNo drug interventionsotherNot Availablecompleted
NCT01304485
PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinomadiagnostic2completed
NCT01187485
A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancertreatment1completed
NCT00114985
Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal BleedingNo drug interventionstreatment2completed
NCT02934685
IG-VMAT for Localized Prostate CancerNo drug interventionstreatment3unknown_status
NCT02083185
A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancertreatment2completed
NCT01355185
Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric ConsequencesNo drug interventionsNot AvailableNot Availableunknown_status
NCT00363285
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancertreatment3unknown_status
NCT01028885
MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the ProstateNo drug interventionstreatment1completed
NCT00900185
Study of a Polymorphism in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03660085
Prostate Cancer - Patient Empowerment ProgramNo drug interventionssupportive_careNot Availablecompleted
NCT06470685
Prophylactic Prostatectomy for Prostate Cancer (PPPC)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03297385
Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablationtreatment2completed
NCT03149185
Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00078585
PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyNo drug interventionstreatment2completed
NCT03419585
The "PC-LIGHT" StudyNo drug interventionspreventionNot Availablecompleted
NCT00104715
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancertreatment3completed
NCT02559115
68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate CancerNo drug interventionsdiagnostic2completed
NCT05361915
Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancertreatment2suspended
NCT03124615
Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancertreatment2unknown_status
NCT01620515
Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancertreatment2completed
NCT00753415
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)No drug interventionstreatment1completed
NCT00003115
Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomysupportive_care3completed
NCT00562315
FACBC PET/CT for Recurrent Prostate Cancerdiagnostic2completed
NCT00054015
3-AP in Treating Patients With Advanced Prostate Cancertreatment2completed
NCT04861415
SBRT vs. Conventional Fractionation With HDR Boost for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00067015
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancertreatment3completed
NCT05533515
Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00581815
Spectroscopy With Surface Coils and DecouplingNo drug interventionsdiagnostic1completed
NCT05744115
Ga-68-PSMA-11 in Men With Prostate CancerNo drug interventionsdiagnostic3terminated
NCT00941915
Stereotactic Body Radiotherapy (SBRT) for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05131815
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00895115
Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate CancerNo drug interventionsprevention1completed
NCT00557037
A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancertreatment2completed
NCT01751737
Choline PET/CT and MRI for Targeted Prostate BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT01454037
Immune Profiles and Circulating Tumor Cell Status Following Prostate CryotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02282137
68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate CancerNo drug interventionsdiagnostic2unknown_status
NCT05568537
Prostate MRI and Pylarify PSMA PET/CTtreatment4not_yet_recruiting
NCT03961737
Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate CancersNo drug interventionsotherNot Availableunknown_status
NCT03987737
Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the ProstateNo drug interventionsdiagnosticNot Availableunknown_status
NCT02046837
An Exercise Trial and Economic Analysis in Men With Prostate CancerNo drug interventionssupportive_care2completed
NCT00199537
Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02477137
Effects of an Interactive ICT-Platform for Assessment and Management of Symptoms in Patients Treated for Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00183937
Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancertreatment2completed
NCT00798837
Intraprostatic MAXimal Simultaneous BoostNo drug interventionstreatmentNot Availableterminated
NCT00585637
Vitamin D for Chemopreventionprevention1completed
NCT00002637
Biological Therapy in Treating Patients With Prostate Cancertreatment1 / 2completed
NCT02057237
A Safety and Feasibility Study of Mitotane in Prostate Cancertreatment1completed
NCT03606837
68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer ImagingNo drug interventionstreatment2recruiting
NCT00164437
CD-ROM Intervention for Prostate Cancer ScreeningNo drug interventionseducational_counseling_training2 / 3completed
NCT06066437
NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trialtreatment1 / 2recruiting
NCT03164837
68Ga-NOTA-RM26 PET/CT in Prostate Cancer PatientsNo drug interventionsdiagnostic1unknown_status
NCT02538432
Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumorstreatment2withdrawn
NCT00354432
Soy Protein/Effexor Hormone Therapy for Prostate Cancersupportive_care3terminated
NCT03120832
Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer PatientsNo drug interventionstreatment1completed
NCT05820932
Predicting Cognitive Decline From Androgen Deprivation TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05978232
NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT00607932
Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate CancertreatmentNot Availablecompleted
NCT01642732
Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate CancerNo drug interventionstreatment1terminated
NCT05472532
Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)No drug interventionsotherNot Availablerecruiting
NCT02704832
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)No drug interventionsother3unknown_status
NCT05324332
68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer PatientsdiagnosticNot Availableunknown_status
NCT00441532
Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate BiopsytreatmentNot Availablecompleted
NCT00082732
Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate CancerNo drug interventionstreatment1completed
NCT00584532
Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.treatment2 / 3completed
NCT00882232
Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate CancerNo drug interventionstreatment1completed
NCT04700332
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancerdiagnostic2recruiting
NCT05720832
Feasibility of Technology-Based SSIP in Prostate Cancer PatientsNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT01985932
Functional MRI Use in Prostate Radiation Treatment PlanningNo drug interventionsdiagnosticNot Availablecompleted
NCT00688532
Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or NotNo drug interventionsNot AvailableNot Availablecompleted
NCT05888532
64Cu-GRIP B in Patients With Advanced Malignanciesdiagnostic1 / 2recruiting
NCT02758132
Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasestreatment2terminated
NCT00003232
Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancertreatment3completed
NCT00005632
Vaccine Therapy Plus QS21 in Treating Patients With Prostate CancerNo drug interventionstreatment1completed
NCT05327452
Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE StudyNo drug interventionssupportive_careNot Availablerecruiting
NCT02735252
PROMOTE: Identifying Predictive Markers of Response for Genitourinary CancerNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT00769652
Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate CancerNo drug interventionssupportive_careNot Availableterminated
NCT01801852
Autologous Natural Killer T Cells Infusion for the Treatment of CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00777452
A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05735652
An Observational Study of Radiotherapy After Injection of SpaceOAR HydrogelNo drug interventionsNot AvailableNot Availablecompleted
NCT01660152
Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing SurgeryNo drug interventionssupportive_careNot Availablecompleted
NCT01705652
Study to Assess the Activity of Nexrutine® in Prostate Cancer Patientstreatment2terminated
NCT04863352
Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part I and IIANo drug interventionsNot AvailableNot Availablecompleted
NCT04560452
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03103152
A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progressionprevention2 / 3completed
NCT05597852
Using Rectal Hydrogel Spacer for Salvage SABR in Prostate CancerNo drug interventionsdevice_feasibilityNot Availablerecruiting
NCT00763152
CMT-07-08: The PROstate Bed Evaluation StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00084552
Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05610852
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused UltrasoundNo drug interventionstreatmentNot Availablerecruiting
NCT00284752
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancertreatment2completed
NCT00014352
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancertreatment2completed
NCT03525652
Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer TreatmentNo drug interventionstreatment1 / 2unknown_status
NCT02840552
The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancerdiagnostic3completed
NCT00122252
Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose EscalationNo drug interventionsNot AvailableNot Availableterminated
NCT05627752
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stagetreatment2 / 3recruiting
NCT04377152
Expanded Access 68Gallium-PSMA-11 PET for Prostate CancerNot AvailableNot Availableapproved_for_marketing
NCT03957252
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02070952
CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT01996852
Improving Erectile Function and Quality of Life After Prostate Cancer Treatmentsupportive_careNot Availableterminated
NCT06402552
Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening AccuracyNo drug interventionsdiagnosticNot Availablerecruiting
NCT03211052
A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alonetreatment2terminated
NCT05123300
PRISMA-PET - Primary Staging of Prostate Cancer With PSMANo drug interventionsdiagnosticNot Availablerecruiting
NCT04037800
An RCT to Compare Early Continence Recovery After RARP With or Without Sustainable Functional Urethral ReconstructionNo drug interventionstreatmentNot Availablecompleted
NCT05614700
Prostate Reirradiation Toxicity Outcomes Feasibility StudyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01943500
Collection of Blood Specimens for Circulating Tumor Cell AnalysisNo drug interventionsNot AvailableNot Availablecompleted
NCT05306600
Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health SystemNo drug interventionsNot AvailableNot Availablerecruiting
NCT02130700
Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancertreatment2completed
NCT00003400
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT00963300
MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation TherapyNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00548600
Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the ProstateNo drug interventionstreatment3completed
NCT05539300
PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - EnzalutamideNo drug interventionsdiagnosticNot Availablerecruiting
NCT03809000
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgerytreatment2active_not_recruiting
NCT05705700
Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)treatment2withdrawn
NCT00754000
The AIM Study: Assessing the Impact of Margin ReductionNo drug interventionsNot AvailableNot Availablecompleted
NCT05929300
A Yoga Program for Patients Undergoing Prostate Cancer SurgeryNo drug interventionspreventionNot Availableenrolling_by_invitation
NCT05600400
Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00052000
A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancertreatment1completed
NCT00925600
Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Losssupportive_care3completed
NCT05010200
The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting.prevention1recruiting
NCT01567800
Prostate Hypoxia FAZANo drug interventionsdiagnosticNot Availablerecruiting
NCT01748500
Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancertreatment2completed
NCT04124900
Telomere Associated Variables (TAVs) in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00133900
Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving ChemotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00140400
Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate CancerNo drug interventionstreatment1 / 2completed
NCT04742959
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumorstreatment1 / 2completed
NCT02608359
A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate CancerNot AvailableNot Availablewithdrawn
NCT00959959
ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancertreatment1completed
NCT05582759
Sleep Hygiene Education, ReadiWatchTM Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia Effect, on Symptom Relief for Men With Prostate Cancer Receiving Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT00006359
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT02271659
Medical and Economic Evaluation for Intermediate-risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT05078359
Optimizing Positive Predicting Value of Prostate MRINo drug interventionsNot AvailableNot Availableunknown_status
NCT03177759
Living With Prostate Cancer (LPC)No drug interventionsNot AvailableNot Availablecompleted
NCT00081159
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastasestreatment2completed
NCT00027859
Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancertreatment3completed
NCT06200259
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot PlacementNo drug interventionstreatmentNot Availablerecruiting
NCT03327675
High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT02268175
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostatetreatment2completed
NCT00005075
Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate CancerNo drug interventionstreatment3terminated
NCT00303875
Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are OverweightNo drug interventionsother2completed
NCT04116775
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.treatment2unknown_status
NCT05116475
Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastasestreatment3recruiting
NCT06313775
Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral OrchiectomyNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT06424275
Prostate Cancer Awareness and Initiative for Screening in the European UnionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02035475
Prevention of Lymphoceles After Robotic PLNDNo drug interventionspreventionNot Availablecompleted
NCT02132975
Motorised Probe Holder Assisting Prostate BiopsiesNo drug interventionsNot AvailableNot Availablecompleted
NCT02825875
Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00241475
Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapytreatment2completed
NCT01191775
A Study of PNT2258 in Patients With Advanced Solid Tumorstreatment1completed
NCT04441775
Artificial Intelligence for Prostate Cancer Treatment PlanningNo drug interventionsNot AvailableNot Availablecompleted
NCT01505075
Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate CancerNo drug interventionstreatment1 / 2unknown_status
NCT02742675
Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)treatment2unknown_status
NCT02070575
Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical RecurrenceNo drug interventionsNot AvailableNot Availablecompleted
NCT04692675
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate CancerNo drug interventionsotherNot Availablerecruiting
NCT02105675
Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancertreatment2completed
NCT05350475
Protons vs. Photons for High-risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05167175
The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutationtreatment2recruiting
NCT00423475
Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancertreatment3completed
NCT00036075
Study Using CP-461 to Treat Advanced Prostate CancerNo drug interventionstreatment2completed
NCT01480375
A Novel 3D Navigation Technology for Improved TRUS Prostate BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT00683475
A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancertreatment2completed
NCT05938270
A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.basic_science1recruiting
NCT00073970
Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomytreatment2terminated
NCT06312670
Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancertreatment2recruiting
NCT05700370
MyProstateScore Equivalency With and Without DRENo drug interventionsscreeningNot Availableenrolling_by_invitation
NCT03543670
Evaluation of Oncoxin-Viusid® in Prostate CancerNo drug interventionssupportive_care2completed
NCT00450970
Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)treatment3terminated
NCT03862170
Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancerprevention3suspended
NCT06217770
Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT01964170
A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancertreatment3completed
NCT02724670
Study of MR-based IGRT for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT02237170
Immune Monitoring on Sipuleucel-TNo drug interventionsNot AvailableNot Availablecompleted
NCT00072670
A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancertreatment2completed
NCT06096870
Enzalutamide and M9241 in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapytreatment2recruiting
NCT03933670
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active SurveillanceNo drug interventionsdiagnostic2recruiting
NCT02185170
DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral ResectionsNo drug interventionsdiagnosticNot Availableterminated
NCT06398470
Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal MicroscopyNo drug interventionsdevice_feasibility1 / 2recruiting
NCT01410942
Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapytreatment2active_not_recruiting
NCT01394042
Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScintNo drug interventionsdiagnostic0unknown_status
NCT04035642
Phase II Study of Single-Dose Image-Guided Radiotherapy (SDRT) for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT02747342
A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancertreatment1completed
NCT05366842
Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of CareNo drug interventionstreatment2recruiting
NCT01729442
Assessment of HIFU-induced Prostate Necrosis With Shear-wave Ultrasound ElastographyNo drug interventionsdiagnosticNot Availablecompleted
NCT03496142
Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic InfectionsNo drug interventionspreventionNot Availableunknown_status
NCT01737242
UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics StudiesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01802242
Tumor TARGET Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04053842
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomyNo drug interventionsdiagnostic2recruiting
NCT04748042
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)treatment2recruiting
NCT01901042
Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis SymptomsNo drug interventionsprevention2 / 3completed
NCT00312442
Phase II/III Study of WST09 in Prostate Cancer After Radiation TherapyNo drug interventionstreatment2 / 3terminated
NCT04430842
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SNo drug interventionstreatment1completed
NCT04107142
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid TumourNo drug interventionsother1unknown_status
NCT01959542
Early Changes In Multiparametric MRI In Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT05613842
Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP)diagnostic2completed
NCT04889742
Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsNo drug interventionstreatment2not_yet_recruiting
NCT01050842
Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancertreatment0completed
NCT00129142
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapyprevention3completed
NCT04221542
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancertreatment1recruiting
NCT00216099
Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancertreatment2completed
NCT03689699
Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)treatment1 / 2active_not_recruiting
NCT04239599
Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT03700099
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamidetreatment2active_not_recruiting
NCT00691899
A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)prevention3withdrawn
NCT01191099
Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic SignificanceNo drug interventionsNot AvailableNot Availableunknown_status
NCT01132599
Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate CancerNo drug interventionsdiagnostic2withdrawn
NCT00027599
APC8015 and Bevacizumab in Treating Patients With Prostate Cancertreatment2completed
NCT02463799
Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPCtreatment2completed
NCT00630799
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patientssupportive_care3terminated
NCT05690399
Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00022399
Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancerprevention2completed
NCT01083199
Global Performance Evaluation of the AMS CONTINUUM™ DeviceNo drug interventionstreatment4completed
NCT00313599
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT01844999
Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care NetworksNo drug interventionsotherNot Availablecompleted
NCT04337099
A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate CancerNot AvailableNot Availableavailable
NCT02844699
A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancertreatment1 / 2unknown_status
NCT06144099
Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgerytreatment4not_yet_recruiting
NCT03911999
Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00122499
A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancertreatment3completed
NCT06235099
Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancerdiagnostic3recruiting
NCT05518799
CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid TumoursotherNot Availablecompleted
NCT03518606
Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumourstreatment1 / 2active_not_recruiting
NCT00032006
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate CancerNo drug interventionstreatment2completed
NCT06450106
Study of STM-416p Administered to Patients Undergoing Radical ProstatectomyNo drug interventionstreatment1not_yet_recruiting
NCT02799706
Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancertreatment3active_not_recruiting
NCT00578006
Internet-based System for Cancer Patients to Self-report ToxicityNo drug interventionsNot AvailableNot Availablecompleted
NCT00601406
Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological CancerNo drug interventionstreatmentNot Availableunknown_status
NCT03380806
Prostate Boost Irradiation With Stereotactic Body RT (SBRT)treatment2unknown_status
NCT05525806
Clinical Utility Study for MyProstateScore+No drug interventionsdiagnosticNot Availablecompleted
NCT05252806
Quantitative mpMRI to Predict Metastatic Potential of Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00255606
Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancertreatment3completed
NCT01423006
Pilot Study on Focal Prostate Radio-Frequency AblationNo drug interventionstreatmentNot Availablecompleted
NCT06179706
11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients.No drug interventionsNot AvailableNot Availablecompleted
NCT03982706
Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and CryotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04293406
pCHIP: Prostate Cancer Health Impact ProgramNo drug interventionsNot AvailableNot Availableterminated
NCT05245006
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate CancerNo drug interventionsdiagnostic1recruiting
NCT05819606
Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03011606
Robotic Surgery After Focal Ablation TherapyNo drug interventionstreatmentNot Availablecompleted
NCT00282906
FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT02218606
Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancertreatment2completed
NCT04147806
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancertreatment2active_not_recruiting
NCT01615406
A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate CancerNo drug interventionsdiagnostic1completed
NCT00374049
MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate CancerNo drug interventionstreatment1completed
NCT06430749
Targeted Microwave Tissue Coagulation for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04638049
Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT)No drug interventionsbasic_scienceNot Availablecompleted
NCT02311049
Hypofractionated Radiotherapy for Prostate CancerNo drug interventionstreatment2completed
NCT02009449
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumorstreatment1active_not_recruiting
NCT02295449
Quantitative Prostate Cancer Contrast-enhanced UltrasoundNo drug interventionsdiagnosticNot Availableunknown_status
NCT00117949
Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486treatment2completed
NCT00537849
Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in CanadaNo drug interventionstreatmentNot Availablewithdrawn
NCT05519449
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)No drug interventionstreatment1recruiting
NCT01521949
Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSANo drug interventionstreatment2completed
NCT00744549
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active SurveillanceNo drug interventionstreatment2completed
NCT02911649
Reducing Sedentary Behaviour With TechnologyNo drug interventionssupportive_careNot Availablecompleted
NCT04658849
Insulin Resistance Following ADT for Prostate CAtreatment0withdrawn
NCT02564549
MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate CaNo drug interventionsdiagnosticNot Availableterminated
NCT02460549
Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen DeprivationNo drug interventionssupportive_careNot Availablecompleted
NCT03639649
STHLM3 - Prostate Cancer Diagnostic TrialNo drug interventionsdiagnosticNot Availablecompleted
NCT01477749
Sipuleucel-T Manufacturing Demonstration StudyNot Available2completed
NCT00458549
Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or SurgeryNo drug interventionsbasic_scienceNot Availableterminated
NCT02957149
Platelet Rich Plasma During Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT02110849
Prostate Cancer Parameters for Patients Receiving Proton TreatmentNo drug interventionsNot AvailableNot Availablewithdrawn
NCT06433349
A Multi-center Investigation of Family Health.No drug interventionsNot AvailableNot Availablerecruiting
NCT00207636
Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer ScreeningNo drug interventionseducational_counseling_training3unknown_status
NCT02911636
5 Fractions of Pelvic SABR With Intra Prostatic SABRNo drug interventionstreatmentNot Availableunknown_status
NCT04891536
Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation TherapyNo drug interventionstreatmentNot Availablerecruiting
NCT02043236
Strategies to Improve Bone Health in Men on ADTNo drug interventionspreventionNot Availablecompleted
NCT06355336
Real World Prostate Cancer RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT03098836
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancertreatment2active_not_recruiting
NCT06549036
Veteran Peer Navigators to Promote Shared Decision Making for PSA ScreeningNo drug interventionsscreeningNot Availablenot_yet_recruiting
NCT01794936
Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate SurgeryNo drug interventionsdiagnosticNot Availableterminated
NCT01667536
A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathologydiagnostic2completed
NCT04563936
Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®treatment3completed
NCT01644136
Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate CancerNo drug interventionssupportive_careNot Availableterminated
NCT02470936
Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8No drug interventionssupportive_careNot Availablecompleted
NCT05455736
STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence After prostatectomy-a Prospective Observational StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01655836
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment1active_not_recruiting
NCT01733836
Prostate Cancer Active Surveillance Metformin Trialtreatment2withdrawn
NCT06573736
Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered ValidationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01009736
Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing ProstatectomyNo drug interventionstreatment1 / 2completed
NCT00214136
Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic NodesNo drug interventionstreatment2completed
NCT04452136
Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate CancerNot AvailableNot Availableapproved_for_marketing
NCT00686036
Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapytreatment2terminated
NCT00544336
Family Quality of Life Among Families With a Member Who is a Cancer PatientNo drug interventionsNot AvailableNot Availablecompleted
NCT05343936
Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian PopulationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04982536
Assessment of VMCore Biopsy Versus Standard of Care BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT02059213
A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancertreatment2completed
NCT01827813
Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate BiopsiesNo drug interventionsdiagnosticNot Availablecompleted
NCT04832113
Impact of Patient's Therapeutic Education in APA and Dietetic on Radiotherapy Reproducibility Sessions for Prostate CancerNo drug interventionsotherNot Availablerecruiting
NCT06398613
Preoperative PSMA PET/CT as Triage for ePLND in Patients Scheduled for RALP (PrePSMA)No drug interventionstreatmentNot Availablerecruiting
NCT01371513
Korean Practice Patterns for Screening PCA(Prostate Cancer)No drug interventionsNot AvailableNot Availablecompleted
NCT02514213
Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancertreatment1completed
NCT01619813
Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancertreatment2completed
NCT05879913
ASCVD Management Using CCTA in Prostate Cancer Patients on ADTNo drug interventionsdiagnosticNot Availablerecruiting
NCT02108613
Living Well on Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablewithdrawn
NCT01215513
Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patientstreatment3completed
NCT03857113
Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT06303713
LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancertreatment1recruiting
NCT03084913
Olive Oil v Prostate Cancer Foundation Diet for Treatment of Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00345813
Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate CancerNo drug interventionstreatment2completed
NCT01176513
GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancerdiagnostic2terminated
NCT01059513
Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02726113
Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomybasic_science2completed
NCT03031613
Effects of PEEP on Intracranial and Intraocular Pressure in Robot-assisted Laparoscopic Radical ProstatectomyNo drug interventionspreventionNot Availableunknown_status
NCT01995513
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patientstreatment4completed
NCT03424213
Race-related Alternative Splicing: Novel Targets in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02494713
Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancertreatment2terminated
NCT01072513
Semen Analysis After Proton Therapy for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03502213
Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active SurveillanceNo drug interventionsNot AvailableNot Availablecompleted
NCT04782713
Smart Prostate Specific Antigen (PSA) Screening StudyNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT05790213
Focal Prostate Ablation With Androgen Deprivation and Novel Hormonal Therapy for Intermediate Risk Prostate Cancertreatment2suspended
NCT01119118
ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancertreatment2terminated
NCT01745718
Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT06059118
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancertreatment2recruiting
NCT00967018
A Long Term Safety Study of Degarelix in Patients With Prostate Cancertreatment3completed
NCT00911118
Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate CancerNo drug interventionstreatment1active_not_recruiting
NCT02036918
Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancerother1completed
NCT01851018
Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard TreatmentNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05982418
Improvement of RARP Outcomes Via 3D Printed/Virtual Prostate ModelsNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06440018
INSPIRE: A Multi-Cancer Early Detection StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00808418
A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancertreatment1completed
NCT04599218
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT04924218
Evaluation of the Effect of Endoscopic Urethral Procedures Applied After Radical Prostatectomy on Urinary IncontinenceNo drug interventionspreventionNot Availablecompleted
NCT00922818
Study of Anatomic Nerve Sparing Radical Perineal ProstatectomyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00111618
Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancertreatment2completed
NCT01229618
Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancerdiagnostic1completed
NCT04882618
Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.treatment4unknown_status
NCT00554918
Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapytreatment2completed
NCT02905318
Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancertreatment2active_not_recruiting
NCT01314118
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigentreatment2active_not_recruiting
NCT00106418
A Research Study for Patients With Prostate Cancertreatment2completed
NCT00510718
A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancertreatment1completed
NCT02489318
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPCtreatment3active_not_recruiting
NCT05804318
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00925418
Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate CancerNo drug interventionsprevention3completed
NCT02570919
Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00003819
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancertreatment1completed
NCT03388619
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy RadiotherapyNo drug interventionstreatment1active_not_recruiting
NCT00006019
Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancertreatment2completed
NCT00984919
Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy VolunteersNo drug interventionsNot AvailableNot Availablecompleted
NCT06144619
Non-Invasive Biomarkers in Prostate Cancer Disease ManagementNo drug interventionsNot AvailableNot Availablerecruiting
NCT00450619
153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancertreatment2completed
NCT01411319
MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05702619
Hypoxia-driven Prostate Cancer Genomics (HYPROGEN)Not AvailableNot Availablerecruiting
NCT00219219
Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastasestreatment4completed
NCT03500419
Penile Length Maintenance Post-ProstatectomyNo drug interventionstreatmentNot Availablecompleted
NCT05285319
Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate CancerNo drug interventionstreatment2unknown_status
NCT06001619
Prostate Medication, Metabolism and Gut Microbiotaother4recruiting
NCT06457919
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancertreatment1 / 2recruiting
NCT03588819
Stereotactic MRI-Guided Radiation for Localized Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT02353819
Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate CancerNo drug interventionstreatment1active_not_recruiting
NCT04595019
Hypofractionated Expedited Radiotherapy for Men With localisEd proState CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00949819
Active Surveillance for Cancer of the Prostate (ASCaP)No drug interventionsNot AvailableNot Availablerecruiting
NCT06509919
Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00879619
Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patientstreatment1 / 2terminated
NCT01520441
BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)diagnostic0withdrawn
NCT00048841
Prevention of Osteoporosis in Men With Prostate Cancerprevention3completed
NCT00562341
Effect of Lap-Band Induced Weight Loss on Serum PSA LevelsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03410641
Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02680041
18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatmentdiagnostic3completed
NCT04831541
68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancerdiagnostic0recruiting
NCT04243941
PSMA-PET/MRI Low- and Intermediate-Risk Prostate CancerNo drug interventionstreatment2withdrawn
NCT05751941
Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancertreatment2recruiting
NCT03569241
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer MetastasesNo drug interventionstreatment2active_not_recruiting
NCT00667641
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumorstreatment1completed
NCT03783741
The Biopsychosocial Burden of Prostate BiopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT06511141
Sacral Neuromodulation for Male Overactive Bladder (MOAB)No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05489341
Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI ChallengeNo drug interventionsNot AvailableNot Availablecompleted
NCT04292041
Fasting Mimicking Diet in Prostate Cancer and Metabolic SyndromeNo drug interventionsNot AvailableNot Availableunknown_status
NCT00850941
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00182741
Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT06579417
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02003417
Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00035217
Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening ProgramNo drug interventionsNot AvailableNot Availablecompleted
NCT05781217
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624treatment3recruiting
NCT04045717
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0No drug interventionstreatment2active_not_recruiting
NCT00617617
The Specific Role of Isoflavones in Reducing Prostate Cancer RiskNo drug interventionsprevention2completed
NCT06150417
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)No drug interventionstreatment2recruiting
NCT00877617
Quality of Life in Men With High Risk Localized Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00400517
GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancertreatment2completed
NCT01250717
Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancertreatment2completed
NCT03554317
COMbination of Bipolar Androgen Therapy and Nivolumabtreatment2completed
NCT04769817
ProsTIC Registry of Men Treated With PSMA TheranosticsNo drug interventionsNot AvailableNot Availablerecruiting
NCT02220517
Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT04242017
Long-term Better Than Short-term ADT With Salvage RTtreatment2 / 3recruiting
NCT04357717
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy SettingNo drug interventionsNot AvailableNot Availableterminated
NCT00003717
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancertreatment2unknown_status
NCT03949517
68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapytreatment1 / 2completed
NCT06504017
FUS-TB VS COG-TB in Small Lesions of Prostate CancerNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT02344017
Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancertreatment1 / 2completed
NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myelomatreatment1recruiting
NCT05555017
Tracer-Guided Surgery for Recurrent Prostate CancerNo drug interventionstreatment2recruiting
NCT03961217
Return to Work Among Cancer Survivors With Treatment-induced Survivorship SyndromesNo drug interventionsNot AvailableNot Availablecompleted
NCT04158817
68Ga-THP-PSMA PET/CT in Prostate Cancer: Clinical Stage and RestageNo drug interventionsdiagnostic0completed
NCT00313534
Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancertreatment1terminated
NCT00003734
Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancertreatment3unknown_status
NCT00005634
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapytreatment1completed
NCT00425334
Safety Study of Hemospan® in Prostatectomy Patientstreatment2completed
NCT06523634
Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05751434
A Study on the Effects of Exercise Therapy on Signs of Prostate CancerNo drug interventionstreatment2recruiting
NCT03458234
RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body RadiotherapyNo drug interventionstreatmentNot Availableterminated
NCT00335634
Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT00928434
A Study of Degarelix in Patients With Prostate Cancertreatment3completed
NCT03753334
Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.treatment2recruiting
NCT03308734
Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT00339534
Survey of Prostate Cancer in Accra, GhanaNo drug interventionsNot AvailableNot Availablecompleted
NCT00336934
Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT04936334
The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate CancerNo drug interventionsdiagnostic2completed
NCT00352924
Agriculture Health StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03927924
High-intensity Focused Ultrasound StudyNo drug interventionstreatmentNot Availableterminated
NCT00464724
3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of ProstateNo drug interventionsdiagnosticNot Availableterminated
NCT00039624
Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate CancerNo drug interventionstreatment2completed
NCT00462124
Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing RadiotherapyNo drug interventionspreventionNot Availablecompleted
NCT01040624
Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00203424
Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinibtreatment2completed
NCT02232724
Choline PET/CT vs. Dual Time Point FDG PET/CT in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT05156424
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate CancerNo drug interventionshealth_services_research1 / 2unknown_status
NCT03296124
Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)No drug interventionsNot AvailableNot Availablewithdrawn
NCT00455624
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03492424
Ablative Therapy in the Management of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05497024
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability TestingNo drug interventionsNot AvailableNot Availablerecruiting
NCT00003124
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancertreatment2completed
NCT00002924
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT03784924
EDRN Prostate MRI Biomarker StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06167824
Assessment of Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure Without Androgen Deprivation TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00228124
PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body CompositionNo drug interventionsNot AvailableNot Availableunknown_status
NCT02003924
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancertreatment3active_not_recruiting
NCT00167024
Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical OutcomeNo drug interventionsNot AvailableNot Availableunknown_status
NCT01867424
Gadoxetate Enhanced Imaging Study to Detect Prostate Cancerdiagnostic2completed
NCT04694924
Prospective Prostate Cancer and Patient-reported Outcomes RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT04341324
Effect of ADT in Chinese Male With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00004124
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancertreatment3completed
NCT04852224
Strength, Aging, and Memory in Prostate CancerNot AvailableNot Availablecompleted
NCT04763824
KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural PracticeNo drug interventionshealth_services_researchNot Availablecompleted
NCT03383016
Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03869216
Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American MenNo drug interventionspreventionNot Availablecompleted
NCT02818816
Preoperative Brimonidine on IOP of Patients Undergoing RALPtreatment4completed
NCT04556916
Early Detection of Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT00685516
Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT03080116
Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomytreatment2active_not_recruiting
NCT02055716
Sulforadex in Healthy Human Males MADtreatment1completed
NCT00923416
Trans-Rectal Ultrasound-Guided (TRUS) Adverse EventsNo drug interventionsNot AvailableNot Availablecompleted
NCT02426216
Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer ChemopreventionNo drug interventionsNot AvailableNot Availableunknown_status
NCT02935816
Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniquesNo drug interventionsNot AvailableNot Availableunknown_status
NCT05681416
Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate CancerNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT05815316
18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate CancerNo drug interventionsdiagnostic2not_yet_recruiting
NCT02790216
Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate BrachytherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03384316
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancertreatment1completed
NCT00447616
Prostatectomy Prospective DatabaseNo drug interventionsNot AvailableNot Availableterminated
NCT02834416
ADT Exercise Trial and Economic AnalysisNo drug interventionssupportive_care3completed
NCT00348816
Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancertreatment2terminated
NCT01547416
The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Functiontreatment4completed
NCT00025116
ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT00034216
Collection of Blood From Patients With CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01864096
The Metformin Active Surveillance Trial (MAST) Studytreatment3active_not_recruiting
NCT02745496
Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT04662996
Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAsNo drug interventionsotherNot Availableactive_not_recruiting
NCT04565496
Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patientstreatment2unknown_status
NCT02946996
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation TherapyNo drug interventionstreatment2terminated
NCT03674996
Safety and Security Evaluation of Patients Submitted to Minimally Invasive Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT03836196
Optimizing Prostate Cancer Treatment in Men With Advanced Local DiseaseNo drug interventionshealth_services_researchNot Availablerecruiting
NCT06117696
Optimizing the Announcement of Advanced or Metastatic Prostate Cancer Using Animated Videos (CartDiag PROSTATE)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00726596
Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancertreatment2completed
NCT06489496
Prostate Cancer 18F-PSMA-1007 PET/CT Access TrialNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02376296
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer PatientsNot AvailableNot Availablecompleted
NCT02488096
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT01414296
Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate CancerNo drug interventionstreatment1completed
NCT06555796
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancertreatment1not_yet_recruiting
NCT00050596
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancertreatment2completed
NCT06494696
68Ga-PSMA PET/MRI in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer RiskNo drug interventionsNot AvailableNot Availablerecruiting
NCT05415696
Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation TherapyNo drug interventionssupportive_careNot Availablewithdrawn
NCT04068896
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination TherapyNo drug interventionstreatment1 / 2completed
NCT00355758
UCI 03-72 Prostate Cancer Detection by Serum Proteomic ProfilingNo drug interventionsNot AvailableNot Availableterminated
NCT00451958
A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapytreatment3completed
NCT00636558
Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04)treatment1completed
NCT03253458
Focal Prostate Imaging With CLE and OCTNo drug interventionsdiagnosticNot Availableunknown_status
NCT00598858
Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostatetreatment2withdrawn
NCT01706458
Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancertreatment2completed
NCT01560858
Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant StateNo drug interventionsNot AvailableNot Availablecompleted
NCT04359758
Streamlined Genetic Testing in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02321358
Trial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT04604158
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00181558
Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bonetreatment2completed
NCT01686958
Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00909558
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on CancerNo drug interventionstreatment1suspended
NCT02307058
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated RadiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT00809458
Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancertreatment3terminated
NCT06145958
Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) Translational StudyNot AvailableNot Availablenot_yet_recruiting
NCT06200558
ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCaNo drug interventionsNot AvailableNot Availablerecruiting
NCT06166758
Feasibility Study: Educational Genetic Test VideoNo drug interventionssupportive_careNot Availablecompleted
NCT01995058
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancertreatment2terminated
NCT06482658
Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT03075735
Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)No drug interventionsNot AvailableNot Availablecompleted
NCT03255135
Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes.No drug interventionstreatmentNot Availableunknown_status
NCT00955435
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15No drug interventionsNot AvailableNot Availableunknown_status
NCT05709535
PSMA-PET/CT RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT00012935
Treatment Decision Intervention for Veterans With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01864135
Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging and BiomarkersNo drug interventionsdiagnosticNot Availablecompleted
NCT04969835
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursNo drug interventionstreatment1recruiting
NCT02077335
Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT06220435
Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03225235
Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00959335
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditionstreatment1completed
NCT00115635
Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancertreatment1 / 2completed
NCT02761135
Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique?No drug interventionsNot AvailableNot Availablecompleted
NCT01076335
Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancertreatment2completed
NCT00900835
Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00087035
Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancertreatment2completed
NCT01649635
Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancertreatment4completed
NCT00373035
Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate BiopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT04066335
Study to Evaluate the Safety of Nanoxel M Inj.No drug interventionsNot AvailableNot Availableunknown_status
NCT00392535
Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT02333435
Effects of EPA on Prostate Cancer Cells Proliferation and Quality of LifeNo drug interventionstreatment2active_not_recruiting
NCT02020135
An Open-label Extension Study of PSMA ADC 2301 in mCRPCNo drug interventionstreatment2completed
NCT05245435
Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT03345563
Project HERO: Health Empowerment & Recovery OutcomesNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT05918263
Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE TrialNo drug interventionssupportive_careNot Availablerecruiting
NCT05628363
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT02656563
Radium 223 Following Intermittent ADTNo drug interventionstreatment2withdrawn
NCT04706663
Precision-Based Genomics in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00024063
SU006668 in Treating Patients With Advanced Solid Tumorstreatment1unknown_status
NCT04879563
Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE ProjectNo drug interventionssupportive_care2active_not_recruiting
NCT05766163
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - ProstateNo drug interventionsotherNot Availablerecruiting
NCT03970863
Focal Therapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00090363
ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)treatment2completed
NCT02425163
Shear Wave Elastography of Prostate CancerNo drug interventionsdiagnostic2completed
NCT02812186
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgerytreatment4completed
NCT00099086
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancertreatment1completed
NCT01982786
Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT03199586
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignanciestreatment1completed
NCT02411786
A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSFtreatment1completed
NCT03412786
Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node MetastasesNo drug interventionstreatment1completed
NCT05172986
Enhanced Recovery Program After a Robotic-assisted Surgery (RAAC) of Radical Prostatectomy. PROSTA-RAACNo drug interventionstreatmentNot Availablecompleted
NCT06258486
Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic LeaksNo drug interventionstreatment4not_yet_recruiting
NCT02189486
Prostate Cancer Upgrading Reference SetNo drug interventionsNot AvailableNot Availablerecruiting
NCT04886986
Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate Cancertreatment1 / 2suspended
NCT00654186
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patientstreatment2completed
NCT03137186
Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancertreatment2unknown_status
NCT00676286
Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and BiomarkersNo drug interventionsscreening1completed
NCT06081686
Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancertreatment1 / 2recruiting
NCT00151086
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancertreatment1 / 2completed
NCT00459186
The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancertreatment1 / 2completed
NCT03027986
Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After ProstatectomyNo drug interventionstreatmentNot Availableunknown_status
NCT00554086
Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients.treatment2completed
NCT01529086
For Cause Prostate Biopsy in REDUCE Population TrialNo drug interventionsNot AvailableNot Availablecompleted
NCT01483586
Safety and Efficacy of Kanglaite Gelcaps in Prostate CancerNo drug interventionstreatment2terminated
NCT02803086
Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01326286
Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00165386
MRI-guided Bone Marrow Biopsies of Prostate Cancer PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT03879486
Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate BiopsyNo drug interventionspreventionNot Availablecompleted
NCT02057939
Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)treatment2completed
NCT02121639
Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapytreatment1 / 2completed
NCT00005939
Brachytherapy in Treating Patients With Recurrent Prostate CancerNo drug interventionstreatment1 / 2unknown_status
NCT00195039
Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancertreatment2completed
NCT00384839
Vidaza to Restore Hormone Thx Prostatetreatment2completed
NCT00406939
Vector Delivery of the IL-12 Gene in Men With Prostate CancerNo drug interventionstreatment1completed
NCT02453139
Exercise, Prostate Cancer and Circulating Tumour CellsNo drug interventionstreatmentNot Availablecompleted
NCT06398639
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate CancerNo drug interventionsscreeningNot Availablerecruiting
NCT00494039
I-125 Versus Pd-103 for Low Risk Prostate CancerNo drug interventionstreatment3unknown_status
NCT00741039
Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Olderprevention2completed
NCT02649439
Prostvac in Patients With Biochemically Recurrent Prostate CancerNo drug interventionstreatment2completed
NCT04804839
Comparison of the Effectiveness of Different Conservative Treatment Protocols in Postprostatectomy Urinary IncontinenceNo drug interventionstreatmentNot Availablecompleted
NCT03580239
Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiencytreatment3unknown_status
NCT02437539
Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission TomographyNo drug interventionsdiagnostic1completed
NCT00547339
Stereotactic Body Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment1 / 2completed
NCT00341939
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics DataNo drug interventionsNot AvailableNot Availablecompleted
NCT05200039
Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part IIBNo drug interventionsNot AvailableNot Availablecompleted
NCT00054522
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapytreatment2completed
NCT05678322
Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical ProstatectomyNo drug interventionsdiagnostic3recruiting
NCT00651222
Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate BrachytherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00072722
Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)treatment2completed
NCT02960022
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Studytreatment2recruiting
NCT03158922
The BARCODE 1 Pilot StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03225222
MRI in PROstate Cancer Diagnosis With Prior Risk AssessmentNo drug interventionsNot AvailableNot Availablecompleted
NCT05957822
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac SurgeryNo drug interventionstreatment4recruiting
NCT04577222
The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical ProstatectomyNo drug interventionsotherNot Availableunknown_status
NCT02182622
LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxeltreatment1withdrawn
NCT00003622
Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapytreatment2withdrawn
NCT00451022
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT02710422
Miami Membrane for Potency (MMEP) TrialNo drug interventionstreatment2terminated
NCT00132522
EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given CyclophosphamideNo drug interventionstreatment1completed
NCT01562522
Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.No drug interventionssupportive_care2terminated
NCT00919022
Androcur Non-interventional Study Among Patients With Carcinoma of the ProstateNot AvailableNot Availableterminated
NCT03665922
Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate CancerNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT04821622
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCtreatment3active_not_recruiting
NCT01085422
A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancertreatment1completed
NCT00214422
Intensity Modulated Radiation Therapy for Prostate CancerNo drug interventionstreatment0completed
NCT02597725
Salvage Radiotherapy After Radical ProstatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02749825
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancertreatment4terminated
NCT04560725
PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate CancerdiagnosticNot Availableactive_not_recruiting
NCT00166725
Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patientstreatment2completed
NCT00881725
A Study of Pre-operative Metformin in Prostate Cancertreatment2terminated
NCT04541225
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsNo drug interventionstreatment1terminated
NCT00551525
Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancertreatment2completed
NCT06040125
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE TrialNo drug interventionssupportive_careNot Availablerecruiting
NCT06536725
Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral MetastasisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04346225
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate CancerNo drug interventionstreatment2recruiting
NCT00465725
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumorstreatment1completed
NCT01353625
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.treatment1completed
NCT02225925
Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and UltrasoundNo drug interventionstreatmentNot Availablecompleted
NCT04357925
Quality of Life in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03232125
Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg PositionpreventionNot Availablecompleted
NCT00155025
Family History in Prostate Cancer Patients in TaiwanNo drug interventionsNot AvailableNot Availableunknown_status
NCT04305925
Focal Laser Ablation of Prostate CancerNo drug interventionstreatment0active_not_recruiting
NCT03623425
Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancerdiagnostic3unknown_status
NCT05722925
Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PETdiagnostic4recruiting
NCT00084825
Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008treatment2completed
NCT01013025
Vantas Implant Retrieval StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00953225
Vitamin D Supplementation in Veterans With Early-Stage Prostate Cancertreatment2completed
NCT02107430
Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate CancerNo drug interventionstreatment2completed
NCT00988130
High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate CancerNo drug interventionstreatment2unknown_status
NCT05856630
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mgtreatment1not_yet_recruiting
NCT00582530
Men Undergoing Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT05720130
Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Castration Resistant Prostate Cancer (TheraPb - Phase I/II Study).No drug interventionstreatment1 / 2recruiting
NCT04175730
Prostate Cancer Detection Screening MRI ProtocolNo drug interventionsscreeningNot Availablecompleted
NCT04356430
Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancertreatment2unknown_status
NCT01424930
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancertreatment2completed
NCT00006430
A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNANo drug interventionstreatment1unknown_status
NCT01105130
L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivorssupportive_care2completed
NCT00104130
Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancertreatment2terminated
NCT01501630
Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01393730
Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancertreatment2completed
NCT05799248
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical ManagementNo drug interventionsdiagnostic3recruiting
NCT05732948
PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancertreatment1recruiting
NCT00731848
Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate CancerNo drug interventionstreatment2unknown_status
NCT01194648
Focal Therapy for Prostate Cancer Using HIFUNo drug interventionstreatmentNot Availablerecruiting
NCT02651948
Transperineal, MRI-guided, Prostate BiopsyNo drug interventionsdiagnostic4completed
NCT03152448
Prospective Prolaris Value and EfficacyNo drug interventionsNot AvailableNot Availableterminated
NCT00005048
Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapytreatment1completed
NCT02016248
Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05346848
Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancertreatment2recruiting
NCT02503748
Prostate Cancer E-Health-TutorialNo drug interventionshealth_services_researchNot Availablecompleted
NCT04633148
Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Markertreatment1terminated
NCT01242748
A Degarelix Trial in Patients With Prostate Cancertreatment3terminated
NCT01163448
Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic CancerNo drug interventionstreatment1withdrawn
NCT02653248
SBRT for Organ Confined Prostate CancerNo drug interventionstreatment1completed
NCT01000948
A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancertreatment2terminated
NCT03396848
Sexual Health and Rehabilitation eClinic (SHAReClinic)No drug interventionssupportive_careNot Availableunknown_status
NCT01045148
CyberKnife Radiosurgery for Localized Prostatic CarcinomaNo drug interventionstreatment2unknown_status
NCT03558048
The Effect of IBD Flares on Serum PSANo drug interventionsNot AvailableNot Availablerecruiting
NCT02739048
Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation.No drug interventionsNot AvailableNot Availableunknown_status
NCT00243048
Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT00653848
Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapytreatment3unknown_status
NCT03786848
Personalized Mini-PDX for Metastatic CRPCNo drug interventionstreatmentNot Availableunknown_status
NCT00482157
Calcitriol or Placebo in Men for Prostate Cancer Active SurveillancetreatmentNot Availablewithdrawn
NCT02113657
T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancertreatment0completed
NCT05948657
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancErNo drug interventionsdiagnosticNot Availablerecruiting
NCT06399757
A Study to Investigate APL-5125 in Adults With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT03998657
Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate LesionsNo drug interventionstreatmentNot Availableunknown_status
NCT00653757
Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancertreatment1 / 2completed
NCT00450957
Lycopene in Healthy Male ParticipantsNo drug interventionsprevention1completed
NCT01398657
Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate CancerNo drug interventionstreatment3unknown_status
NCT02325557
ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)treatment1 / 2completed
NCT00049257
Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT06463457
Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)treatment2not_yet_recruiting
NCT06542757
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided RadiotherapyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00872157
BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone MetsNo drug interventionstreatment1completed
NCT02985957
A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)treatment2active_not_recruiting
NCT05197257
68Ga-PSMA-11 PET in Patients With Prostate CancerNo drug interventionsdiagnostic3completed
NCT01784757
Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancerbasic_science1completed
NCT00757757
A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastasestreatment1 / 2terminated
NCT03489057
Efficacy of a Couple-Focused mHealth Symptom Self-management ProgramNo drug interventionssupportive_careNot Availablecompleted
NCT00977457
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing SurgeryNo drug interventionsdiagnostic1active_not_recruiting
NCT01193257
Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.treatment3completed
NCT03235557
CyberKnife for Prostate Cancer Patients Aged 70 y or MoreNo drug interventionsNot AvailableNot Availablecompleted
NCT02388126
Prostate Magnetic Resonance Imaging in Patient With Previous Negative BiopsiesNo drug interventionsdiagnosticNot Availablecompleted
NCT00046826
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapytreatment2completed
NCT00003026
Hormone Therapy in Treating Patients With Advanced Prostate Cancertreatment3completed
NCT02346526
A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancertreatment2completed
NCT01136226
Evaluate Recovery of Testosterone for Patients Using Eligardtreatment4completed
NCT01045226
Proton Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT00933426
Lenalidomide and Paclitaxel in Prostate Cancertreatment1terminated
NCT00604526
High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam RadiotherapyNo drug interventionstreatment1completed
NCT00651326
Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancertreatment3terminated
NCT01176526
The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer DiagnosisNo drug interventionsNot AvailableNot Availablecompleted
NCT04462926
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly DiagnosedNo drug interventionsdiagnosticNot Availablerecruiting
NCT00003626
Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapytreatment2completed
NCT02871726
Transrectal Ultrasound Robot-Assisted Prostate BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT03237026
Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03313726
The Effect of ADT on PSMA-PET.diagnosticNot Availableunknown_status
NCT00898326
PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05258526
Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study)No drug interventionstreatmentNot Availableunknown_status
NCT01516866
Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00085566
Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancertreatment1 / 2completed
NCT04063566
ReIMAGINE Prostate Cancer ScreeningNo drug interventionsscreeningNot Availablecompleted
NCT00952666
Transrectal Ultrasound Imaging of the Prostate Gland and Neurovascular Bundles During Robot-Assisted Laparoscopic Radical ProstatectomyNo drug interventionstreatment0terminated
NCT00782366
Predictive Genetic Risk Assessment TrialNo drug interventionsNot AvailableNot Availablecompleted
NCT00118066
Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial NeoplasiaNo drug interventionsprevention2terminated
NCT00270166
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapytreatment3completed
NCT01707966
Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapytreatment3completed
NCT06229366
[Ac-225]-PSMA-62 Trial in Biochemically Recurrent and Metastatic Castration Resistant Prostate CancerNo drug interventionstreatment1recruiting
NCT01744366
One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Populationtreatment3completed
NCT01100866
Study of POMELLA™ Extract to Treat Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT02450266
Study Comparing MRI/Ultrasound Fusion-guided Prostate Biopsy Versus Systematic Transrectal Ultrasound-guided BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT01230866
Study of Hypo-fractionated Proton Radiation for Low Risk Prostate CancerNo drug interventionstreatment3active_not_recruiting
NCT04558866
Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)treatment2active_not_recruiting
NCT02376166
Metformin for Rising PSA Remote TrialotherNot Availablecompleted
NCT03635866
PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT00895466
Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer PatientsNo drug interventionsNot Available1 / 2unknown_status
NCT00381966
Study of Robotic Template Guidance for Needle Placement in Transperineal Prostate BrachytherapyNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT00245466
Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patientstreatment2terminated
NCT00258466
Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate CancerNo drug interventionstreatment3withdrawn
NCT00124566
Study of Irofulven in Patients With Hormone-refractory Prostate Cancertreatment2completed
NCT00771966
Radical Prostatectomy and Perioperative Fluid TherapyNo drug interventionstreatment4completed
NCT02883166
Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intaketreatment1completed
NCT05847166
A Phase 2/3,PSMA-T4, Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT05753566
Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancertreatment2recruiting
NCT01804465
Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancertreatment2completed
NCT00004065
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancertreatment1completed
NCT03160365
Innovative Planning and Guidance System for Prostate Focal BrachytherapyNo drug interventionsotherNot Availablecompleted
NCT00087165
GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancertreatment2completed
NCT00899665
Proteases in Patients With Prostate Cancer That Has Spread to the BoneNo drug interventionsNot AvailableNot Availablecompleted
NCT02229565
Molecular Mechanisms Underlying Prostate Cancer DisparitiesNo drug interventionsNot AvailableNot Availablecompleted
NCT05851365
Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate CancerNo drug interventionsdiagnostic0recruiting
NCT01094665
MRI Targeted Focal Laser Thermal Therapy of Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05739565
Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer PatientsNo drug interventionspreventionNot Availablerecruiting
NCT05002465
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate CancerNot AvailableNot Availableno_longer_available
NCT03545165
177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPCtreatment1 / 2terminated
NCT00223665
Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancertreatment2completed
NCT00126165
Short-course Hypofractionated Radiotherapy for Localized Prostate CancerNo drug interventionstreatment1 / 2completed
NCT03536065
Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic SurgeryNo drug interventionspreventionNot Availablecompleted
NCT00006365
External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT00348465
Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 SeedsNo drug interventionsNot AvailableNot Availablecompleted
NCT04655365
Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.treatment2recruiting
NCT00375765
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancertreatment4completed
NCT01090765
A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)treatment1 / 2completed
NCT01838265
Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided ManagementNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05246774
Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00898274
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male ParticipantsNo drug interventionsNot AvailableNot Availablecompleted
NCT01511874
Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancertreatment4completed
NCT00692874
Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT03082274
Prospective Validation of Prostate Biomarkers for Repeat BiopsyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05974774
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway InhibitorsNo drug interventionstreatment3not_yet_recruiting
NCT04781374
Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancertreatment2withdrawn
NCT00089674
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancertreatment3completed
NCT00002874
Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomytreatment3completed
NCT00140374
Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)No drug interventionstreatment1 / 2completed
NCT05712174
A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate CancerNo drug interventionsdiagnostic2recruiting
NCT01376674
T-cell-immunity During Standard Radiotherapy in Localised Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01654874
99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404diagnostic1completed
NCT00054574
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancertreatment2completed
NCT04009174
Multi-modality Prostate Cancer Image Guided InterventionsNo drug interventionsdiagnosticNot Availablecompleted
NCT03480074
Staple vs. Suture in Robotic ProstatectomyNo drug interventionstreatmentNot Availablecompleted
NCT04647474
Mental Wellbeing and Quality of Life in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01444820
Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the ProstateNo drug interventionstreatment3unknown_status
NCT00186420
Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiationprevention2completed
NCT02564120
North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)No drug interventionsNot AvailableNot Availablecompleted
NCT02678520
Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer PatientsNot Available2withdrawn
NCT02432820
Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate RadiotherapyNo drug interventionsNot AvailableNot Availableterminated
NCT05179720
The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT00244920
Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancertreatment2withdrawn
NCT00901420
Urodynamic Evaluation in Post-radiation Salvage Prostatectomy PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT00946920
A Trial of Degarelix in Patients With Prostate Cancertreatment3completed
NCT02867020
Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levelstreatment2completed
NCT03002220
Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Statustreatment2completed
NCT01284920
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patientstreatment1 / 2completed
NCT00116220
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancertreatment3completed
NCT06202820
CV CARE: CardioVascular Care in PC PatientsNo drug interventionshealth_services_researchNot Availablerecruiting
NCT01603420
External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancertreatment2 / 3terminated
NCT00589420
Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapytreatment2completed
NCT00002520
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerotherNot Availablecompleted
NCT00594620
Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation TherapyNo drug interventionstreatment2terminated
NCT00264420
Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliationtreatment1completed
NCT00807820
Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR BrachytherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00657982
Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancertreatment2unknown_status
NCT02869282
STUDY OF THE EXPRESSION OF CIRCULATING AND INTRA-TUMORAL CHEMOKINES IN PATIENTS WITH PROSTATE CANCERNo drug interventionsNot AvailableNot Availableunknown_status
NCT00786682
Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancertreatment2terminated
NCT05248282
Clinical Validation of the Prognostic Value of the PrTS on Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04110782
Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad)No drug interventionsNot AvailableNot Availableunknown_status
NCT00849082
Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancertreatment3completed
NCT05382182
Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021No drug interventionsNot AvailableNot Availableunknown_status
NCT00080782
Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastasestreatment2terminated
NCT00560482
Efficacy Study of ABR-215050 to Treat Prostate Cancertreatment2completed
NCT02611882
Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patientsdiagnostic2completed
NCT05540782
A Study of Cognitive Health in Survivors of Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02269982
Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studYNo drug interventionsNot AvailableNot Availablecompleted
NCT03689582
Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancerdiagnostic2terminated
NCT05326282
Evaluating the Role of Ultrasound in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT02826382
Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041No drug interventionsdiagnostic0completed
NCT00063882
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment3completed
NCT01792882
Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood SamplesNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00526331
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative TherapyNo drug interventionstreatment4completed
NCT00242931
Flu/TBI in Treating Patients Not Responding to Previous Hormone TherapyNo drug interventionstreatment2withdrawn
NCT00915031
Use of Hypothermia During Robotic ProstatectomyNo drug interventionspreventionNot Availablecompleted
NCT00059631
Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantronetreatment1completed
NCT00623831
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 AntigenNo drug interventionstreatment1completed
NCT00042731
Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT05318131
Sleep, Exercise, Nutrition and Survivorship in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT03615131
Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00076531
Clinical Trial for Prostate Cancertreatment3completed
NCT01804231
Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00460031
Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapytreatment2completed
NCT00811031
Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)treatment2withdrawn
NCT00055731
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapsetreatment3completed
NCT03091231
Multiparametric Ultrasound-Study for the Detection of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00215631
Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?prevention3terminated
NCT02913131
Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor MalignanciesNo drug interventionsdiagnostic1 / 2terminated
NCT01283373
A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate CancerNo drug interventionstreatment1completed
NCT01878773
Prostate Delineation: High Quality Volume CTNo drug interventionsdiagnosticNot Availablecompleted
NCT03927573
Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA MarkerNo drug interventionstreatment1terminated
NCT01978873
Efficacy Study Evaluating Chemotherapy in Prostate Cancertreatment3unknown_status
NCT00773773
Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With CancerNo drug interventionsdiagnosticNot Availableterminated
NCT01409473
Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate CancerNo drug interventionstreatment2withdrawn
NCT00381173
A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosingtreatment1completed
NCT00738673
Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancertreatment2completed
NCT01220973
Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancertreatment2completed
NCT00758173
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United KingdomNo drug interventionsNot AvailableNot Availableunknown_status
NCT02242773
MRI Based Active Selection for Treatment TrialNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05759273
A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in ItalyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04243473
Biopsy Collection for Men Undergoing Brachytherapy for Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06236373
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio EmiliaNo drug interventionsNot AvailableNot Availablerecruiting
NCT05900973
A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancerdiagnostic2recruiting
NCT00331773
Radiation Therapy in Treating Patients With Stage II Prostate CancerNo drug interventionstreatment3completed
NCT02914873
SPCG17: Prostate Cancer Active Surveillance Trigger TrialNo drug interventionstreatmentNot Availablerecruiting
NCT04903873
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT05120973
Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer.No drug interventionsNot AvailableNot Availablecompleted
NCT02577627
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOCNo drug interventionsNot AvailableNot Availableunknown_status
NCT02659527
PET/MRI in Patients With Suspected Prostate Cancerdiagnostic3completed
NCT03134027
Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) CancersNo drug interventionsNot AvailableNot Availableterminated
NCT06484127
Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05025527
Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled StudyNo drug interventionsscreeningNot Availablenot_yet_recruiting
NCT00670527
[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes MetastasesNo drug interventionsdiagnosticNot Availableunknown_status
NCT00045227
Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT00565227
Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.treatment1terminated
NCT02785627
Assessment of Bone Loss in Men Receiving Treatment for Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00924027
A Study of Patients Receiving High-Dose Rate BrachytherapyNo drug interventionstreatment2active_not_recruiting
NCT00911027
SonoVue Guided Prostate Biopsydiagnostic3terminated
NCT04873427
In Situ Clonal Heterogeneity in Prostatic Diagnostic BiopsiesNo drug interventionsNot AvailableNot Availableterminated
NCT02006927
A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote Regeneration and Erectile FunctionNo drug interventionstreatmentNot Availableterminated
NCT03936127
Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT04271527
Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT05098327
Pioglitazone and Insulin Resistance in ADTtreatment3withdrawn
NCT05553327
Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.No drug interventionstreatmentNot Availablerecruiting
NCT00005827
Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate CancerNo drug interventionstreatment1withdrawn
NCT03495427
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scoresdiagnostic2 / 3recruiting
NCT01220427
Micro-RNA Expression Profiles in High Risk Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT00316927
Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancertreatment3completed
NCT05355727
PROSAIC-DS Study (PROState AI in Cancer - Decision Support)No drug interventionsotherNot Availableunknown_status
NCT00631527
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancertreatment1completed
NCT05797727
Real-Life Pilot Feasibility Study (LC_RLP)No drug interventionsotherNot Availablecompleted
NCT03348527
A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate CancerNo drug interventionstreatment2completed
NCT04808427
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT06546527
Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer(mCRPC)treatment0not_yet_recruiting
NCT05000827
Dutch National Randomized Study: PSMA-PET/CT as a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT05467176
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYXNot AvailableNot Availablerecruiting
NCT02887976
Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201treatment3completed
NCT04661176
Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto RicoNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01940276
Abiraterone Race in Metastatic Castrate-resistant Prostate Cancertreatment2completed
NCT00511576
Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumorstreatment1terminated
NCT02431676
Survivorship Promotion In Reducing IGF-1 Trialprevention2completed
NCT04605276
Threedimensional Multiparametric Ultrasound for Prostate Cancer DetectionNo drug interventionsNot AvailableNot Availablecompleted
NCT00580476
Assessing Depression in a Geriatric Cancer PopulationNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00544076
ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancersupportive_care3terminated
NCT06516276
Technologies to Improve QoL of Prostate CancerNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00169676
Registry and Database Lap ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT02534376
Cellular Effect of Cholesterol-Lowering Prior to Prostate Removalsupportive_care0completed
NCT00987376
Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE CollaborationNo drug interventionsdiagnostic1completed
NCT01691976
Mild Cognitive Impairment in Men Following Androgen DeprivationNo drug interventionsotherNot Availablewithdrawn
NCT03101176
Multiparametric Ultrasound Imaging in Prostate CancerdiagnosticNot Availableunknown_status
NCT02375776
Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health InterventionNo drug interventionssupportive_careNot Availablecompleted
NCT00811876
Retrospective, Non-interventional Study of Depo-Eligard®.No drug interventionsNot AvailableNot Availablecompleted
NCT01828476
Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancertreatment2terminated
NCT00953576
Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancertreatment1 / 2terminated
NCT03205176
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomastreatment1completed
NCT04393376
PSA Glycomics Assay for Early Detection of Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT00846976
Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancertreatment3completed
NCT04394676
The Impact of Low Pressure Pneumo in RARP IINo drug interventionssupportive_careNot Availablerecruiting
NCT02020876
Decision Impact Study to Measure the Influence of DECIPHER on Treatment RecommendationsNo drug interventionsNot AvailableNot Availablecompleted
NCT01417676
DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II StudyNo drug interventionstreatmentNot Availablecompleted
NCT02972060
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancertreatment2active_not_recruiting
NCT03910660
A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.treatment1 / 2active_not_recruiting
NCT02524860
Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion DeviceNo drug interventionsdiagnosticNot Availableunknown_status
NCT03761160
Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT05586360
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancertreatment2recruiting
NCT03594760
PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate CancerNo drug interventionsdiagnostic3recruiting
NCT06279260
National Robotics-Assisted Radical Prostatectomy DatabaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT02138760
Comparison of MRI Fusion Biopsy Techniques in Men With Elevated PSA and Prior Negative Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT01993160
18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate CancerdiagnosticNot Availablecompleted
NCT06380660
Study of ACE-86225106 to Treat Patients With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT00242060
Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT03679260
Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active SurveillanceNo drug interventionstreatment2completed
NCT02903160
Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)treatment2completed
NCT05141760
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer PatientsNo drug interventionsdiagnostic2completed
NCT03203460
Exercise During Active Surveillance for Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT03585660
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT00005960
Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapytreatment2unknown_status
NCT03061760
Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical ProstatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05917860
Neoadjuvant ADT With TULSA in the Treatment of Intermediate Risk Prostate Cancertreatment1recruiting
NCT02382094
Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapyhealth_services_research3completed
NCT03017794
Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following RadiotherapyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05179694
The TRANSLATE TrialNo drug interventionsdiagnosticNot Availableunknown_status
NCT04100694
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorNot AvailableNot Availableavailable
NCT06540794
Evaluating Respiratory Effects of Driving Pressure Guided Mechanical Ventilation Using Electrical Impedance Tomography in Patients Undergoing Robot-Assisted Laparoscopic Radical ProstatectomyNo drug interventionsotherNot Availableenrolling_by_invitation
NCT05736094
Ultrasound for Detection of Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT06568094
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancertreatment1 / 2not_yet_recruiting
NCT04404894
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® TestingNo drug interventionsNot AvailableNot Availablerecruiting
NCT04615494
Internal Carotid Artery Blood Flow in Robot-Assisted Laparoscopic ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT05000294
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Typestreatment1 / 2recruiting
NCT03424694
HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05671094
Implementation of a Multimodal Prehabilitation Program in Robotic Oncological SurgeryNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03744494
Cosmetic Appeal, HRQoL and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT01726894
Focal Therapy for Localised Prostate Cancer Using Irreversible ElectroporationNo drug interventionsNot AvailableNot Availableunknown_status
NCT00038194
Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancertreatment1completed
NCT00309894
Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapytreatment2completed
NCT00681694
Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00672594
Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomytreatment2completed
NCT05893394
Core Stability as a Prognostic Factor of Urinary Incontinence in Patients Undergoing Robot-assisted Laparoscopic ProstatectomyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00064194
Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate NeoplasiaNo drug interventionsprevention3completed
NCT00244894
Acupuncture in Treating Hot Flashes in Patients With Prostate CancerNo drug interventionssupportive_careNot Availableterminated
NCT04021394
Influence of EMT on CTCs and Disease Progression in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04182594
Cardiovascular Events in GnRH Agonist vs. Antagonisttreatment2unknown_status
NCT05629494
Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Testtreatment4recruiting
NCT06441994
Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate CancerNo drug interventionstreatment1recruiting
NCT04861194
EREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT)No drug interventionstreatmentNot Availablerecruiting
NCT02805894
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinomatreatment1 / 2terminated
NCT03207594
Improving Evidence-Based Care for Cancer PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01899391
Periperal Blood Lymphocytes During Prostate RTNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00809991
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the ProstateNo drug interventionstreatment2active_not_recruiting
NCT04085991
Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate CancerNo drug interventionstreatment2terminated
NCT02020291
Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancertreatment1completed
NCT01292291
MRI in Diagnosing Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT00694291
Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancertreatment2withdrawn
NCT02645591
Randomized AmnioFix Study During Radical ProstatectomyNo drug interventionstreatment2withdrawn
NCT02770391
Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancertreatment2completed
NCT01446991
Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapytreatment2completed
NCT00335491
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT06362291
Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled TrialNo drug interventionsdiagnosticNot Availablerecruiting
NCT02107391
Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancertreatment2completed
NCT03971591
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availablerecruiting
NCT03477591
Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening DecisionsNo drug interventionsscreeningNot Availablecompleted
NCT05683691
Water Vapor Ablation for Localized Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT01378091
Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancertreatment1completed
NCT00020891
CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation TherapyNo drug interventionsdiagnostic2completed
NCT05313191
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsNo drug interventionstreatmentNot Availablerecruiting
NCT01431391
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancertreatment2completed
NCT00003391
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyNo drug interventionstreatment1completed
NCT03322891
Improving Health Literacy in African-American Prostate Cancer PatientsNo drug interventionsotherNot Availablecompleted
NCT01588262
Early Rehabilitation of Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT02585362
Whey Protein Supplement in Combination With Physical Exercise and Nutrition ProgramNo drug interventionssupportive_careNot Availablecompleted
NCT02279862
Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naivetreatment2completed
NCT03005262
MLN8237 for a Subject With Adenocarcinoma of the ProstateNot AvailableNot Availableno_longer_available
NCT00086762
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid TumorsNo drug interventionsotherNot Availablecompleted
NCT06051162
HPI Effect in Robotic Urological Surgery on AKINo drug interventionspreventionNot Availablerecruiting
NCT00949962
Post-operative or Early Salvage XRT and ADT for High Risk PCatreatment3terminated
NCT04571762
Adaptive MR-guided SBRT for Localized Prostate CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01120262
S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and GoserelinNo drug interventionsNot AvailableNot Availablecompleted
NCT05154162
PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRINo drug interventionsdiagnostic3recruiting
NCT04869462
DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)No drug interventionsNot AvailableNot Availablecompleted
NCT05024162
Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a TumourNo drug interventionsdiagnosticNot Availablerecruiting
NCT01744262
A Comparison of Totally Intravenous and Inhalation Anesthesia for Intraocular Pressure During Robot-Assisted Laparoscopic Radical ProstatectomyNo drug interventionspreventionNot Availablecompleted
NCT02769962
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancertreatment1 / 2recruiting
NCT02123862
Cultured Circulating Tumor Cells in Prostate and Other CancersNo drug interventionsNot AvailableNot Availableunknown_status
NCT05622162
Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7treatment3active_not_recruiting
NCT00585962
Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the ProstateNo drug interventionstreatment2completed
NCT05297162
PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective TrialNo drug interventionsdiagnosticNot Availablerecruiting
NCT00006380
Monoclonal Antibody Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment1completed
NCT02430480
Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancerdiagnostic2active_not_recruiting
NCT02391480
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancertreatment1completed
NCT05191680
TherApeutics in Early ProState Cancer (TAPS02)treatment3recruiting
NCT00818480
An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155treatment2completed
NCT00002480
Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment1completed
NCT03201380
Evaluation of the Practice of the TEP Choline at Patients With Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04925180
A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in EuropeNot AvailableNot Availablecompleted
NCT02058680
Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent PatientsNo drug interventionstreatment1unknown_status
NCT02759380
Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation?No drug interventionspreventionNot Availablerecruiting
NCT02694380
Measuring the Effect of Radiation Therapy on Patient Activity LevelsNo drug interventionsNot AvailableNot Availableterminated
NCT04896580
IIT2020-20-SHIRAZIP-WALK: Nature WalksNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00577980
Testosterone in Castration-Resistant Prostate Cancertreatment2withdrawn
NCT04986280
Diagnostic Accuracy and Performance of 18F-PSMA-1007No drug interventionsNot AvailableNot Availablecompleted
NCT00044980
Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT05160480
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDGNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT03619980
A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or DeathNo drug interventionsNot AvailableNot Availablecompleted
NCT00332280
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus PlaceboNo drug interventionstreatment2 / 3terminated
NCT00567580
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancertreatment3active_not_recruiting
NCT02923180
Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancertreatment2active_not_recruiting
NCT00524680
Vitamin D in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT04337580
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancertreatment2recruiting
NCT06226129
Gadopiclenol in Contrast Enhanced MRI of the Prostatediagnostic4not_yet_recruiting
NCT02920229
68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically TreatedNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT03600129
Qudratus Lumborum Block for Postoperative Pain After Endoscopic Prostatectomy.supportive_careNot Availablecompleted
NCT05910229
Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner for Patients With Prostate CancerNo drug interventionsotherNot Availablerecruiting
NCT00975429
Study Using WST11 in Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT05364229
MR-guided Tumour BoostNo drug interventionstreatmentNot Availablerecruiting
NCT03893929
The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese PopulationNo drug interventionsNot AvailableNot Availablerecruiting
NCT00003329
Identification of Genes Associated With Cancer in Patients and Siblings Who Have CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00859729
Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate CancerNo drug interventionstreatment1 / 2completed
NCT00004929
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate CancerNo drug interventionstreatment1completed
NCT04751929
Abemaciclib With or Without Atezolizumab for mCRPCtreatment2active_not_recruiting
NCT00450229
Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancertreatment1completed
NCT00918229
Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer SubjectsNo drug interventionspreventionNot Availablecompleted
NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumorstreatment1active_not_recruiting
NCT06375629
ES-HIFU, Prospective Data Collection of Patients Treated With Partial Gland HIFU Ablation for Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00922129
Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancertreatment2 / 3withdrawn
NCT05516329
Study of 18F-Thretide PET/CT in Patients With Prostate CancerNo drug interventionsdiagnostic1 / 2completed
NCT01088529
Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancertreatment2completed
NCT03043989
Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycintreatment1terminated
NCT02423889
Stereotactic Volumetric Radiotherapy in Prostate CancerNo drug interventionstreatment2completed
NCT00456989
Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancertreatment1 / 2completed
NCT05573789
Tumor Molecular Profiling in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00031889
Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancertreatment2completed
NCT03294889
ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate CancerNo drug interventionstreatment1 / 2recruiting
NCT00524589
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapytreatment2terminated
NCT01310192
Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission TomographyNo drug interventionsdiagnostic1completed
NCT06027892
Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT02430792
Effectiveness of Community-based Football in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00814892
Vaccine Therapy in Treating Patients With Non-Metastatic Prostate CancerNo drug interventionstreatment2terminated
NCT05540392
An Acupuncture Study for Prostate Cancer Survivors With Urinary IssuesNo drug interventionstreatment1 / 2active_not_recruiting
NCT02181192
Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate CarcinomaNo drug interventionstreatmentNot Availableunknown_status
NCT01845792
Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancertreatment2terminated
NCT05841992
Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer PatientsNo drug interventionsdiagnostic2 / 3recruiting
NCT03366792
Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate CancerNo drug interventionsdiagnosticNot Availableterminated
NCT02928692
Minocycline Attenuate Postoperative Cognitive Dysfunction and Deliriumprevention3unknown_status
NCT00106392
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomyprevention4completed
NCT00831792
TKI258 in Castrate Resistant Prostate CancerNo drug interventionstreatment2completed
NCT01688492
Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancertreatment1 / 2active_not_recruiting
NCT04266392
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA LigandNo drug interventionsdiagnostic0completed
NCT02465892
Pillars4Life TrialNo drug interventionssupportive_careNot Availablecompleted
NCT00584792
Diet, Genetic Variation and Prostate Cancer Among African AmericansNo drug interventionsNot AvailableNot Availablecompleted
NCT06065592
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphismsprevention1recruiting
NCT00102544
Use of Tracking Devices to Locate Abnormalities During Invasive ProceduresNo drug interventionsdevice_feasibilityNot Availableenrolling_by_invitation
NCT03227744
A Pilot Study of Prostate Cancer-specific Anxiety in Active SurveillanceNo drug interventionssupportive_careNot Availableterminated
NCT02282644
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow CytometryNo drug interventionsdiagnosticNot Availablecompleted
NCT05864144
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT01325844
The Effects of Epidural Anesthesia on the Bioavailability of Nitric Oxide and Renal Function in Patients Undergoing Laparoscopic SurgeryNo drug interventionspreventionNot Availablecompleted
NCT04631744
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)treatment2recruiting
NCT00509444
Cancer Prevention and Treatment Among African American Older Adults: Treatment TrialNo drug interventionstreatment3completed
NCT05363644
BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical ProstatectomyNo drug interventionsprevention3withdrawn
NCT02186444
Navigator Guided e-Psychoeducational InterventionNo drug interventionsNot AvailableNot Availablecompleted
NCT05345444
Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)No drug interventionstreatmentNot Availablerecruiting
NCT03429244
PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate CancerNo drug interventionsdiagnostic2completed
NCT04681144
A Study to Learn More About How Radium-223 Affects the Quality of Life of Colombian Patients With Prostate Cancer That Has Not Responded to Testosterone Lowering Treatment and Has Spread to the Bones, and to Better Understand Its SafetyNot AvailableNot Availablecompleted
NCT06116344
Improving Prostate Lesion Classification and Development of a PI-RADS 3 ClassifierNo drug interventionsNot AvailableNot Availablecompleted
NCT02759744
Fusion Guided Focal Laser Ablation of Prostate CancerNo drug interventionsdevice_feasibilityNot Availablesuspended
NCT00007644
Prostate Cancer Intervention Versus Observation Trial (PIVOT)No drug interventionstreatment3completed
NCT00561444
Quality of Life Study for Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00288444
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancertreatment1terminated
NCT01695044
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)No drug interventionstreatment2completed
NCT05399940
The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological ParametersNo drug interventionsNot AvailableNot Availablecompleted
NCT05854940
Multicenter, Prospective Clinical Study of the Serum Raman Spectroscopy Intelligent System for the Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT05202340
Factors Affecting Androgen Deprivation Therapy Choice in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03550040
3D Versus Robot Assisted Laparoscopic Prostatectomy.No drug interventionstreatmentNot Availableterminated
NCT00417040
Collection of Patient-Reported Symptoms and Performance Status Via the InternetNo drug interventionsotherNot Availablecompleted
NCT05286840
64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate CancerNo drug interventionsdiagnostic1 / 2unknown_status
NCT00514540
Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancertreatment2completed
NCT00466440
A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patientstreatment2completed
NCT00738140
Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer SurvivorsNo drug interventionsprevention2completed
NCT00588640
Study of D-Methadone in Patients With Chronic Paintreatment1 / 2completed
NCT01146340
Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate CancerNo drug interventionstreatment1 / 2completed
NCT05617040
Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate CancerNo drug interventionstreatment1 / 2recruiting
NCT03353740
Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrencediagnostic3completed
NCT02016040
Focal Therapy Using HIFU for Localised Prostate CancerNo drug interventionstreatment2 / 3unknown_status
NCT04374240
A Clinical Trial of AdNRGM Plus CB1954 in Prostate CancerNo drug interventionstreatment1completed
NCT01909440
Resistance Training and Protein Supplementation for Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT03934840
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abirateronetreatment2active_not_recruiting
NCT00003740
Trastuzumab in Treating Patients With Prostate Cancertreatment2completed
NCT06138067
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer PatientsNo drug interventionsotherNot Availablenot_yet_recruiting
NCT05069467
Acupuncture Versus Sham Acupuncture or Usual Care for Antiandrogen-Induced Hot fLashes in Prostate Cancer (AVAIL)No drug interventionssupportive_careNot Availablerecruiting
NCT02110667
Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT02615067
Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancerdiagnostic3completed
NCT04282967
Streaming Web-based Exercise At Home: A Pilot StudyNo drug interventionssupportive_care0completed
NCT02911467
Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate CancerNo drug interventionsdiagnostic1terminated
NCT05137067
A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.treatment2completed
NCT00514267
An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumorstreatment1 / 2completed
NCT03181867
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancerdiagnostic2enrolling_by_invitation
NCT04485767
RESIST-ADT (Androgen Deprivation Therapy)No drug interventionssupportive_careNot Availablecompleted
NCT04009967
Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanningtreatment2active_not_recruiting
NCT01342367
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancertreatmentNot Availableactive_not_recruiting
NCT04796467
68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer PatientsNo drug interventionsdiagnostic2 / 3unknown_status
NCT00635167
Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)No drug interventionsdiagnosticNot Availableterminated
NCT00258401
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.No drug interventionsotherNot Availablecompleted
NCT00132301
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinomatreatment3completed
NCT04896801
MR-guided Prostate Stereotactic Body Radiotherapy in Seven DaysNo drug interventionstreatmentNot Availablerecruiting
NCT00079001
Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastasestreatment3completed
NCT04557501
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate CancerNo drug interventionstreatment3active_not_recruiting
NCT02944201
Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostatetreatment2unknown_status
NCT04574401
A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic ProstatectomyNo drug interventionsother1completed
NCT01054001
Early Start of Oral Sildenafil 100mg for Erectile Dysfunction After Robotic Assisted Laparoscopic Radical ProstatectomytreatmentNot Availableunknown_status
NCT03819101
Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancertreatment3recruiting
NCT04349501
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)No drug interventionsdiagnostic2recruiting
NCT03823001
Virtual Prostate Biopsy Protocol for Patients on Active Surveillance and at Risk of Prostate CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT02933801
ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.treatment2terminated
NCT00848601
Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphomaother1terminated
NCT00838201
Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancertreatment3completed
NCT01834001
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02312401
Evaluation of Treatment Response Using Multiparametric MRI After Prostate RadiotherapyNo drug interventionsdiagnostic2active_not_recruiting
NCT05202301
A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication CompletelyNot AvailableNot Availableactive_not_recruiting
NCT00956904
Ultrasound-Guided Navigation in Robot-Assisted Laparoscopic Radical ProstatectomyNo drug interventionstreatment0terminated
NCT00096304
Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancertreatment1terminated
NCT00923104
An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated SkinNo drug interventionsNot AvailableNot Availablecompleted
NCT04102904
The Prostate Liquid Study (PLiS)No drug interventionsNot AvailableNot Availableunknown_status
NCT02341404
A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT03556904
FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)treatment2completed
NCT01132404
Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448treatment1 / 2terminated
NCT03859804
Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided BiopsyNo drug interventionssupportive_careNot Availablecompleted
NCT03211104
Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation TherapyNo drug interventionstreatmentNot Availablecompleted
NCT02022904
Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition BiologyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05737004
Effects of Prostate Cancer on Brain FunctionNo drug interventionsNot AvailableNot Availablerecruiting
NCT06372704
Is the HIFEM Procedure an Effective Treatment for Men With Post-prostatectomy Incontinence?No drug interventionsNot AvailableNot Availablecompleted
NCT05612204
Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory StudyNo drug interventionsdiagnosticNot Availablerecruiting
NCT02588404
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer PatientNot AvailableNot Availablenot_yet_recruiting
NCT00715104
Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancertreatment2completed
NCT03948204
Quality of Life and Shared Decision Making in Prostate CancerNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT03662204
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT00702104
Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco AreaNo drug interventionsNot AvailableNot Availablecompleted
NCT00514072
Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancertreatment2unknown_status
NCT01492972
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancertreatment3recruiting
NCT01274572
Blood for Immune Response to Provenge® in HRPCNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01401972
Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02154672
Prostate Cancer Screening in Men With Germline BRCA2 MutationsNo drug interventionsNot AvailableNot Availablecompleted
NCT01309672
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapytreatment2active_not_recruiting
NCT00148772
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapyprevention2completed
NCT02531672
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission TomographyNot AvailableNot Availableno_longer_available
NCT05481372
PINPOINT Feasibility StudyNo drug interventionsotherNot Availableunknown_status
NCT03276572
Phase I Trial of 225Ac-J591 in Patients With mCRPCtreatment1completed
NCT00081172
Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the ProstateNo drug interventionstreatment2completed
NCT01275872
Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT06126172
Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes PredictionsNo drug interventionsotherNot Availableactive_not_recruiting
NCT00581672
Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black MenNo drug interventionsNot AvailableNot Availablecompleted
NCT00005072
Leuvectin in Treating Patients With Locally Recurrent Prostate Cancertreatment1 / 2terminated
NCT04025372
INTREPId (INTermediate Risk Erection PreservatIon Trial)treatment2recruiting
NCT05498272
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterationstreatment2recruiting
NCT06091072
Image-guided Navigation During Robotic Sentinel Node RemovalNo drug interventionsotherNot Availablerecruiting
NCT03331068
French Validation of the Memorial Anxiety Scale for Patients With Prostate Cancer.No drug interventionsNot AvailableNot Availablecompleted
NCT00538668
Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 AntibodyNo drug interventionstreatment1completed
NCT00708968
Prostate Cancer: Family Care for Patients and SpousesNo drug interventionssupportive_careNot Availablecompleted
NCT02526368
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancerdiagnostic0recruiting
NCT01221168
Epidemiologic and Genetic Study on Familial Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT05132868
Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional CounselingNo drug interventionssupportive_careNot Availablecompleted
NCT00038168
Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinomatreatment1 / 2completed
NCT00071968
Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapsetreatment2completed
NCT00186368
Microarray Analysis of Gene Expression in Prostate TissuesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05816668
Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomyprevention3not_yet_recruiting
NCT04733768
18F-PSMA-1007 PET/CT Imaging in Patients With Biochemically Recurrent or High-risk Prostate CancerNo drug interventionsdiagnostic2active_not_recruiting
NCT02918968
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancertreatment4completed
NCT00859768
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT03987568
Characterize Tumor Hypoxia by Magnetic Resonance ImagingNo drug interventionsdiagnosticNot Availablewithdrawn
NCT04403568
Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostatebasic_science0withdrawn
NCT01083368
Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapytreatment1 / 2completed
NCT01436968
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancertreatment3active_not_recruiting
NCT01174368
Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-TNo drug interventionstreatment2completed
NCT00539968
A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)treatment1 / 2terminated
NCT00572468
Statin Therapy Versus Placebo Prior to ProstatectomyscreeningNot Availablecompleted
NCT00913068
Postoperative Pain Control for ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT03042468
Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPCtreatment1 / 2active_not_recruiting
NCT00703768
Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 YearNo drug interventionsNot AvailableNot Availableunknown_status
NCT00390468
Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastasestreatment2completed
NCT00574769
Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancertreatment1 / 2completed
NCT00043069
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancersupportive_care3completed
NCT01148069
Surgery Combined With Intensity Modulated Radiation Therapy - Image-Guided Radiation Therapy (IMRT-IGRT) in Locally-advanced Prostate CancersNo drug interventionstreatment2completed
NCT02691169
Integrated 18F-labelled PSMA Projectdiagnostic0unknown_status
NCT05960669
Nerve-sparing, Robot-assisted Radical Prostatectomy Using a Personalized, 3D-printed Prostate Model for Selective Resection of Positive Surgical MarginsNo drug interventionstreatmentNot Availablecompleted
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsNo drug interventionstreatment1recruiting
NCT05304169
Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.treatment4completed
NCT00305669
GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancertreatment1completed
NCT04619069
Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate CancerNo drug interventionstreatment1 / 2active_not_recruiting
NCT02609269
Decipher Genomics Resource for Intelligent DiscoveryNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04905069
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body RadiotherapyNo drug interventionspreventionNot Availablerecruiting
NCT06171269
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of LifeNo drug interventionssupportive_careNot Availablerecruiting
NCT00924469
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancertreatment2completed
NCT01530269
C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate AdenocarcinomaNo drug interventionsdiagnostic2completed
NCT04167969
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate CancerNo drug interventionsdiagnostic1recruiting
NCT04962269
Application of DWI in Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01514669
Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03533946
Rucaparib in Nonmetastatic prOstAte With BRCAnesstreatment2terminated
NCT02326246
MRI in Active Surveillance of Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00433446
S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapytreatment2completed
NCT00415246
Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancertreatment3terminated
NCT00243646
Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trialtreatment3terminated
NCT01585246
Saw Palmetto: Symptom Management for Men During Radiation Therapytreatment1 / 2completed
NCT01574846
Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00685646
Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastasestreatment3completed
NCT02705846
Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline MutationsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00670046
Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancertreatment2terminated
NCT02886546
Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic ProstatectomyNo drug interventionsscreeningNot Availableunknown_status
NCT02809846
Quell Opioid Reduction and Pain Relief in Patients With CancerNo drug interventionssupportive_careNot Availableterminated
NCT05500846
Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated TrialNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05753046
Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative PainNo drug interventionsother4enrolling_by_invitation
NCT06378346
GU-01: Glycyrrhizin in Prostate Cancertreatment2recruiting
NCT00503646
Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their PartnersNo drug interventionsNot AvailableNot Availableunknown_status
NCT04989946
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancertreatment1 / 2recruiting
NCT04484246
Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03821246
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomytreatment2recruiting
NCT01199146
Abiraterone Post Ketoconazole for Prostate Cancertreatment2completed
NCT05608746
Prehabilitation in Prostate Cancer Patients, TelePrehabTrialNo drug interventionsotherNot Availablerecruiting
NCT06299046
Bleeding After Robot-assisted Radical Prostatectomy: a Respective StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00748046
Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeletonbasic_science1completed
NCT02459912
Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate CancerNo drug interventionstreatment2terminated
NCT04269512
Role of Lymphnode Dissection in Men With Prostate Cancer Treated With Radical ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT00121212
Positron Emission Tomography in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT01326312
Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancertreatment2terminated
NCT05140512
Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®treatment1completed
NCT05739812
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological TelesurgeryNo drug interventionsotherNot Availablerecruiting
NCT03356912
CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapysupportive_care2unknown_status
NCT03778112
MRI Guided SBRT for Localized Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05043012
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)No drug interventionsdiagnosticNot Availablerecruiting
NCT02899312
PSMA PET/CT for Assessment of Recurrent Prostate CancerNot AvailableNot Availablerecruiting
NCT01414712
Circulating Tumor Cells in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT03386812
Investigating Bone and Skeletal Muscle Interaction in Men With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03013712
A Clinical Research of CAR T Cells Targeting EpCAM Positive CancerNo drug interventionstreatment1 / 2unknown_status
NCT01804712
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomytreatment0unknown_status
NCT02409212
Exercise Training as a Novel Primary Therapy for Men With Localised Prostate CancerNo drug interventionstreatment2completed
NCT00022412
Doxercalciferol Before Surgery in Treating Localized Prostate CancerNo drug interventionstreatment2completed
NCT03338712
Micro-RNA Expression Profiles in Localised Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04004312
Single Fractions SBRT for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT01338012
Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancertreatment2terminated
NCT00124410
Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal ManipulationNo drug interventionsNot AvailableNot Availablecompleted
NCT00853710
Test Semiquantitative Prostate Specific Antigen (PSA)No drug interventionsdiagnosticNot Availablecompleted
NCT05720910
Streamlined Geriatric and Oncological Evaluation Based On IC TechnologyNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT03516110
Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT02470910
Incorporating MR Imaging Into Prostate Radiotherapy Treatment PlanningNo drug interventionsdiagnosticNot Availablecompleted
NCT04297410
177Lu-PSMA-I&T Prior to Radical Prostatectomy for Locally Advanced DiseaseNo drug interventionstreatmentNot Availableunknown_status
NCT04383210
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumorstreatment2active_not_recruiting
NCT02040610
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03488810
Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancertreatment3withdrawn
NCT06469710
A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00895310
Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapytreatment2completed
NCT01748110
Health Interventions in Men Undergoing Radical ProstatectomyNo drug interventionssupportive_careNot Availablewithdrawn
NCT00960310
Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditionstreatment1completed
NCT05109910
The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT00822510
Telephone Counseling: Men With Prostate Cancer & PartnersNo drug interventionstreatment1completed
NCT00500110
Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancertreatment2completed
NCT05974410
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsNot AvailableNot Availableavailable
NCT01811810
Proton Therapy for High Risk Prostate CancerNo drug interventionstreatmentNot Availablewithdrawn
NCT00983710
Prostate Cancer Symptom Management for Low Literacy MenNo drug interventionssupportive_care2completed
NCT00005810
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT06074510
PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancerdiagnostic4recruiting
NCT05645510
LIVInG With chrONic Cancer TrEatments (LONGEVITI) StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04727710
Testing the Effect of Mindfulness for Prostatectomy OutcomesNo drug interventionssupportive_careNot Availableterminated
NCT03526510
Hypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00405210
Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancertreatment1completed
NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT00003781
Docetaxel in Treating Patients With Stage IV Prostate Cancertreatment2completed
NCT05017181
Novel MRI Assessment of Prostate Cancer VALIDATE-PRONo drug interventionsNot AvailableNot Availableunknown_status
NCT02545881
Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer AggressivenessNo drug interventionsNot AvailableNot Availableunknown_status
NCT00946881
Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancertreatment1 / 2completed
NCT06449781
177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancertreatment2not_yet_recruiting
NCT03100981
Online Mindfulness for Women Treated for Breast Cancer and Men Treated for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT01673581
Shared Decision Making in Low Risk Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04926181
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancertreatment2active_not_recruiting
NCT00038181
Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancertreatment2completed
NCT00002981
PET Scan in Treating Patients With Metastatic Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00559481
Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation TherapytreatmentNot Availablewithdrawn
NCT04176081
Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancertreatment2not_yet_recruiting
NCT06280781
Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)No drug interventionsotherNot Availablenot_yet_recruiting
NCT06223295
Effectiveness of Focal Therapy in Men With Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT01006395
Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)treatment2 / 3completed
NCT06462495
Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and MetastasisNo drug interventionsdiagnostic0recruiting
NCT00020995
Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate CancerNo drug interventionsprevention2completed
NCT04853095
Effect of Peritoneal Fixation on Lymphocele FormationNo drug interventionstreatmentNot Availablecompleted
NCT03148795
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancertreatment2completed
NCT05435495
Mechanisms of Resistance to PSMA Radioligand TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03796195
(SGB) in Men Treated for Prostate Cancer Improve Hot Flashestreatment4terminated
NCT05110495
Windows Trial of INsulin-like Growth Factor Neutralising Antibody Xentuzumab in MEN Scheduled for Radical Prostatectomy (WINGMEN)treatment0active_not_recruiting
NCT06071195
All-in-One Prostate Cancer Staging With MRINo drug interventionsNot AvailableNot Availablerecruiting
NCT00620295
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumorstreatment1completed
NCT01162395
Open Label Prostate Cancer StudyNo drug interventionstreatment1completed
NCT01530295
Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate CancerNot AvailableNot Availableunknown_status
NCT00245895
Study of Aranesp to Treat Anemia in Prostate Cancer Patients.prevention2completed
NCT02826395
C11 Sodium Acetate PET/CT Imaging of PCaNot AvailableNot Availableno_longer_available
NCT00348595
Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancertreatment1 / 2completed
NCT03504995
Efficacy and Safety Assessment of IRE of Localized Prostate Cancer.No drug interventionstreatmentNot Availablecompleted
NCT03001895
Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancerdiagnostic2completed
NCT02090114
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)treatment2completed
NCT03674814
Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancertreatment1active_not_recruiting
NCT02681614
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment PlanningNo drug interventionsdiagnosticNot Availablecompleted
NCT01525914
Response of Patients on Surveillance for Prostate Cancer to DutasterideNot AvailableNot Availablecompleted
NCT00579514
Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT04029714
Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative TreatmentNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00006114
Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2unknown_status
NCT01666314
Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancertreatment1 / 2completed
NCT02784314
Cost Efficacy Evaluation of Robot Assisted Radical ProstatectomyNo drug interventionstreatmentNot Availablecompleted
NCT01007214
Guided Biopsy for Mapping Prostate CancerNo drug interventionsdiagnosticNot Availableterminated
NCT00561314
High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT00489814
Study of Quality of Life for Prostate Proton TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05022914
PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHENo drug interventionsNot AvailableNot Availablerecruiting
NCT04946214
A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00328614
Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancertreatment1completed
NCT05301114
Social Risk Factors and Discrimination in Cancer SurvivorshipNo drug interventionshealth_services_researchNot Availablerecruiting
NCT06347614
Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06462014
Description of Relugolix Use in Patients With Prostate Cancer Within the VHANot AvailableNot Availableactive_not_recruiting
NCT04483414
68Ga PSMA-11 PET/CT in Recurrent Prostate CancerNo drug interventionsdiagnostic2withdrawn
NCT05471414
Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04892914
Embr Thermal Device for Hot Flash Management in Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00004014
Liposomal Doxorubicin in Treating Patients With Prostate Cancertreatment2completed
NCT04138914
Phase II Trial of Focal Cryotherapy for Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00002855
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancertreatment3completed
NCT04486755
Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)No drug interventionstreatment1recruiting
NCT02543255
Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)treatment2completed
NCT04228055
Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2)No drug interventionstreatmentNot Availableunknown_status
NCT00337155
BAY88-8223, Dose Finding Study in Patients With HRPCtreatment2completed
NCT00116155
Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancertreatment1 / 2completed
NCT06458855
Nerve Grafting Technique to Restore Erectile Function Post Radical ProstatectomyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01193855
Dutasteride in Treating Patients With Prostate Cancertreatment2unknown_status
NCT01368055
Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04501055
Anesthesia in PROstate Biopsy Pain Obstruction StudyNo drug interventionstreatmentNot Availablecompleted
NCT00963755
F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04677855
Study of PCUR-101 in Combination With ADT in Patients With mCRPCtreatment1terminated
NCT04300855
Clinical Trial of Green Tea Catechins in Men on Active Surveillanceother2recruiting
NCT05520255
18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028No drug interventionsdiagnostic3recruiting
NCT01856855
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)No drug interventionstreatmentNot Availablecompleted
NCT00134355
Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancertreatment2completed
NCT01440855
Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community SettingNo drug interventionssupportive_careNot Availablecompleted
NCT06397755
Observational Study of Patients Who Underwent Diagnostic Investigation (Prostate Biopsy) and/or Radical Prostatectomy Surgery.No drug interventionsNot AvailableNot Availablerecruiting
NCT03214055
Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic ProstatectomyNot AvailableNot Availablecompleted
NCT00536055
Dyadic Coping in Breast and Prostate Cancer Patients and Their SpousesNo drug interventionsNot AvailableNot Availableunknown_status
NCT02649855
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancertreatment2completed
NCT01578655
Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancertreatment3completed
NCT05413850
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injectiontreatment1 / 2recruiting
NCT03471650
Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancerdiagnostic2active_not_recruiting
NCT06199050
The Effect of 360° Virtual Reality Movies on Fear and AnxietyNo drug interventionshealth_services_researchNot Availablerecruiting
NCT02911350
Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancertreatment1completed
NCT05269550
PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER)No drug interventionstreatmentNot Availablerecruiting
NCT01420250
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancertreatment1completed
NCT01234350
A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGONNo drug interventionsNot AvailableNot Availablecompleted
NCT01769950
Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT00928850
Modifications to Radical Prostatectomy: Feasibility StudyNo drug interventionstreatmentNot Availablecompleted
NCT00004050
Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancertreatment2terminated
NCT04585750
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)treatment1 / 2recruiting
NCT05568550
Pembro With Radiation With or Without Olaparibtreatment2recruiting
NCT00391950
Maintaining Bone Strength in Men With Prostate Cancertreatment3terminated
NCT05708950
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)treatment1 / 2recruiting
NCT02032550
Treatment Preference and Patient Centered Prostate Cancer CareNo drug interventionstreatmentNot Availablecompleted
NCT03204123
PSMA PET Imaging of Recurrent Prostate CancerNo drug interventionsdiagnostic2active_not_recruiting
NCT02989623
Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSANo drug interventionsdiagnosticNot Availablecompleted
NCT06360523
To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial IntelligenceNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00311623
Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancertreatment1 / 2completed
NCT01546623
A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapytreatment3completed
NCT02065323
A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADTtreatment2withdrawn
NCT04981223
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound ImagingNo drug interventionsdiagnosticNot Availablerecruiting
NCT05498623
MR Fingerprinting for Diagnostic of Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00524823
Early Detection of Prostate Cancer by FACSNo drug interventionsNot AvailableNot Availableunknown_status
NCT02004223
Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00818623
Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patientstreatment2completed
NCT00959023
Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00769223
Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06363123
Plasma Metabolic Biomarkers for Multi-Cancer DiagnosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT00006023
Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT06320223
PROMISE PET Registry on PSMA-PET and Outcome in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01168323
Spaced Education to Optimize Prostate Cancer ScreeningNo drug interventionshealth_services_researchNot Availablecompleted
NCT01664923
Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancertreatment2completed
NCT00103623
The Plenaxis® Experience Studytreatment4suspended
NCT00003323
Hormone Therapy in Treating Patients With Prostate Cancertreatment2completed
NCT03162523
Experiences With HDR-brachytherapy in NorwayNo drug interventionsNot AvailableNot Availablecompleted
NCT05477823
Imaging and Genomic Biomarkers to Predict Response in Prostate CancerNo drug interventionsscreening0recruiting
NCT03787823
RCT-evaluation of Retzius-sparing Robotic ProstatectomyNo drug interventionstreatmentNot Availableunknown_status
NCT03079323
Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate CancerNo drug interventionstreatment2recruiting
NCT06259123
Neoadjuvant PSMA-RLT in Oligometastatic PCatreatment2recruiting
NCT00916123
Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancerother1completed
NCT00988208
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancertreatment3completed
NCT03290508
Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT02397408
11C- and 18F-Choline PET/MR Imaging for Prostate Cancerdiagnostic2completed
NCT00828308
Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancertreatment2completed
NCT04602208
FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND FOR PRIMARY LOCALIZED PROSTATE CANCER: MIDTERM ONCOLOGICAL OUTCOMESNo drug interventionsNot AvailableNot Availablecompleted
NCT00637208
Sclerotherapy of Internal Spermatic Veins in Patients With Varicocele and Localized Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT01188408
Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancertreatment2withdrawn
NCT01484808
The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and StageNo drug interventionsNot AvailableNot Availableunknown_status
NCT03228108
Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.prevention4completed
NCT03956108
Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active SurveillanceNo drug interventionsdiagnosticNot Availablecompleted
NCT00080808
Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancersupportive_care2completed
NCT04736108
Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostatetreatment2not_yet_recruiting
NCT02388308
Evaluation of Clarity Ultrasound Guidance for Prostate TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT01903408
Radiotherapy of the Prostate and the Pelvic Lymph Nodes After Neoadjuvant Antihormonal TreatmentNo drug interventionstreatment2completed
NCT02663908
A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Diseasetreatment3terminated
NCT04993508
Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance ImagingNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT00499408
Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate CancerNo drug interventionstreatment2completed
NCT01478308
Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancertreatment2withdrawn
NCT02064608
Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate Cancertreatment1completed
NCT01666808
FACBC Outcomes for Post ProstatectomyNo drug interventionstreatment2 / 3completed
NCT01075308
SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancertreatment2completed
NCT03532308
Nutrition and Prostate CancerNo drug interventionstreatment3terminated
NCT06366308
Decade-Long Insights Into Transperineal Prostate Biopsy in a West China PopulationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00147238
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle ContrastNo drug interventionstreatmentNot Availableterminated
NCT04484038
Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate CarcinomaNo drug interventionstreatmentNot Availablerecruiting
NCT06084338
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpctreatment2recruiting
NCT01588938
External Immobilization Compared to Limited Immobilization Using a Novel Real-time Localization System of the ProstateNo drug interventionsNot AvailableNot Availableunknown_status
NCT06298838
High-resolution Intra-operative PSMA PET-CT in Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00138138
Psychostimulants for Fatigue in Prostate Cancertreatment2completed
NCT00272038
Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancertreatment2completed
NCT00002938
Surgery in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT02497638
LIpitor and biGuanide to Androgen Delay Trialtreatment2withdrawn
NCT00429338
3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of ProstateNo drug interventionsdiagnosticNot Availableterminated
NCT00018538
Calcifidol Therapy in Men With CancerNo drug interventionstreatment2completed
NCT01817738
Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate CancerNo drug interventionstreatment1 / 2terminated
NCT01553838
A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA ValuesNo drug interventionsdiagnosticNot Availablecompleted
NCT00632138
Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the ProstateNo drug interventionssupportive_care3completed
NCT00273338
DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])treatment3terminated
NCT01859338
Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRINo drug interventionsNot AvailableNot Availableterminated
NCT00392938
Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the BoneNot AvailableNot Availablecompleted
NCT04792138
Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.No drug interventionsNot AvailableNot Availableunknown_status
NCT01968538
Metabolomic Study for Localized Prostate CancerNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00123838
Positioning and Tracking the Prostate During External Beam RadiationNo drug interventionstreatmentNot Availablecompleted
NCT00003238
Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT00693238
Proton Therapy for Low and Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00836238
Questionnaire and Fall Risk AssessmentNo drug interventionsNot AvailableNot Availablecompleted
NCT04746638
Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26No drug interventionsdiagnostic1completed
NCT01522443
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancertreatment3terminated
NCT04984343
Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate CancerNo drug interventionstreatment2recruiting
NCT04854343
SLPI for Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT03507543
The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumorstreatment1completed
NCT03753243
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancertreatment2unknown_status
NCT00582543
MRI/MRSI in Risk Assessment of Prostate Cancer PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT02033343
Feasibility Study Into Adjustment of the Radiation Beam to Account for Prostate Motion During Radiotherapy.No drug interventionstreatmentNot Availablecompleted
NCT00003343
Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancertreatment3completed
NCT00946543
Intensity-Modulated Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment1unknown_status
NCT00059943
Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancertreatment2completed
NCT04470843
Impact of Acetazolamide in Reducing Referred Postoperative Paintreatment1completed
NCT01296243
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancertreatment2unknown_status
NCT03637543
Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancertreatment2active_not_recruiting
NCT06145243
Comparison of the Effectiveness of Supervised, Video-based and Home-based Resistance Exercise Program in Patients With Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02766543
Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03162003
Irish Programme for Stratified Prostate Cancer TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT04867603
Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate LesionsNo drug interventionsNot AvailableNot Availablecompleted
NCT00581503
Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02473003
Physical Training and Cancer-a Multicenter Clinical TrialNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00283803
Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancertreatment2completed
NCT00002503
Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone MetastasesNo drug interventionstreatment3completed
NCT02097303
Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasistreatment2completed
NCT03494803
Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMCNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02294903
Focal Prostate Radiofrequency AblationNo drug interventionstreatmentNot Availableunknown_status
NCT05773703
Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate CancerNo drug interventionsother0completed
NCT03089203
CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancertreatment1active_not_recruiting
NCT00868803
Aberrant Gene Expression Prostate CarcinomaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04181203
Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomytreatment3recruiting
NCT00003903
Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02643303
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancerstreatment1 / 2completed
NCT04845503
Stereotactic MRI-guided Radiation Therapy for Localized prostatE CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03423303
A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)No drug interventionsscreeningNot Availableenrolling_by_invitation
NCT03317990
Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy.No drug interventionstreatmentNot Availableactive_not_recruiting
NCT02747290
68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer PatientsNo drug interventionsdiagnostic0unknown_status
NCT03338790
An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancertreatment2active_not_recruiting
NCT05195190
Validity, Reliability and Minimum Detectable Changes of 2-Minute Walk , Timed Up and Go, Sit and Stand Test in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01508390
Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the ProstateNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04842890
Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT04192890
Efficacy and Safety Assessment of IRE of Localized Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00378690
A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARDtreatment3completed
NCT06168890
Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure.No drug interventionsNot AvailableNot Availablecompleted
NCT00936390
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancertreatment3active_not_recruiting
NCT00036790
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancertreatment1completed
NCT00030290
Ultrasound in Treating Patients With Prostate Cancer Confined to the ProstateNo drug interventionstreatment1completed
NCT04317690
Online Trial Examining Validity and Reliability of the Shared Decision Making Process SurveyNo drug interventionsNot AvailableNot Availablecompleted
NCT00108290
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate CancerNo drug interventionstreatment2completed
NCT02049190
Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancertreatment1 / 2unknown_status
NCT03873090
SBRT in 4 Fractions for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT06527690
Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancertreatment2not_yet_recruiting
NCT04766190
DISCO: A Patient Intervention to Reduce the Financial Burden of CancerNo drug interventionshealth_services_researchNot Availablerecruiting
NCT00091390
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerNo drug interventionstreatment2completed
NCT02159690
A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomytreatment2withdrawn
NCT00736164
Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate CancerNo drug interventionstreatment2withdrawn
NCT04291664
PK and Dose Escalation and Expansion Study of DST-2970treatment1active_not_recruiting
NCT05427864
Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer StagingNo drug interventionsdiagnosticNot Availableunknown_status
NCT04354064
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01429064
Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001treatment2completed
NCT06257264
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumorstreatment1recruiting
NCT06085664
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomytreatment1 / 2recruiting
NCT02969564
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.No drug interventionsNot AvailableNot Availablecompleted
NCT03441464
Feasibility of the LUM Imaging System for Detection of Prostate CancerNo drug interventionsdevice_feasibility1 / 2terminated
NCT06170164
Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes?No drug interventionsNot AvailableNot Availablecompleted
NCT04000464
Comprehensive Lifestyle Improvement Program for Men With Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00108264
Tumor RNA Transfected Dendritic Cell VaccinesNo drug interventionsNot Available1completed
NCT03408964
Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05683964
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expressiondiagnostic0recruiting
NCT05705921
Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04701021
TENDU Vaccine in Patients With Relapse After Primary Radical ProstatectomyNo drug interventionstreatment1completed
NCT00499421
Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00002721
Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancertreatment1completed
NCT03927521
Feasibility Study on the Use of PET-MRI / 68Ga-PSMA Imaging for HIFU-focal Treatment in the Event of Recurrent Prostate Cancer After Radiotherapy - PSMA StudyNo drug interventionstreatmentNot Availablecompleted
NCT05802121
Akkermansia Muciniphilia and Metabolic Side Effects of ADTprevention0not_yet_recruiting
NCT03833921
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancertreatment2recruiting
NCT03252821
Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing RadiotherapyNo drug interventionstreatmentNot Availablecompleted
NCT00513721
Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT05100121
To Live Better and Longer With Prostate Cancer:No drug interventionssupportive_careNot Availablerecruiting
NCT03572621
Development and Evaluation of a Therapeutic Education Intervention in Prostate Cancer Patients Treated With Radical Prostatectomy to Improve Their SexualityNo drug interventionsotherNot Availableunknown_status
NCT00487721
The Effect of High-dose Silybin-phytosome in Men With Prostate Cancerbasic_science2completed
NCT05650021
Rectal Spacer for Prostate Cancer Radiation Image GuidanceNo drug interventionstreatmentNot Availablerecruiting
NCT02357121
Focal Laser Ablation of Prostate TissueNo drug interventionstreatment0completed
NCT02402621
Comparison Between Conventional and Model-based Infusion Strategy of IV PCA in Patients Undergoing RALPtreatmentNot Availablecompleted
NCT02415621
Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancertreatment0active_not_recruiting
NCT01036321
Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectivenesstreatment2completed
NCT01777802
Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or BrachytherapyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05384002
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's ContinuumNo drug interventionsNot AvailableNot Availablerecruiting
NCT01578902
Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT04996602
Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPCtreatment0unknown_status
NCT00006002
SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT00779402
PROvenge Treatment and Early Cancer Treatmenttreatment3completed
NCT05715502
Focal Salvage Brachytherapy Study (FocaSaBra)No drug interventionstreatmentNot Availablerecruiting
NCT00002602
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerNo drug interventionstreatment1 / 2completed
NCT00996502
Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancertreatment1 / 2terminated
NCT04775602
Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients With Prostate Cancer.No drug interventionsdiagnostic2unknown_status
NCT06435702
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort StudyNot AvailableNot Availablenot_yet_recruiting
NCT05361902
A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate CancerNo drug interventionsotherNot Availableactive_not_recruiting
NCT00969202
Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate CancerNo drug interventionstreatment1unknown_status
NCT00030602
Vaccine Therapy in Treating Patients With Recurrent Prostate Cancertreatment2completed
NCT03293602
MISOBOLD - Prostate Cancer Hypoxia Using BOLD MRI and 18F-MISO PET ImagingNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00003084
Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancertreatment2completed
NCT02125084
Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancertreatment1completed
NCT02468284
Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancerbasic_science1completed
NCT02712684
Cancer Diagnosis by Multiparametric UltraSound of the ProstateNo drug interventionsNot AvailableNot Availableunknown_status
NCT02209584
Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02526784
A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancertreatment3completed
NCT02135484
Radium 223 in Castrate Resistant Prostate Cancer Bone MetastasestreatmentNot Availablecompleted
NCT00181584
Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancerprevention2completed
NCT05069584
TransPERineal Fusion Biopsy Versus transrECTalNo drug interventionsdiagnosticNot Availablecompleted
NCT01386684
Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04587284
Economic Evaluation of Robot-assisted Laparoscopic Radical Prostatectomy vs Conventional Laparoscopic Radical Prostatectomy and Open Retropubic Radical Prostatectomy in Prostate Cancer: a Real-life Study Based on the French National Healthcare Data System (SNDS)No drug interventionsNot AvailableNot Availableunknown_status
NCT00503984
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patientstreatment1 / 2terminated
NCT01530984
Ipilimumab and GMCSF Immunotherapy for Prostate Cancertreatment2withdrawn
NCT03800784
Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancerdiagnostic2 / 3withdrawn
NCT02572284
Dose Escalation Study of Preoperative SBRT for High Risk Prostate CancerNo drug interventionstreatment1completed
NCT01697384
Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancertreatment3completed
NCT03908684
Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck CancersNo drug interventionsNot AvailableNot Availablerecruiting
NCT02252484
Energy Balance for Prostate Cancer SurvivorshipNo drug interventionspreventionNot Availablecompleted
NCT02793284
Advanced Prostate Imaging of Recurrent Cancer After RadiotherapyNo drug interventionsdiagnosticNot Availablecompleted
NCT03979079
Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical ModelNo drug interventionsNot AvailableNot Availablecompleted
NCT05567679
A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancertreatment0withdrawn
NCT02264379
Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT02485379
Assessment of Prostate MRI Before Prostate BiopsiesNo drug interventionsdiagnosticNot Availablecompleted
NCT00588679
Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 TeslaNo drug interventionsdiagnosticNot Availablecompleted
NCT06259279
High Impact Training to Patients With Prostate Cancer and Bone MetastasesNo drug interventionssupportive_careNot Availablerecruiting
NCT03495479
Aneustat Treatment of Localized Prostate Cancer Under Active SurveillanceNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02131779
Men's Prostate Awareness Church TrainingNo drug interventionsscreeningNot Availablecompleted
NCT05437679
Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® SystemNo drug interventionsNot AvailableNot Availableterminated
NCT04028479
The Registry of Oncology Outcomes Associated With Testing and TreatmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT00743379
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumorstreatment1 / 2completed
NCT03465579
Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging.No drug interventionsdiagnosticNot Availablerecruiting
NCT01168479
FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate CancerNo drug interventionstreatment3completed
NCT00116779
A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancertreatment2completed
NCT00310479
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT03440879
Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucosebasic_scienceNot Availableterminated
NCT00176579
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00007579
To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population.No drug interventionsNot AvailableNot Availablecompleted
NCT03212079
Physical Activities by Technology Help (PATH)No drug interventionsotherNot Availablecompleted
NCT04305379
Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical ProstatectomyNo drug interventionspreventionNot Availableterminated
NCT02334579
Stereotactic Body Radiotherapy for Stage I-III Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT02745587
Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer.No drug interventionstreatment3terminated
NCT03035487
Urology of Virginia Case SeriesNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT00274287
GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxoteretreatment2completed
NCT05584787
Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort AnalysisNo drug interventionstreatmentNot Availablerecruiting
NCT01374087
Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancertreatment2terminated
NCT02111187
A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancertreatment1completed
NCT00127387
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexiadiagnostic2 / 3terminated
NCT06168487
Telmisartan in Prostate Cancertreatment0recruiting
NCT00383487
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancertreatment2terminated
NCT02785887
Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology PatientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT05432687
Impact of Abdominal Incompetence on Urinary Incontinence After Prostatectomy (PROSTABDO)No drug interventionsscreeningNot Availablerecruiting
NCT01441687
Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy OutcomeNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT03034187
Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program ProstateNo drug interventionsNot AvailableNot Availablerecruiting
NCT00375687
Investigation of Early Hormonotherapy Efficacy of Prostate CancertreatmentNot Availableunknown_status
NCT03535987
Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT01546987
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancertreatment3active_not_recruiting
NCT01089387
Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile DysfunctionNo drug interventionstreatment1 / 2completed
NCT00200187
A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate SurgeryNo drug interventionsprevention2completed
NCT00140387
Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)No drug interventionstreatment1 / 2completed
NCT06060587
Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abirateronetreatment2active_not_recruiting
NCT01792687
Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetatetreatment1completed
NCT00728533
Open-Label, Randomised Parallel-Group Studytreatment3withdrawn
NCT00894933
Performance Evaluation of the AMS CONTINUUM™ DeviceNo drug interventionstreatmentNot Availablecompleted
NCT01481233
Oral Colchicine in Men With Castrate Resistant Prostate Cancertreatment2withdrawn
NCT00416533
Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT02721433
4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastasestreatment4completed
NCT06262633
A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03439033
Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancerscreening2terminated
NCT04702633
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01867333
Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancertreatment2completed
NCT04862533
Effect of Beta-alanine and Pelvic Floor Muscle Training on Urinary Incontinence After Radical Prostatectomy (BELA)treatmentNot Availablecompleted
NCT00831233
Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancertreatment3terminated
NCT03392233
Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite TumorsNo drug interventionstreatment2recruiting
NCT00573833
Internal Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00898833
Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583No drug interventionsNot AvailableNot Availableterminated
NCT04642833
Prostate Cancer in Renal Transplants RecipientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05820633
Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.No drug interventionstreatmentNot Availablerecruiting
NCT00036933
Vaccine Therapy Plus QS21 in Treating Patients With Prostate CancerNo drug interventionstreatment1completed
NCT03025633
Explaining the Invisible Using the PEARL SystemNo drug interventionssupportive_careNot Availablecompleted
NCT00030654
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancertreatment3completed
NCT01261754
A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy VolunteersNo drug interventionsdiagnostic1completed
NCT05378854
Training Data Collection & AI DevelopmentNo drug interventionsotherNot Availablecompleted
NCT01545154
The Use of Transperineal Ultrasound for Radiation Therapy Treatment Planning and Image Guidance in the Treatment of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06037954
A Study of Mental Health Care in People With CancerNo drug interventionsotherNot Availablerecruiting
NCT00459654
A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancertreatment2completed
NCT02303054
MRI-Targeted Focal Ablation of the Prostate in Men With Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT03174054
The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate LesionsNo drug interventionsNot AvailableNot Availableunknown_status
NCT00967954
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00866554
Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapytreatment2completed
NCT05989854
The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate CancerNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT01445054
111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast CancerNo drug interventionsdiagnostic0terminated
NCT00627354
Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapytreatment2completed
NCT00004054
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancertreatment3completed
NCT00888654
Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomytreatment2completed
NCT00026754
Eligibility Screening for the NIH Intramural Research Program Clinical ProtocolsNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT03983954
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumorstreatment1active_not_recruiting
NCT05411354
Analyzing Clinical Trial Experiences of Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03845751
EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.No drug interventionsprevention2recruiting
NCT03213951
Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic LesionsNo drug interventionsNot AvailableNot Availablecompleted
NCT00439751
Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapytreatment3completed
NCT04402151
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancertreatment2recruiting
NCT01751451
3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomytreatment2completed
NCT00350051
ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancertreatment2completed
NCT01618851
Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00897351
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803No drug interventionsNot AvailableNot Availablecompleted
NCT03819751
MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer DetectionNo drug interventionsdiagnosticNot Availablerecruiting
NCT00694551
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive TreatmenttreatmentNot Availablecompleted
NCT02963051
A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancertreatment1terminated
NCT01613651
Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate CancerNo drug interventionssupportive_care3completed
NCT04632251
Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT06397651
A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of CareNo drug interventionssupportive_careNot Availablerecruiting
NCT04159051
Charité HT-ProstateNo drug interventionstreatmentNot Availableunknown_status
NCT06235151
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancerdiagnostic3recruiting
NCT05603351
Prostate Cancer Screening With Abbreviated MRI ProtocolNo drug interventionspreventionNot Availablerecruiting
NCT03880851
MR-based Hypofractionated Adaptive IGRT of Prostate Cancer (M-base HyPro 2.0)No drug interventionstreatmentNot Availableunknown_status
NCT02773251
The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity SurgeryNo drug interventionstreatment4completed
NCT06116851
Prostate Metabolism, Cancer Risk and Gut MicrobiotaNo drug interventionsNot AvailableNot Availablerecruiting
NCT01790451
Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in HumansNo drug interventionstreatment1completed
NCT03284151
Focused Stereotactic Radiation Treatment of Prostatic AdenocarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00294151
Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate CancerNo drug interventionstreatment3unknown_status
NCT01549951
Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancertreatment2completed
NCT05230251
Radioligand fOr locAl raDiorecurrent proStaTe cancERtreatment2active_not_recruiting
NCT00116753
A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancertreatment2completed
NCT00003653
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancertreatment3completed
NCT01459653
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating FactorNo drug interventionsNot AvailableNot Availablecompleted
NCT03431753
Early and Accurate Detection of Prostate Cancer in General PracticeNo drug interventionsdiagnosticNot Availableunknown_status
NCT05882253
Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)No drug interventionshealth_services_researchNot Availablerecruiting
NCT02135653
A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00670553
A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancertreatment1completed
NCT00692653
Personal Patient Profile Prostate (P4) Randomized, Multisite TrialNo drug interventionsNot AvailableNot Availablecompleted
NCT06395753
A Dose Finding Study of Debio 4228 in Participants With Locally Advanced/Metastatic Prostate CancerNo drug interventionstreatment2recruiting
NCT01377753
MR Image Guided Therapy in Prostate CancerNo drug interventionstreatment2completed
NCT04034953
Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong KongNo drug interventionsscreeningNot Availableunknown_status
NCT05253053
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT06131853
Kinesiophobia in Prostate CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT01174953
High Risk Prostate Cancer Prevention StudypreventionNot Availablecompleted
NCT00987753
Study Evaluating the Safety and Tolerability of L-377202treatment1 / 2completed
NCT00105053
Vaccine Treatment for Hormone Refractory Prostate CancerNo drug interventionstreatment1 / 2completed
NCT02042053
PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate CancerNo drug interventionsotherNot Availableterminated
NCT03837353
A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1treatment1 / 2terminated
NCT05957653
Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfortprevention4not_yet_recruiting
NCT05806853
PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric StudyNo drug interventionsdiagnostic2completed
NCT03734653
Testosterone Therapy in Castration Resistant Prostate Cancertreatment0active_not_recruiting
NCT03763253
Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment AlgorithmsNo drug interventionstreatment2recruiting
NCT04046653
Accumulation of Dietary Bioactives and Prostate CancerNo drug interventionspreventionNot Availablecompleted
NCT04102553
F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrencediagnostic3completed
NCT00015977
Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT04724577
12 Fractions Carbon Ion Radiotherapy for Localized Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00945477
Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockadetreatment2terminated
NCT00426777
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancerprevention3completed
NCT05075577
EPI-7386 in Combination With Enzalutamide Compared With Enzalutamide Alone in Subjects With mCRPCtreatment1 / 2recruiting
NCT02626377
Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-ComtéNo drug interventionsotherNot Availableterminated
NCT01793077
Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer PatientsNot AvailableNot Availablecompleted
NCT06523777
PRISM: Patient Experiences With PET Imaging in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02969577
Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for MenNo drug interventionssupportive_careNot Availablecompleted
NCT05348577
Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)treatment3recruiting
NCT04261777
Ferumoxtran-10-enhanced MRI in Prostate Cancer PatientsNo drug interventionsdiagnostic3recruiting
NCT00691977
Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the ProstateNo drug interventionstreatment1withdrawn
NCT00919477
Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mgNo drug interventionsNot AvailableNot Availablecompleted
NCT05403177
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)No drug interventionsNot AvailableNot Availablerecruiting
NCT00026377
SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancertreatment1completed
NCT01886677
Improving Energy Balance in Men With Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT03756077
A Study of the Value of Hybrid PET/MR and PET/CT in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00953277
Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate CancerNo drug interventionstreatment4completed
NCT06099977
Binaural Sound for Remimazolam InductionNo drug interventionssupportive_careNot Availablerecruiting
NCT05027477
A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03246347
A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancertreatment2active_not_recruiting
NCT04064047
Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided BiopsyNo drug interventionssupportive_careNot Availablecompleted
NCT00634647
Satraplatin and Prednisone to Treat Prostate Cancertreatment2completed
NCT01886547
2013 Annual National Digital Rectal Exam (DRE) Day StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00541047
RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgerytreatment3completed
NCT04049747
Comparative Health Research Outcomes of NOvel Surgery in Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00061347
Using Fiducial Markers to Aid in Prostate Cancer Radiation TreatmentNo drug interventionsdiagnostic1completed
NCT04487847
18F-PSMA-1007 PET Imaging to Detect Primary Prostate CancerNo drug interventionsdiagnostic1 / 2active_not_recruiting
NCT02202447
Phase 1 of EC1169 In Patients With Recurrent MCRPCNo drug interventionstreatment1completed
NCT02844647
Hyperpolarized Carbon-13 Imaging of Metastatic Prostate CancerNo drug interventionsdiagnostic1terminated
NCT00819247
The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancertreatment2completed
NCT05448547
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate CancerNo drug interventionstreatment3recruiting
NCT03157947
Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)treatment1active_not_recruiting
NCT06043947
Survival Monitoring in Russian Cancer RegistriesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00082147
Magnetic Resonance Imaging to Locate and Characterize Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00005947
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment3completed
NCT00013247
Facilitating Shared Decisionmaking About Prostate Cancer ScreeningNo drug interventionstreatmentNot Availablecompleted
NCT06274047
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.treatment3not_yet_recruiting
NCT01764347
Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT01411345
MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS TrialNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01566045
MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00476645
Fulvestrant in Hormone Refractory Prostate Cancertreatment2completed
NCT01677845
Hypo-Fractionated Radiation Therapy for Localized Prostate CancerNo drug interventionstreatment1terminated
NCT04186845
Imaging Study to Investigate Safety and Diagnostic Performance of rhPSMA 7.3 (18F) PET Ligand in Suspected Prostate Cancer Recurrence (SPOTLIGHT)No drug interventionsdiagnostic3completed
NCT02479945
Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT04550845
Understanding of Genetics by Men at Risk for Prostate CancerNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04272645
Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancertreatment2withdrawn
NCT06125145
Geriatric Assessment and Promotores (GAP) Pilot Feasibility StudyNo drug interventionssupportive_careNot Availablerecruiting
NCT02061345
PET Imaging in MCI Following ADT for PCaNo drug interventionsNot AvailableNot Availablecompleted
NCT00215345
A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancertreatment2unknown_status
NCT00736645
Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancertreatment2completed
NCT00292045
Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancertreatment1completed
NCT00069745
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimentreatment3completed
NCT00918645
Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone MetastasisdiagnosticNot Availableterminated
NCT02799745
A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillancetreatment2completed
NCT03493945
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)treatment1 / 2active_not_recruiting
NCT00003645
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrencetreatment3terminated
NCT05319145
PeRsonalizing the Approach to the Oncologic Frail Individual Through Tailored Assessment and Intervention (PROFIT Study)No drug interventionstreatmentNot Availableunknown_status
NCT00223145
Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alonetreatment3unknown_status
NCT00804245
C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancerdiagnostic1completed
NCT03776045
PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO)No drug interventionspreventionNot Availablecompleted
NCT03516045
A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate CancerNo drug interventionsdiagnostic1 / 2unknown_status
NCT06482645
Evaluation of Perilesional Biopsy in Diagnosis of Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT04382898
PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)treatment1 / 2terminated
NCT00376298
Urology Database to Evaluate Clinical Information and Improve Patient Care.No drug interventionsNot AvailableNot Availablecompleted
NCT06075498
Comparison of Analgesia Efficacy of Transversus Abdominis Plane Block and Posterior Approach Quadratus Lumborum BlockNo drug interventionspreventionNot Availablecompleted
NCT00060398
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancersupportive_care3completed
NCT05697198
PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision MedicineNo drug interventionsNot AvailableNot Availablerecruiting
NCT01352598
Stereotactic Body Radiotherapy for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT06159998
New Markers for Treatment Response to Radiotherapy in Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05428098
The Effect of the Educatıon and Counselıng of Prostatectomy PatıentsNo drug interventionssupportive_careNot Availablecompleted
NCT02917798
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient OutcomesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03180398
Multi-parametric Magnetic Resonance Imaging for Prostate Cancer PatientsNo drug interventionstreatmentNot Availableterminated
NCT01535898
Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate CancersNo drug interventionsNot AvailableNot Availablecompleted
NCT01672905
PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802No drug interventionsNot AvailableNot Availablecompleted
NCT02692105
Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate CancerNo drug interventionstreatment3active_not_recruiting
NCT00632905
Bone Health Observational StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00989105
Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate CancerNo drug interventionsdiagnostic1terminated
NCT00083005
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostatetreatment2completed
NCT00033605
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvissupportive_care3completed
NCT00122005
GVAX in Advanced Prostate Cancer Patients Made LymphopenicNo drug interventionstreatment1 / 2unknown_status
NCT05180305
A Study to Assess Mitomic Prostate Test for Prostate Cancer ScreeningNo drug interventionsNot AvailableNot Availableunknown_status
NCT06298305
Artificial Intelligence & Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06347705
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate CancerNo drug interventionstreatment2recruiting
NCT00176605
Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancertreatment2completed
NCT01020305
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancertreatment1 / 2terminated
NCT00218205
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancertreatment2unknown_status
NCT05422105
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer PatientNo drug interventionsNot AvailableNot Availablerecruiting
NCT00773305
Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01705405
Merging of Endoscopic and Ultrasound Images for Laparoscopic SurgeryNo drug interventionsNot AvailableNot Availableterminated
NCT03300505
ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancertreatment1terminated
NCT00365105
Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancersupportive_care3completed
NCT04803305
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexiatreatment1completed
NCT06292897
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer ProgressionNo drug interventionsNot AvailableNot Availablerecruiting
NCT00214097
Phase I/II Hypofractionated Radiotherapy for Prostate CancerNo drug interventionstreatment1 / 2completed
NCT06389097
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment OptimizationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03493997
Multicentre International STudy for the Prevention With Ialuril® of Radio-induced Cystitis (MISTIC)No drug interventionsprevention2completed
NCT00354497
Prostate Cancer Screening and Dietary Heterocyclic Amines in African American MenNo drug interventionsscreening2unknown_status
NCT00002597
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancertreatment3completed
NCT02212197
Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancertreatment2completed
NCT01813097
Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04663997
177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancertreatment2active_not_recruiting
NCT02408497
Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05778097
Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)treatment2not_yet_recruiting
NCT00658697
Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancertreatment2completed
NCT06235697
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate TreatmentNo drug interventionstreatment3recruiting
NCT04050397
Exercise and Quality of Life During Androgen Deprivation TherapyNo drug interventionstreatmentNot Availableunknown_status
NCT00181597
Trilostane for Androgen-Independent Prostate Cancertreatment2completed
NCT03882697
Ability of Cardio Q for Prediction of HypotensionNo drug interventionsNot AvailableNot Availablecompleted
NCT04972097
Pivotal Study of the NanoKnife System for the Ablation of Prostate TissueNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02981797
Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223No drug interventionsNot AvailableNot Availablecompleted
NCT01913197
Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate BrachytherapyNo drug interventionstreatment1 / 2terminated
NCT03044197
Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT03278197
Evaluation of a Web-based Decision Aid Tool for Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00050297
YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate CancerNo drug interventionstreatment2terminated
NCT02001597
Intra-operative Trans-rectal Ultrasound Guidance for Robot-assisted Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT01450683
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapytreatment2terminated
NCT01324583
Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancertreatment1completed
NCT05800483
Improving Decision-Making for Low Health Literate Prostate CA PatientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT03912883
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful WaitingNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03178383
Integration of Cancer Health Activities Into African American ChurchesNo drug interventionspreventionNot Availablecompleted
NCT02816983
SBRT for Oligometastatic Castration-Refractory Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00175383
Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancertreatment3unknown_status
NCT02954783
PROstaTe Cancer - Exercise-STudy (PRO-TEST)No drug interventionsbasic_scienceNot Availablecompleted
NCT06212583
High-Risk Metachronous Oligometastatic Prostate Cancer Trialtreatment2recruiting
NCT05141383
Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT02064283
Early Assessment of Treatment Response Using Functional Diffusion MappingNo drug interventionsNot AvailableNot Availablecompleted
NCT01414283
Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate CancerNo drug interventionstreatment1completed
NCT05527483
Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer PatientsNot AvailableNot Availablecompleted
NCT01250483
Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS)No drug interventionsNot AvailableNot Availablecompleted
NCT02833883
Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancertreatment1completed
NCT00668083
Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00430183
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancertreatment3active_not_recruiting
NCT03336983
Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patientstreatment2completed
NCT01685983
A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancertreatment2completed
NCT03694483
Prostasomes as Diagnostic Tool for Prostate Cancer DetectionNo drug interventionsNot AvailableNot Availablesuspended
NCT04831983
ABlative Radiotherapy (for) Unfavorable Prostate TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01602783
11C Acetate Imaging Post ProstatectomyNo drug interventionsdiagnosticNot Availableterminated
NCT01936883
Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR BrachytherapyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00215683
An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancertreatment2 / 3completed
NCT05424783
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)No drug interventionsNot AvailableNot Availablerecruiting
NCT05773183
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in MenNot AvailableNot Availablenot_yet_recruiting
NCT06194461
LTFU for All Cell and Gene Therapy StudiesNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06484361
PET/MRI to Stage Prostate Cancer PatientsNo drug interventionsdiagnostic2recruiting
NCT02066961
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01485861
Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapytreatment1 / 2completed
NCT00792961
Real Time Microscopic Imaging During Robot Assisted Prostate Cancer SurgeryNo drug interventionsdiagnosticNot Availablecompleted
NCT05137561
Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed TRUS Guided Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT00093561
Lycopene in Preventing Prostate Cancer in Healthy ParticipantsNo drug interventionsprevention1completed
NCT02176161
Metformin Prostate Cancer Adjuvant Trialtreatment2completed
NCT01900561
Optimizing Veteran-Centered Prostate Cancer Survivorship CareNo drug interventionssupportive_careNot Availablecompleted
NCT05946161
Testing an e-Health Intervention for Prostate Cancer Survivors' Mental and Sexual HealthNo drug interventionstreatmentNot Availablerecruiting
NCT00004261
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaNo drug interventionsdiagnostic1terminated
NCT04278261
Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01420861
GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancertreatment2terminated
NCT04066361
OPTimizing Treatment Focused Genetic Testing IN CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02460861
Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical ProstatovesiculectomyNo drug interventionsbasic_scienceNot Availableunknown_status
NCT04622761
Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcometreatment2not_yet_recruiting
NCT04569461
Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)treatment2not_yet_recruiting
NCT06238661
Prostate Cancer Screening: a Pilot StudyNo drug interventionsscreeningNot Availablenot_yet_recruiting
NCT05547061
A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapytreatment1 / 2recruiting
NCT04684628
68Ga-PSMA PET/CT in Prostate CancerNo drug interventionsdiagnostic3suspended
NCT04090528
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancertreatment2active_not_recruiting
NCT03609528
CamPROBE: Developing a Safer and Simple Device for Local Anaesthetic Transperineal Prostate BiopsiesNo drug interventionsdiagnosticNot Availablecompleted
NCT00085228
Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostatetreatment2completed
NCT01172028
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT01565928
Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancertreatment1completed
NCT02821728
Sulphate Accumulation in ProstateNo drug interventionspreventionNot Availablecompleted
NCT04221828
Trial of NanoPac Focal Therapy for Prostate Cancertreatment2terminated
NCT02423928
Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancertreatment1completed
NCT04685928
Extended Systematic Versus Mri-Assisted pRostate Transperineal BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT00005028
Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT01385228
Pazopanib, Docetaxel, Prednisone Prostatetreatment1completed
NCT02115828
A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsytreatment0completed
NCT00004928
Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancertreatment1completed
NCT04113811
Microwave Needle Thermoablation for Treatment of Localized Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02053311
Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agentstreatment3withdrawn
NCT01234311
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancertreatment3completed
NCT05064111
Utility of Adding MR Fusion to Standard US Guided Prostate BiopsyNo drug interventionsNot AvailableNot Availablesuspended
NCT00969111
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT04290611
a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitYNot AvailableNot Availablecompleted
NCT03851211
Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL EvaluationNo drug interventionsNot AvailableNot Availableunknown_status
NCT06072911
Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT06430411
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET StudyNot AvailableNot Availablenot_yet_recruiting
NCT00394511
Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate CancerNo drug interventionstreatment3completed
NCT03508011
A Study of IMP4297 in Patients With Advanced Solid Tumorstreatment1completed
NCT03573011
PSMA PET/CT for Prostate CancerNo drug interventionsdiagnostic2completed
NCT04100811
Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ PlatformNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04228211
Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term EvaluationNo drug interventionsNot AvailableNot Availablerecruiting
NCT00260611
Study of Oxaliplatin and Taxotere in Prostate Cancertreatment2completed
NCT06018311
Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver DyadsNo drug interventionspreventionNot Availablerecruiting
NCT03558711
PSMA-PET/CT for Prostate CancerNo drug interventionsdiagnostic1completed
NCT00874211
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesNo drug interventionsNot AvailableNot Availablecompleted
NCT00004211
Vaccine Therapy in Treating Patients With Metastatic Prostate CancerNo drug interventionstreatment1 / 2completed
NCT00897793
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00921193
Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01385293
BKM120 in Metastatic Castration-resistant Prostate Cancertreatment2terminated
NCT00590993
Magnetic Resonance Imaging and Spectroscopy of the ProstateNo drug interventionsNot AvailableNot Availablecompleted
NCT01875393
Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancertreatment3completed
NCT01653093
3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate CancerNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT03664193
MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT03886493
Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancertreatment2terminated
NCT05679193
Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrencetreatment2completed
NCT03996993
Defining Recurrent Disease With Axumin™Not AvailableNot Availableunknown_status
NCT06099093
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetandiagnostic4recruiting
NCT02279693
Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate CancerNo drug interventionshealth_services_researchNot Availableterminated
NCT06335693
Adjuvant Hypofractionated Radiotherapy for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03749993
Evaluation of a MRI-based Prostate Cancer Screening ProgramNo drug interventionsscreeningNot Availablecompleted
NCT01079793
Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgerytreatment1 / 2withdrawn
NCT00737893
Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomytreatment2completed
NCT02663193
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) TolerabilityNo drug interventionsNot AvailableNot Availablecompleted
NCT02054793
Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)treatment1 / 2withdrawn
NCT00268593
Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancertreatment2completed
NCT02225093
A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancerbasic_science1completed
NCT01252693
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancertreatment2completed
NCT05946993
Linking In With Advice and Supports for Men Impacted by Metastatic CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT00286793
Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPCtreatment1 / 2completed
NCT02167893
Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"Not AvailableNot Availablecompleted
NCT04108871
Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve MenNo drug interventionsdiagnosticNot Availableunknown_status
NCT00861471
Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancertreatment1 / 2terminated
NCT01759771
Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trialtreatment2completed
NCT04576871
Re-treatment 225Ac-J591 for mCRPCtreatment0recruiting
NCT01225471
Novel Peptide Vaccination for Patients With Advanced Prostate CancerNo drug interventionstreatment1 / 2unknown_status
NCT03261271
Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical ProstatectomyNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT01849471
Socioeconomic Aspects Before and After Radiation Therapy in Patient With Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT03822871
A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancertreatment1completed
NCT01194271
Neoadjuvant Ipilimumab in Prostate Cancertreatment2completed
NCT00193271
Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancertreatment2completed
NCT03141671
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)treatment2active_not_recruiting
NCT01950871
Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanningNo drug interventionsdiagnostic4terminated
NCT05454371
Investigation of Urinary Biomarkers for the Detection of Prostate CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT02689271
CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancErNo drug interventionsNot AvailableNot Availablecompleted
NCT00637871
Casodex - Nolvadex Combinationtreatment2completed
NCT01774071
Study of 89Zr-DFO-MSTP2109A in Patients With Prostate CancerNo drug interventionsdiagnostic1 / 2completed
NCT05605171
Posterior Urethrovesical Anastomotic Reconstruction in Comparison to Conventional Urethrovesical AnastomosisNo drug interventionstreatmentNot Availablecompleted
NCT02284971
Pilot Study of SBRT and CDX-1127 in Prostate Cancertreatment1terminated
NCT03896178
Prostate Cancer in Firemen: Early Diagnosis Because of Increased Diagnostic Pressure?No drug interventionsNot AvailableNot Availablecompleted
NCT03274778
Effect of Ruxolitinib on Tumor Infiltrating Myeloid CellstreatmentNot Availablewithdrawn
NCT05232578
Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher AggressivenessNo drug interventionstreatment3not_yet_recruiting
NCT02252978
Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsydiagnostic2withdrawn
NCT04170478
Transperineal Laser Ablation for Focal Treatment of Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT04656678
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00140478
Mifepristone (RU-486) in Androgen Independent Prostate Cancertreatment2completed
NCT00715078
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigentreatment2completed
NCT05597878
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomysupportive_care2 / 3recruiting
NCT00638378
Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancertreatment2terminated
NCT04995978
Insulin Resistance and Androgen Deprivation Therapytreatment2withdrawn
NCT03368378
Early DVC Ligation and Urinary Continence Recovery After RARPNo drug interventionstreatmentNot Availablecompleted
NCT03520478
A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancertreatment3active_not_recruiting
NCT05352178
Metastasis-directed Therapy for Oligorecurrent Prostate CancerNo drug interventionstreatment3recruiting
NCT00127478
A Long Term Safety Study With Atrasentantreatment2 / 3completed
NCT02024178
Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing SurgeryNo drug interventionsdiagnosticNot Availablecompleted
NCT01379378
Male Stress Urinary Incontinence and Sexual HealthNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00257478
A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapytreatment2completed
NCT06158178
Evaluation of the Predictive Role of Choline PET/CT on the Survival of Patients Affected by Prostate Cancer.No drug interventionsNot AvailableNot Availablecompleted
NCT06185478
Prostate Diffusion Imaging With Distortion CorrectionNo drug interventionsdiagnosticNot Availablesuspended
NCT04641078
Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancertreatment2recruiting
NCT04797078
US/MRI Fusion Local Anestesia TransPerineal Prostate Biopsies for Detection of Prostate CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT03703778
Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)Not AvailableNot Availableactive_not_recruiting
NCT01909388
Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate BrachytherapyNo drug interventionstreatment2unknown_status
NCT03995888
Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate CancerNo drug interventionsdiagnostic1completed
NCT05947188
Circulating Tumor Cells and mpMRI for Non-invasive Diagnosis of Prostate Cancer(CMNDPC)No drug interventionsdiagnosticNot Availablerecruiting
NCT03830788
Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body RadiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT06282588
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracerstreatment2 / 3recruiting
NCT03351088
Outcomes From a RCT Comparing Preventive Versus Delayed Ligation of DVC During Robot-assisted Radical ProstatectomyNo drug interventionstreatmentNot Availableunknown_status
NCT00323388
Identification of Risk Allels for Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01341288
Robotic Seed Implantation for Prostate Cancer BrachytherapyNo drug interventionstreatment1terminated
NCT00327288
Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patientstreatment1completed
NCT01226888
Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT03617588
68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate CancerNo drug interventionsdiagnostic2completed
NCT01858688
A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT02103088
Sexual and Urological Rehabilitation to Men Operated for Prostate Cancer and Their PartnersNo drug interventionssupportive_careNot Availablecompleted
NCT04549688
Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00541788
Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen DeprivationNo drug interventionstreatment1completed
NCT00814788
Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancertreatment2completed
NCT00069888
A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomytreatment2completed
NCT03568188
Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT02123888
Simultaneous CBCT Acquisition During Arc RadiotherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01351688
An Open Label Prostate Cancer Study in Japanese PatientsNo drug interventionstreatment1completed
NCT00058188
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivationsupportive_care3terminated
NCT04409288
Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancertreatment3terminated
NCT05011188
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancertreatment1 / 2recruiting
NCT02213107
Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.treatment2completed
NCT02131207
MRI Before Biopsy in Diagnosing Patients With Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT02796807
Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate CancerNo drug interventionsbasic_science2completed
NCT05558007
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patientstreatment2recruiting
NCT00789607
Fiducial Localization and Individualized Radiotherapy -Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT05522907
Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00852007
A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1No drug interventionsNot Available1 / 2completed
NCT04612907
Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03173807
Prostate Nutrition and Exercise STudy (ProNEST)No drug interventionssupportive_careNot Availablewithdrawn
NCT05179707
A Research for Combination of Prostate Health Index (Phi) and mpMRI PI-RADS in the Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT03043807
A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomytreatment2completed
NCT01802307
Focal Therapy for Prostate CancerNo drug interventionstreatment2withdrawn
NCT02293707
A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate CancerNo drug interventionstreatment2completed
NCT03177707
Intimacy and Mindfulness Post-Prostate Cancer TreatmentNo drug interventionssupportive_careNot Availablecompleted
NCT02042807
To Evaluate the Effect of MCS® in Prostate Cancer PreventionNo drug interventionsprevention2active_not_recruiting
NCT03383107
Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local MicrobiomeNo drug interventionsNot AvailableNot Availablecompleted
NCT04221607
An Intimacy Intervention for Couples Completing Breast or Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT05767307
Danish Prostate Cancer Consortium Study-1No drug interventionsNot AvailableNot Availablerecruiting
NCT01983709
Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate CancerNo drug interventionstreatment1terminated
NCT05615909
PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRTNo drug interventionsNot AvailableNot Availablecompleted
NCT01197209
Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate CancerNo drug interventionstreatment1withdrawn
NCT02726009
A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancertreatment4completed
NCT00578409
Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker DataNo drug interventionsNot AvailableNot Availablecompleted
NCT00946309
Effects of Sulforaphane on Normal Prostate Tissueprevention1 / 2completed
NCT02997709
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT06434909
CYTALUX™for the Intraoperative Imaging of Prostate CancerNo drug interventionsdiagnostic0not_yet_recruiting
NCT06330909
Image-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Stereotactic rtNo drug interventionstreatmentNot Availablerecruiting
NCT00244309
Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancertreatment3completed
NCT00062309
Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate CancerNo drug interventionstreatment3completed
NCT02861209
Collaborative Network to Take Responsibility for Oral Anticancer TherapyNo drug interventionssupportive_careNot Availableunknown_status
NCT00313456
A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxeltreatment1terminated
NCT00436956
AZD2171 to Treat Prostate Cancertreatment2completed
NCT01311856
Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer SurvivorsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05523856
New Treatment Modalities for Localized Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03017456
PC 360 SurvivorshipNo drug interventionssupportive_careNot Availablecompleted
NCT04307056
Evaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPYNo drug interventionstreatmentNot Availablecompleted
NCT00132756
Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancertreatment1 / 2terminated
NCT03264456
Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRIdiagnostic1 / 2completed
NCT05176756
RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)No drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT01578356
Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT00089856
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancertreatment3terminated
NCT06496256
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) TrialNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT04235556
Integrated Care Pathway in Oncology (PASSION)No drug interventionsNot AvailableNot Availableunknown_status
NCT00261456
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04960956
Glycosylation of Exosomes in Prostate and Urothelial CarcinomaNo drug interventionsNot AvailableNot Availableterminated
NCT01314456
3D Recording of a Trans-rectal Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT05322356
Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D SystemNo drug interventionstreatmentNot Availablerecruiting
NCT02717156
Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumorstreatment2recruiting
NCT02600156
Focal Laser Ablation of Low to Intermediate Prostate Cancer TumorsNo drug interventionstreatmentNot Availablerecruiting
NCT00193856
RADAR Trial - Randomised Androgen Deprivation and Radiotherapytreatment3completed
NCT00635856
Open Label Trial to Assess Iressa in Prostate Cancer PatientsNot Available2completed
NCT02280356
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate CancerNo drug interventionstreatment2completed
NCT06472856
Vasomotor Symptom Alleviation Through Acupuncture in Patients With Prostate CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03151356
Prostate Health Index for Prostate Cancer DiagnosisNo drug interventionsNot AvailableNot Availablecompleted
NCT01410656
Prostate Cancer Survivors Moving Toward Exercise (PROMOTE) TrialNo drug interventionssupportive_careNot Availablecompleted
NCT02512185
Towards Optimal Prescription of Chemotherapy in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06453785
Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer DetectionNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT06039085
Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin AssessmentNo drug interventionsNot AvailableNot Availablerecruiting
NCT00588185
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT03333785
Randomized Trial of eOncoNoteNo drug interventionshealth_services_researchNot Availablecompleted
NCT01243385
Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancertreatment2completed
NCT02042885
A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced CancerNo drug interventionstreatment1 / 2terminated
NCT05617885
Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancertreatment1 / 2active_not_recruiting
NCT03030885
Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)treatment1completed
NCT01279785
A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing ProstatectomyNot AvailableNot Availablewithdrawn
NCT00918385
Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancertreatment2terminated
NCT01650285
Cabazitaxel and Radiation For Patients With Prostate Cancertreatment2terminated
NCT00424385
Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)treatment1completed
NCT02232685
Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT05672485
99mTc-P137 SPECT/CT in Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT00199485
Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate CancerNo drug interventionstreatment4completed
NCT05104515
First-in-human Study of OVM-200 as a Therapeutic Cancer VaccineNo drug interventionstreatment1recruiting
NCT05231915
Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in MartiniqueNo drug interventionsscreeningNot Availablerecruiting
NCT02381015
Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4aNo drug interventionsbasic_scienceNot Availablecompleted
NCT02179515
Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)treatment1completed
NCT00791115
Salvage Prostatectomy After RadiotherapyNo drug interventionstreatmentNot Availablecompleted
NCT00619515
Stereotactic Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT04212715
Prostate SABR With Intra-Prostatic SABR BoostNo drug interventionstreatment2recruiting
NCT00678015
Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancertreatment2terminated
NCT00991315
Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the ProstateNo drug interventionsNot AvailableNot Availableterminated
NCT02353715
Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise TestingNot AvailableNot Availablecompleted
NCT02804815
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumoursother3recruiting
NCT05940415
Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00992615
Comparison of 20-core Versus 12-core Prostate Biopsy Diagnostic Performance in the Detection of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05313815
Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00126815
Mathematical Modeling Analysis of Serum Prostate Specific Antigen After RadiotherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT03214315
Structural Network on Prostate Cancer in the French Greater West RegionNo drug interventionsNot AvailableNot Availablecompleted
NCT01071915
Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancertreatment3completed
NCT02457715
Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral SclerosisNo drug interventionsNot AvailableNot Availablecompleted
NCT02656615
Abiraterone-Rechallenge Study for CRPC Patientstreatment2terminated
NCT04763915
Improving Care After Inherited Cancer TestingNo drug interventionspreventionNot Availablerecruiting
NCT03964337
Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancerother2terminated
NCT04083937
Prostate Cancer Patients Treated With Alternative Radiation Oncology StrategiesNo drug interventionstreatmentNot Availablerecruiting
NCT05430737
A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT06392737
Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer DiagnosisNo drug interventionsdiagnosticNot Availablerecruiting
NCT01940237
A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic CancerNo drug interventionstreatmentNot Availableterminated
NCT02236637
A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical CareNo drug interventionsNot AvailableNot Availablecompleted
NCT03795337
Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-II)No drug interventionstreatmentNot Availableactive_not_recruiting
NCT00060437
Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancertreatment2completed
NCT05447637
PROCLAIM: Germline Genetic Testing for Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02876237
Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT05902637
The Efficacy Of Mapping For Cognitive Prostate BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT00294437
ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastasestreatment3terminated
NCT02014337
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumorstreatment1completed
NCT01574937
XL-184+Abiraterone in Post-Chemo CRPCtreatment1completed
NCT04260737
Interactive Decision Aid for Men Diagnosed With Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02319837
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)treatment3active_not_recruiting
NCT02916537
A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057diagnostic1completed
NCT05645237
HRQOL in Prostate Cancer Patients Treated With RadiotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00441337
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignanciestreatment1completed
NCT03424837
A Survivorship Care Plan and Embedded Navigation ToolNo drug interventionstreatmentNot Availablecompleted
NCT02737332
A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancertreatment2completed
NCT02928432
SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With AbirateroneNo drug interventionstreatment2completed
NCT03891732
MRI Prostate for Chinese Men Being Screened for Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01215032
Metformin in Castration-Resistant Prostate Cancertreatment2terminated
NCT00024232
Monoclonal Antibody Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT01231932
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer SurvivorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00663832
A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancertreatment1completed
NCT05333432
Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer (HRPCa-II)No drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT02353832
Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal SpacerNo drug interventionstreatment2completed
NCT04422132
Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 WeeksNo drug interventionstreatment2active_not_recruiting
NCT05038332
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])No drug interventionstreatment2recruiting
NCT03838432
The Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Ablation TherapyNo drug interventionstreatmentNot Availableunknown_status
NCT03035032
A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patientstreatment4completed
NCT00193232
Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancertreatment2completed
NCT05884632
Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer PatientsNo drug interventionstreatmentNot Availablerecruiting
NCT06305832
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancertreatment2recruiting
NCT04545632
Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating FactorNo drug interventionsNot AvailableNot Availablecompleted
NCT00471432
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumorstreatment1completed
NCT02678832
Momentum Project Heidelberg - Dealing Actively With a Cancerous DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT05035732
A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study)No drug interventionsdiagnosticNot Availablewithdrawn
NCT06468332
Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01411332
Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT TrialNo drug interventionstreatmentNot Availablecompleted
NCT00161252
Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among ElderlyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03668652
Focal Prostate Ablation Versus Radical ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT03824652
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgyNo drug interventionstreatment2recruiting
NCT00860652
Radiotherapy - Adjuvant Versus Early SalvageNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00816452
Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02307552
Transurethral Ultrasonic Imaging For Detection and Classification of Prostate CancerNo drug interventionsdiagnosticNot Availableterminated
NCT03858452
Relations Between Pelvic Floor, Diaphragm and Trunk MusclesNo drug interventionstreatmentNot Availablecompleted
NCT02871752
Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness EducationNo drug interventionssupportive_careNot Availablecompleted
NCT00182052
Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancertreatment3completed
NCT02085252
A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancertreatment3completed
NCT04048252
Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01341652
Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancertreatment2completed
NCT01098552
Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow UpNo drug interventionsNot AvailableNot Availablecompleted
NCT05021952
Postoperative Prognosis Management Service Based mHealth for Prostate Cancer PatientsNo drug interventionssupportive_careNot Availableunknown_status
NCT02080052
Robot-Assisted MRI-Guided Prostate BiopsyNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT00340600
Continuation of Follow-up of DES-Exposed CohortsNo drug interventionsNot AvailableNot Availablecompleted
NCT03334500
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancertreatment0active_not_recruiting
NCT03692000
Designing a Digital Tool to Support Healthy Lifestyle in Men With Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04621500
Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veteransbasic_science2completed
NCT00403000
Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapytreatment2completed
NCT04465500
EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate CancerNo drug interventionstreatment2recruiting
NCT02618200
Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT05008900
Timing of Post-prostatectomy PSMA ImagingNo drug interventionsdiagnostic2recruiting
NCT00442000
Outcomes Comparison of Robotic, Retropubic, and Perineal ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT05765500
RecoverPC: Relugolix vs GnRH Agonist in Quality of Lifetreatment2recruiting
NCT00982800
Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy?treatment4completed
NCT03840200
A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.treatment1completed
NCT00570700
Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancertreatment2completed
NCT06214000
Primary Care-Based Follow-up of Cancer Survivors of the Prostate and KidneyNo drug interventionsNot AvailableNot Availablecompleted
NCT02121600
18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate CancerNo drug interventionsdiagnosticNot Availableterminated
NCT00542100
PCMRI - an MRI/TRUS System for the Evaluation of the ProstateNo drug interventionsdiagnosticNot Availableunknown_status
NCT02856100
Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05181800
FIRMAGON Intensive Drug Monitoring ProtocolNo drug interventionsNot AvailableNot Availablecompleted
NCT02198859
Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancertreatment1completed
NCT04219059
MR Radiomic Features in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00207259
Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility TrialNo drug interventionssupportive_careNot Availablecompleted
NCT01543659
Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate CancerNo drug interventionsdiagnostic1 / 2completed
NCT02041559
The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04635059
Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancertreatment2active_not_recruiting
NCT04827459
Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT00087659
A Prostate Cancer Study in Men Undergoing Androgen Deprivation TherapytreatmentNot Availablecompleted
NCT01313559
Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancertreatment2terminated
NCT00304759
PROFIT - Prostate Fractionated Irradiation TrialNo drug interventionstreatment3completed
NCT00057759
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancersupportive_careNot Availablecompleted
NCT00003259
Vinorelbine in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT01084759
A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate CancertreatmentNot Availablecompleted
NCT02265159
Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate CancerNo drug interventionstreatment2 / 3unknown_status
NCT02913859
Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate CancerNo drug interventionstreatment2unknown_status
NCT06065059
Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumorstreatment1 / 2terminated
NCT05010759
Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT02379559
Exercise Intervention Metabolic Syndrome Prostate Cancer Black MenNo drug interventionspreventionNot Availablecompleted
NCT02786459
Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept StudyNo drug interventionsdiagnosticNot Availablecompleted
NCT00777959
Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)treatment2completed
NCT03362359
Ga-68-PSMA-11 in High-risk Prostate CancerNo drug interventionsdiagnostic1 / 2completed
NCT06473259
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer PatientsNot AvailableNot Availablerecruiting
NCT03445559
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer ImagingNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT02730975
Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancertreatment1completed
NCT00002775
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancertreatment1 / 2unknown_status
NCT05975775
Outpatient Laparoscopic Radical ProstatectomyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00780975
A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancertreatment2terminated
NCT06139575
Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancertreatment1 / 2recruiting
NCT03734575
ClariCore System Used in Transperineal Prostate BiopsyNo drug interventionsdiagnosticNot Availablesuspended
NCT03803475
Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patientsdiagnostic3completed
NCT05680675
Dual-Tracer Theranostic PETNo drug interventionsdiagnosticNot Availablecompleted
NCT00407875
Intensity Modulated Versus Interstitial - Radiation TherapyNo drug interventionstreatmentNot Availableunknown_status
NCT00987675
High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate CancerNo drug interventionstreatment2unknown_status
NCT02125175
BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT01492270
Imaging for Significant Prostate Cancer Risk EvaluationNo drug interventionsdiagnosticNot Availableunknown_status
NCT01674270
Degarelix Neo-Adjuvant Radical Prostatectomy Trialtreatment2completed
NCT01832870
Sipuleucel-T and Ipilimumab for Advanced Prostate Cancertreatment1completed
NCT04946370
Phase I/II Trial of Pembrolizumab and Androgen-receptor Pathway Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancertreatment1 / 2suspended
NCT04245670
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:No drug interventionstreatmentNot Availableactive_not_recruiting
NCT03122470
Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT01813370
A Registry for Patients Treated on the Clinical Trial TAX 3503No drug interventionsNot AvailableNot Availablecompleted
NCT04027270
Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients Undergoing ProstatectomyNo drug interventionssupportive_careNot Availablewithdrawn
NCT05169970
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate CancerNo drug interventionstreatment2recruiting
NCT05064670
Exercise as Medicine for People With Cancer SwedenNo drug interventionssupportive_careNot Availablerecruiting
NCT00580970
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injurysupportive_care2completed
NCT00278070
Metronomic Oral Vinorelbine in Patients With Metastatic Tumorstreatment2completed
NCT05826470
Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound ImagingNo drug interventionstreatmentNot Availablerecruiting
NCT05177770
Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancertreatment2terminated
NCT01051570
Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxeltreatment2completed
NCT00265070
Trial of Iressa in Prostate Cancer Patientstreatment2completed
NCT03348670
Pharmacogenomics IND EXEMPT SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphismshealth_services_research2 / 3active_not_recruiting
NCT06545942
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumorstreatment1recruiting
NCT03888742
The Effect of Androgen Deprivation Therapy on Gut and Urinary Microbiota in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05786742
Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.No drug interventionstreatmentNot Availablerecruiting
NCT05633342
Project CADENCE (CAncer Detected Early caN be CurEd)No drug interventionsNot AvailableNot Availablerecruiting
NCT03076242
Genetic Evaluation of Men (GEM)No drug interventionsNot AvailableNot Availableterminated
NCT00831142
Characterization of Prostate Cancer With 3T MRNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00065442
Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapytreatment3completed
NCT00012142
CCI-779 in Treating Patients With Prostate Cancertreatment2completed
NCT01379742
Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate BrachytherapyNo drug interventionstreatment4unknown_status
NCT00582842
Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02233842
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and SurvivorsNo drug interventionsNot AvailableNot Availablecompleted
NCT00901342
Open Label Study of Sipuleucel-T in Metastatic Prostate Cancertreatment2completed
NCT00116142
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancertreatment3completed
NCT01439542
FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancertreatment2terminated
NCT03693742
MSG Use With 18F-DCFPyL PET/CT ImagingNo drug interventionsdiagnosticNot Availablecompleted
NCT02050542
Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies.No drug interventionshealth_services_researchNot Availablecompleted
NCT00801242
Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancertreatment3completed
NCT01825642
Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate CancerNo drug interventionstreatment2 / 3completed
NCT02194842
Phase III Radium 223 mCRPC-PEACE IIItreatment3active_not_recruiting
NCT01434342
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patientsother0completed
NCT00668642
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancertreatment2completed
NCT01992042
Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancertreatment2completed
NCT05682742
Clinical Investigation of the da Vinci Surgical SystemNo drug interventionsotherNot Availableactive_not_recruiting
NCT00165399
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatmenttreatment2completed
NCT06154499
Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy SurgeryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05106699
Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes MetastasesNo drug interventionstreatmentNot Availablerecruiting
NCT01987999
Eradication of Prostate Cancer Using F-989No drug interventionstreatment2completed
NCT06190899
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancertreatment1 / 2recruiting
NCT00486499
I-125 Versus Pd-103 for Medium Risk Prostate CancerNo drug interventionstreatment3unknown_status
NCT01317199
Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate CancerNo drug interventionstreatment1 / 2completed
NCT04543799
Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01547299
Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancertreatment2completed
NCT05572099
ExoDx Prostate Evaluation in Active Surveillance Patient PopulationNo drug interventionsNot AvailableNot Availablerecruiting
NCT00234299
Effects of ASA on Prostate TissuepreventionNot Availablecompleted
NCT01174199
Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancertreatment1terminated
NCT03531099
Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate CancerNo drug interventionstreatment3active_not_recruiting
NCT00574899
Prostate Biomarker StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT02012699
Integrated Cancer Repository for Cancer ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT00039299
Biological Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment1completed
NCT00427999
Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancertreatment2completed
NCT04231006
Salvage HDR for Locally Recurrent Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03488706
Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA LevelNo drug interventionsNot AvailableNot Availableunknown_status
NCT00134706
A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancertreatment2completed
NCT00288106
S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPTNo drug interventionsNot AvailableNot Availableterminated
NCT00957606
Osteoporosis Among Men Treated With Androgen Deprivation for Prostate CancerNo drug interventionsdiagnostic3unknown_status
NCT06474806
Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate CancerNo drug interventionsdiagnostic2recruiting
NCT03373006
A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancerdiagnostic2completed
NCT00054106
Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancertreatment1completed
NCT03934606
Evaluating an Alternative Clinical Genetics Cancer Care Deliver ModelNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00433706
Image Guided Radiation Therapy For Prostate CancerNo drug interventionsNot Available3completed
NCT01325506
Effectiveness of Open and Robotic ProstatectomyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04983706
Optimization of the Core Number and Location for Targeted Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT00142506
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancerprevention3completed
NCT04628806
Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor CellsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02095249
Prostate Hypoxia - TICotherNot Availableactive_not_recruiting
NCT05187949
Promoting Shared-decision Making in Opportunistic Screening for Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumorstreatment1 / 2recruiting
NCT03321149
Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT06434649
Posterior Extra-fascial RARP in Intermediate or High Risk Prostate CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01823549
Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04172649
Acupuncture With Press Tack Needles for Perioperative Pain After Open Radical ProstatectomyNo drug interventionstreatmentNot Availablecompleted
NCT00207649
Shared Decision Making: Prostate Cancer ScreeningNo drug interventionsNot AvailableNot Availableunknown_status
NCT03768349
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate CancerNo drug interventionsdiagnostic0active_not_recruiting
NCT02582749
Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastasestreatment2terminated
NCT00011349
Early Stage Prostate Cancer CohortNo drug interventionsNot AvailableNot Availablecompleted
NCT00199849
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccinetreatment1completed
NCT01687049
Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active SurveillanceNo drug interventionstreatment2unknown_status
NCT06520449
68Ga-NTA-476 Imaging in Prostate CancerNo drug interventionsdiagnostic0not_yet_recruiting
NCT00496249
The Effect of Radiation on Semen Quality and Fertility in Men With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00276549
Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT02131649
PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-ProstatectomyNo drug interventionsdiagnosticNot Availablecompleted
NCT00004149
Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapytreatment2completed
NCT05840549
A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men With Urinary Symptoms Secondary to Prostate EnlargementNo drug interventionsotherNot Availablerecruiting
NCT06064149
The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility StudyNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05973149
Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate CancerNo drug interventionstreatment1not_yet_recruiting
NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential NeedsNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT01135849
B-Receptor Signaling in CardiomyopathyNo drug interventionsNot AvailableNot Availablecompleted
NCT01885949
Tivozanib + Enzalutamide in Adv Prostate Cancertreatment2active_not_recruiting
NCT01177436
Prostate Cancer Antigen 3 (PCA-3) Gene ProjectNo drug interventionsdiagnosticNot Availablecompleted
NCT04783636
To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteerstreatment1unknown_status
NCT06029036
A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancertreatment2recruiting
NCT02645136
The Effects of Pilates in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary IncontinenceNo drug interventionstreatmentNot Availablecompleted
NCT02776436
Reducing Dexamethasone Around Docetaxel Infusiontreatment1unknown_status
NCT05470036
Improving Germline Testing in At-Risk Patients With Prostate CancerNo drug interventionssupportive_careNot Availablerecruiting
NCT02573636
The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients With Biochemical Failure Status Post Salvage or Radical Radiation TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01511536
Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancertreatment1 / 2completed
NCT00086736
Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomytreatment2completed
NCT05805436
Preop Laxatives in Robotic Urologic Surgerytreatment4recruiting
NCT03609736
PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real LifeNo drug interventionsNot AvailableNot Availableunknown_status
NCT03245736
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.treatment2completed
NCT05150236
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPCtreatment2active_not_recruiting
NCT05832736
Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04081636
Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and ComplicationsNo drug interventionsdiagnosticNot Availablerecruiting
NCT05995236
Prostate-Specific Membrane Antigen (PSMA) Radionuclide TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00774436
Study of Focal Cryoablation in Low-Risk Prostate CancerNo drug interventionstreatment2completed
NCT04727736
18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancerdiagnostic2terminated
NCT00878436
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castrationtreatment1 / 2completed
NCT00016913
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancertreatment2completed
NCT02948413
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical TrialsNo drug interventionsNot AvailableNot Availablecompleted
NCT01784913
A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancertreatment1 / 2unknown_status
NCT03474913
Upright MRI for Prostate Cancer ScreeningNo drug interventionsNot AvailableNot Availablerecruiting
NCT00581113
Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain MetastasesNo drug interventionstreatment3terminated
NCT01253213
BR55 in Prostate Cancer: an Exploratory Clinical TrialNo drug interventionsdiagnostic0completed
NCT00924313
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate CancerNo drug interventionsdiagnostic1 / 2completed
NCT00800813
Change in Penile Length Following Bilateral Nerve-Sparing Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT05820113
Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRINo drug interventionsdiagnosticNot Availablecompleted
NCT06111313
The University of Miami Adapt (UAdapt) Trialtreatment2not_yet_recruiting
NCT03207113
Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalised Prostate Cancer Survivorship Care.No drug interventionssupportive_careNot Availableunknown_status
NCT01896713
The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00621413
Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02203513
A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancertreatment2terminated
NCT02945813
SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomytreatment2terminated
NCT06080113
Cancer of the Prostate Treated With Focal Implantation of a RadioactivE SourceNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT03017313
To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02250313
PASCUAL (Prostate Assay Specific Clinical Utility at Launch) StudyNo drug interventionsNot AvailableNot Availableterminated
NCT01254513
Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patientstreatment2completed
NCT02424513
A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate CancerNo drug interventionsdiagnostic2withdrawn
NCT00590213
Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEXtreatment4completed
NCT04423913
Safety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical ProstatectomyNo drug interventionstreatment2terminated
NCT01961713
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing ProstatectomyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02873013
Asia Study Group of Prostate Cancer (A-CaP Study)No drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04838613
Study of Diagnostic Performance of [18F]CTT1057 in BCRdiagnostic3completed
NCT06331013
CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancErNo drug interventionstreatmentNot Availablerecruiting
NCT00841113
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancertreatment3completed
NCT06534918
Precise Oncology Interventions in Nutrition and Training (OnPoint)No drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00595218
Patient Preference Survey for Radiation OncologistsNo drug interventionsotherNot Availablecompleted
NCT01367418
Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical Prostatectomybasic_science3completed
NCT00978718
Selenium in Preventing Prostate CancerNo drug interventionsprevention3completed
NCT00471718
ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapytreatment1 / 2terminated
NCT05155618
Intervention Study in Prostate Cancer Patients Undergoing RadiotherapyNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04997018
A Study of MRI-guided High-dose Radiation Therapy in Prostate CancerNo drug interventionstreatment2recruiting
NCT02724618
Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)supportive_care2unknown_status
NCT00138918
Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancertreatment2completed
NCT00773318
SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate CancerNo drug interventionsdiagnosticNot Availableterminated
NCT04100018
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancertreatment3completed
NCT00242918
Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancertreatment2completed
NCT05380518
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's ContinuumNo drug interventionsNot AvailableNot Availablerecruiting
NCT04389918
Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02153918
Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical ProstatectomyNo drug interventionstreatment2completed
NCT03687918
External Validation of Prostate MRI QCAD/LyonNo drug interventionsNot AvailableNot Availableunknown_status
NCT01522118
MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced DiseaseNo drug interventionssupportive_care1completed
NCT03365518
Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBTNo drug interventionssupportive_careNot Availablecompleted
NCT00642018
A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancertreatment2completed
NCT00137618
Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer ScreeningNo drug interventionsNot AvailableNot Availablecompleted
NCT05223218
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT03663218
PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)No drug interventionstreatment1active_not_recruiting
NCT00203918
Prostate Cancer Utilities and Cost-Effectiveness AnalysisNo drug interventionsNot AvailableNot Availablecompleted
NCT05311618
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumorstreatment1active_not_recruiting
NCT00292019
Robotic Laparoscopic Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT02126319
Facilitating Participation in a Prostate Cancer Risk Assessment ProgramNo drug interventionspreventionNot Availablecompleted
NCT05931419
High-Risk prostatE Cancer radiatiOn Versus surgERyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06116019
Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)No drug interventionsNot AvailableNot Availablerecruiting
NCT03679819
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04978519
Effectiveness of Cryotherapy Study for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00379119
Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT03367819
Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignanciestreatment1 / 2terminated
NCT04186819
Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer (LIGHTHOUSE)No drug interventionsdiagnostic3completed
NCT02793219
Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancertreatment2withdrawn
NCT04094519
A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancertreatment1completed
NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesNo drug interventionstreatment1recruiting
NCT01724619
Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHTdiagnostic0terminated
NCT03748719
Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate CancerNo drug interventionstreatmentNot Availablewithdrawn
NCT06242119
Clinical Application of the J-PET Scanner PrototypeNo drug interventionsNot AvailableNot Availablerecruiting
NCT02648919
Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate CancerNo drug interventionstreatment2terminated
NCT03889119
Stereotactic Body Radiation Therapy (SBRT) for Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT06524219
Comparison of Nerve-sparing Techniques in Radical Prostatectomy for Oncological Outcome and Functional Recovery.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01393119
Phase II, Dose Finding Study of GTx-758treatment2terminated
NCT00022919
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic MethodsNo drug interventionsNot AvailableNot Availablecompleted
NCT02630641
Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone.Not AvailableNot Availablecompleted
NCT01168141
Window Study of ZD4054 in Metastatic Prostate Cancerbasic_scienceNot Availableunknown_status
NCT00585741
Pilot Study of 18F-FLT PETNo drug interventionstreatmentNot Availableterminated
NCT04197141
Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT05558241
Micro-UltraSound In Cancer - Active SurveillanceNo drug interventionsdiagnosticNot Availablerecruiting
NCT06255041
Detection of Cancer in Breath Samples by Trained Detection DogsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01302041
A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapytreatment2completed
NCT01118741
Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)treatmentNot Availablecompleted
NCT03310541
AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutationstreatment1completed
NCT01065441
Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV CancerNo drug interventionstreatment1 / 2completed
NCT01481441
Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate CancerdiagnosticNot Availableterminated
NCT01317641
Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancertreatment1 / 2completed
NCT00908141
GM-CSF in Treating Patients With Relapsed Prostate Cancertreatment2completed
NCT00289341
Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.No drug interventionstreatment1 / 2completed
NCT00104741
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancertreatment3completed
NCT03419741
Brain Stimulation For Cancer SmokersNo drug interventionstreatmentNot Availablecompleted
NCT00299741
Study of SU11248 in Men With Advanced Prostate Cancertreatment2completed
NCT01762241
Xbox Kinect Training in Men With Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT03792841
Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCtreatment1completed
NCT02551341
Lung Protective Ventilation During Robotic Assisted ProstatectomyNo drug interventionstreatment3completed
NCT02628041
HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate CancerNo drug interventionstreatment2completed
NCT05803941
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancerother4recruiting
NCT04424641
A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsNo drug interventionstreatment1 / 2terminated
NCT00252941
Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate AdenocarcinomaNo drug interventionstreatment1 / 2completed
NCT01248741
CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using VitesseNo drug interventionstreatmentNot Availablecompleted
NCT02906241
PACCT: Partnering Around Cancer Clinical TrialsNo drug interventionsotherNot Availablecompleted
NCT06500741
Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00771017
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancertreatment2withdrawn
NCT02663817
DMH-Based Plan Evaluation and Inverse Optimization in RadiotherapyNo drug interventionshealth_services_researchNot Availablecompleted
NCT00585117
Pilot Study of (61)CuATSM-PET Imaging in Cancer PatientsNo drug interventionsdiagnosticNot Availableterminated
NCT03290417
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00124917
Phase I Study of Intensity Modulated Radiation Therapy for Prostate CancerNo drug interventionstreatment1terminated
NCT01174017
Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the ProstateNo drug interventionstreatment3completed
NCT01826617
Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy OutcomeNo drug interventionsNot AvailableNot Availablecompleted
NCT00340717
Markers for Early Detection of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00937417
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumorstreatment1withdrawn
NCT02840617
ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodesdiagnostic1unknown_status
NCT04247217
Immune Profiling After HDR in Local Relapsed Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03017417
A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT04596917
Music Listening as a Postanesthesia Care Unit (PACU) Nursing InterventionNo drug interventionstreatmentNot Availablecompleted
NCT03852017
Investigating Mindfulness and Music to Ease Radiation Side Effects in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT02397317
Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction MonitoringNo drug interventionstreatment2unknown_status
NCT05191017
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPCtreatment1 / 2withdrawn
NCT00643617
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy DosimetryNo drug interventionstreatmentNot Availablecompleted
NCT04763317
Precision Medicine in the Prostate Cancer Care PathwayNo drug interventionsNot AvailableNot Availablerecruiting
NCT02229734
Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2No drug interventionstreatment2completed
NCT00535834
Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154No drug interventionsNot AvailableNot Availablecompleted
NCT02077634
Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)treatment2completed
NCT02723734
Validation Study on the Impact of Decipher® Testing - VANDAAM StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05742334
Evaluating Return to Continence and Potency Following Radical ProstatectomyNo drug interventionstreatmentNot Availablewithdrawn
NCT02640534
Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alonetreatment2terminated
NCT06391034
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancerdiagnostic2not_yet_recruiting
NCT00023634
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancertreatment1terminated
NCT01709734
A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancertreatment2terminated
NCT01288534
Hypofractionated Stereotactic Body Radiation Therapy (SBRT)No drug interventionstreatment2completed
NCT03554434
An Expanded Access Program for AM0010 (Pegilodecakin)Not AvailableNot Availableno_longer_available
NCT05179824
Tempus Priority Study: A Pan-tumor Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03173924
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancerdiagnostic2active_not_recruiting
NCT00029224
Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesionstreatment4completed
NCT02292524
Prostate Biomarkers in Men Consuming Tomato ProductsNo drug interventionspreventionNot Availablecompleted
NCT00581724
Pain in Cancer SurvivorsNo drug interventionsNot AvailableNot Availablecompleted
NCT00761124
Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino MenNo drug interventionspreventionNot Availableactive_not_recruiting
NCT00037024
Study of Health Promotion in Patients With Early-Stage Breast or Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT05549024
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patientsdiagnostic0recruiting
NCT06163924
The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADTNo drug interventionsNot AvailableNot Availablerecruiting
NCT05452824
Participating in Tai Chi to Reduce Anxiety and Keep up Physical FunctionNo drug interventionsotherNot Availableactive_not_recruiting
NCT03730324
Predicting Prostate Biopsy Results With Biomarkers and mpMRI.No drug interventionsdiagnosticNot Availablecompleted
NCT00133224
Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patientstreatment3terminated
NCT05438524
The Performance of MRI Prostate in Men With Different Prostate Health Index (Phi) ValuesNo drug interventionsNot AvailableNot Availablerecruiting
NCT00662324
Development of a Clinical Trial Specific Question Prompt ListNo drug interventionsNot AvailableNot Availablecompleted
NCT00510224
Sandostatin for Patients With Androgen Independent Prostate Cancertreatment2terminated
NCT05351424
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad OncNo drug interventionshealth_services_researchNot Availablerecruiting
NCT00200824
Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Healthprevention2completed
NCT04340024
Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03418324
Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapytreatment2completed
NCT05590624
Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate CancerNo drug interventionsotherNot Availablenot_yet_recruiting
NCT04102124
A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPCtreatment2unknown_status
NCT03370016
The Impact of Low Pressure Pneumo in RARPNo drug interventionssupportive_careNot Availablecompleted
NCT01915316
Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate BiopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT06357416
The Man Van ProjectNo drug interventionsdiagnosticNot Availablerecruiting
NCT03354416
Profiling of Radiological Factors in Treatment and Outcomes in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT06461416
A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical FrameworkNo drug interventionsotherNot Availablerecruiting
NCT05373316
Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided RadiotherapyNo drug interventionstreatment2not_yet_recruiting
NCT00581516
Molecular Urine Tests for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04550416
Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility StudyNo drug interventionshealth_services_researchNot Availablecompleted
NCT03762616
Urology San Antonio MRI/MicroUS ComparisonNo drug interventionsdiagnosticNot Availablecompleted
NCT03194516
Ketogenic Diet and Prostate Cancer Surveillance PilotNo drug interventionsNot AvailableNot Availablecompleted
NCT00005916
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate CancerNo drug interventionstreatment2completed
NCT00201916
Shorter Radiation Schedule for the Treatment of Prostate CancerNo drug interventionstreatment3completed
NCT00127816
Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant TherapyNo drug interventionstreatmentNot Availablecompleted
NCT04397016
Cost Talk: Discussing Cancer Care CostsNo drug interventionshealth_services_researchNot Availablecompleted
NCT03817216
Prostatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate CancerNo drug interventionssupportive_careNot Availablewithdrawn
NCT01046916
Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigentreatment2completed
NCT02106416
Use of PET/MRI Tracer to Further Understanding of Prostate Cancer DevelopmentNo drug interventionsdiagnosticNot Availablecompleted
NCT00585416
Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancertreatment2terminated
NCT00217516
Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancertreatment1completed
NCT00003516
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancertreatment2terminated
NCT01735396
Abiraterone Acetate Trial in African American Prostate Cancer Patientstreatment2terminated
NCT03936296
Prostate Cancer Detection Rates of Standard Transrectal Prostate Biopsy and MR-guided Fusion Transrectal Prostate BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT00175396
Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation TherapyNo drug interventionstreatment3unknown_status
NCT02085096
Problem Solving Therapy for Prostate Cancer Spousal CaregiversNo drug interventionssupportive_careNot Availablecompleted
NCT03921996
Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate CancerNo drug interventionstreatment3terminated
NCT00534196
Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00005096
Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancertreatment2completed
NCT00664196
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative ConditioningNo drug interventionstreatment1suspended
NCT05803096
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Painsupportive_care4completed
NCT03050996
Retrograde Perfusion Sphinterometry and Autologous Sling to Improve Urinary Continence in Robotic Radical ProstatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00619996
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancertreatment2completed
NCT05864196
Two Fraction Prostate SBRT With DIL SIBNo drug interventionstreatment1recruiting
NCT01990196
Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancertreatment2active_not_recruiting
NCT00293696
Casodex/Zoladex Biomarkers in Localised Prostate Cancertreatment4completed
NCT03511196
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancertreatment0active_not_recruiting
NCT00801996
Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab CountriesNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05416996
A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03331458
Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility StudyNo drug interventionssupportive_careNot Availablecompleted
NCT02882958
Validation of Software-based Fusion of Ultrasound and MRI Images of the ProstateNo drug interventionsNot AvailableNot Availablecompleted
NCT04037358
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancerstreatment2active_not_recruiting
NCT00921258
Active Control of Prostatic Cancer With Criteria of LatenceNo drug interventionsNot AvailableNot Availableterminated
NCT00003858
Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrencetreatment2withdrawn
NCT03662958
Comparison of a Novel Leuprolide With Market LeuprolidetreatmentNot Availableunknown_status
NCT04004858
Prostate Margin Reduction to Reduce Acute Rectal Toxicity (PROTRACT)No drug interventionstreatmentNot Availableunknown_status
NCT01982058
Intimacy-Enhancing Couples' Intervention for Localized Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00796458
Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancertreatment3unknown_status
NCT00860158
Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancertreatment2terminated
NCT02936258
PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation ProceduresNo drug interventionsotherNot Availableunknown_status
NCT04832958
Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer PatientsNo drug interventionsdiagnostic2recruiting
NCT04897958
Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims DataNot AvailableNot Availablecompleted
NCT05589558
Prospective Comparison of the Four Biopsy Methods for Prostate Cancer DetectionNo drug interventionsdiagnosticNot Availablecompleted
NCT06257758
A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT05754658
African Cancer Genome: GMDNo drug interventionsNot AvailableNot Availablerecruiting
NCT01584258
Prostate Advances in Comparative EvidenceNo drug interventionstreatment3active_not_recruiting
NCT00032058
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00887458
A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapytreatment2completed
NCT00710658
Internet Support for Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT06363435
AI-based Measurements of Tumour Burden in PSMA PET-CTNo drug interventionsNot AvailableNot Availablerecruiting
NCT03344835
Hong Kong Prostate Cancer Study Group DatabaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT00830635
Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00004635
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancertreatment3completed
NCT04887935
Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancertreatment1recruiting
NCT04331535
The Genomic Medicine at VA StudyNo drug interventionsscreeningNot Availablerecruiting
NCT01162135
Digoxin for Recurrent Prostate Cancertreatment2completed
NCT02628535
Safety Study of MGD009 in B7-H3-expressing TumorsNo drug interventionstreatment1terminated
NCT04586335
Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.treatment1terminated
NCT00919035
Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patientstreatment2completed
NCT04751435
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05384535
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk CohortNo drug interventionsscreeningNot Availablerecruiting
NCT00020735
Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancerprevention2completed
NCT05060835
ONCOlogy-targeted NLP-powered Federated Hyper-archItecture and Data Sharing Framework for Health Data ReusabilityNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04188535
Serial MRI Scans During Radiation TherapyNo drug interventionsotherNot Availablerecruiting
NCT05344235
Observational Study on Extreme Hypofractionation for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03511235
Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® TestingNo drug interventionsNot AvailableNot Availablecompleted
NCT00479635
A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancertreatment2terminated
NCT05506735
The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family HistoryNo drug interventionsNot AvailableNot Availablecompleted
NCT01320735
Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in RussiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00951535
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17No drug interventionstreatment2active_not_recruiting
NCT02375035
Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00893035
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04607135
ARFI Imaging for Targeted Prostate BiopsyNo drug interventionsdiagnosticNot Availableterminated
NCT00705835
Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogeltreatment1completed
NCT02512835
Understanding the Value of Community Vital Signs in Primary CareNo drug interventionsNot AvailableNot Availablecompleted
NCT00450463
Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancertreatment2completed
NCT01161563
Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue AdministrationNot Available4completed
NCT02768363
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)treatment2active_not_recruiting
NCT00490763
Active Surveillance in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02390063
Vaccination in Prostate Cancer (VANCE)treatment1completed
NCT02822963
Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the ProstateNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05512663
Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT03407963
Feasibility of Prostatic Arterial Embolization in Low-risk Patients With Unilateral Prostate Cancer Under Active Surveillance: Monocentric Pilot StudyNo drug interventionstreatmentNot Availablecompleted
NCT00913263
An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the ProstateNo drug interventionstreatment1 / 2completed
NCT01486563
Hydroxyethyl Starch and Renal Function After Radical Prostatectomydiagnostic4completed
NCT00728663
Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT04614363
68 Ga-PSMA for High Risk Prostate CancerNo drug interventionsdiagnostic1 / 2completed
NCT01394263
Study of Histrelin Subdermal Implant in Patients With Prostate Cancertreatment3completed
NCT02295163
Stellate Ganglion Block for Hot Flushes in Men Treated With ADTNo drug interventionstreatmentNot Availablewithdrawn
NCT03358563
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancertreatment0completed
NCT06462963
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00017563
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancertreatment2completed
NCT00967863
Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)No drug interventionstreatmentNot Availableactive_not_recruiting
NCT02657863
Cancer DNA Detection in Blood and UrineNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02747563
Evaluation of PSA Blood Levels Prior to and After Digital Rectal ExaminationNo drug interventionsdiagnostic1unknown_status
NCT01407263
Trial of Modifications to Radical ProstatectomyNo drug interventionstreatment3active_not_recruiting
NCT00905086
Psychosocial Adjustment After Radiation Therapy in Patients With CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02297386
[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancerdiagnostic1completed
NCT02978586
A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT00117286
Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancertreatment2 / 3completed
NCT01447186
Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking MenNo drug interventionsNot AvailableNot Availablecompleted
NCT00937586
Prostate Cancer Prospective CohortNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00573586
Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in CanadaNo drug interventionstreatmentNot Availableunknown_status
NCT00023686
Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate CancerNo drug interventionstreatment3completed
NCT01868386
Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the ProstateNo drug interventionstreatment1 / 2completed
NCT00326586
A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate CancerNo drug interventionstreatment1completed
NCT06199986
DeADT - Living Well With Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00468286
Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapytreatment2completed
NCT04116086
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early StageNo drug interventionsdiagnosticNot Availableunknown_status
NCT00992186
A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancertreatment2completed
NCT03620786
HIFU for Focal Ablation of Prostate Tissue: An Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00767286
Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancertreatment3completed
NCT01555086
Prospective Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During ProstatectomyNo drug interventionstreatmentNot Availableunknown_status
NCT03486886
PSMA-PET Imaging in Patients With Metastatic Prostate Cancer: Institutional Evaluation of Detection Yield Performance and ReproducibilityNo drug interventionsdiagnosticNot Availablecompleted
NCT00060086
Pomegranate Juice in Treating Patients With Recurrent Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00014586
Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancertreatment3terminated
NCT02766686
Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With ProtonsNo drug interventionstreatmentNot Availablerecruiting
NCT03716739
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiencysupportive_care2recruiting
NCT00309439
ALA and Prostate CancerNo drug interventionsNot Available2unknown_status
NCT03913039
Reduction of Prostate Biopsy MorbidityNo drug interventionsNot AvailableNot Availablecompleted
NCT00752739
Selenium in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT00444639
Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)treatment2terminated
NCT00171639
The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosistreatment3completed
NCT00122239
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck CancersNo drug interventionsNot AvailableNot Availableunknown_status
NCT04334239
Effectiveness of Care in Certified Cancer Centres in GermanyNo drug interventionsNot AvailableNot Availablecompleted
NCT05478239
ArtemiCoffee in Patients With Rising PSANo drug interventionstreatment2recruiting
NCT01589939
Reduced Planning Target Volume (PTV) Margins for the Treatment of Prostate Cancer Using the Calypso 4D Localization SystemNo drug interventionsNot AvailableNot Availableunknown_status
NCT01346839
Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary CareNo drug interventionshealth_services_researchNot Availablecompleted
NCT02828839
Prostate Biopsy Access Needle & Needle Guide Feasibility StudyNo drug interventionsscreeningNot Availablecompleted
NCT05375539
AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer PatientsNo drug interventionstreatment1recruiting
NCT00196339
A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patientstreatment2completed
NCT00334139
Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancertreatment4completed
NCT02349139
Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate CancerNo drug interventionstreatment1terminated
NCT06171139
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate CancerNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04895839
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment ProgramNo drug interventionssupportive_careNot Availablerecruiting
NCT00869739
Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01296139
Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancerdiagnostic1completed
NCT03061539
Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signaturetreatment2active_not_recruiting
NCT00058539
Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancertreatment2completed
NCT02349022
Comparison of PET With [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide in the Detection of Prostate Cancer Pre-ProstatectomyNo drug interventionsdiagnostic2completed
NCT04167722
How Does Prostate Cancer Metastasize? Studying the Role of Secreted Packages (Exosomes) From Fat Tissue in Lean and Obese PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT01591122
Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancertreatment3completed
NCT03344822
Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer PatientsNo drug interventionsdiagnostic2 / 3unknown_status
NCT02241122
MRI and Biomarkers in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT05020522
Comparison of Diagnostic Accuracy of Luminal Index and MP MRI for Accelerated deTEction of Significant Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT02173522
Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer PatientsNo drug interventionstreatmentNot Availableterminated
NCT03269422
Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)No drug interventionstreatment1active_not_recruiting
NCT06303622
Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION TrialNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT00770822
Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT02713022
Body Composition and White Adipose Tissue InflammationNo drug interventionsNot AvailableNot Availablecompleted
NCT04185922
Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node DissectionNo drug interventionstreatmentNot Availablecompleted
NCT03382522
Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate CarcinomaNo drug interventionsNot AvailableNot Availablecompleted
NCT06223022
Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer TreatmentNo drug interventionssupportive_careNot Availablerecruiting
NCT02911922
Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT06094322
Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate ImagingNo drug interventionsdiagnosticNot Availablecompleted
NCT04421222
Oral EPI-7386 in Patients With Castration-Resistant Prostate Cancertreatment1recruiting
NCT03294122
Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT06384222
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abirateronetreatment2not_yet_recruiting
NCT01197625
Vaccine Therapy in Curative Resected Prostate Cancer PatientsNo drug interventionstreatment1 / 2active_not_recruiting
NCT04263025
AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord AllograftNo drug interventionstreatment2 / 3recruiting
NCT03030625
VMAT for Dominant Intraprostatic LesionNo drug interventionstreatmentNot Availablecompleted
NCT03507725
Early Staged Consent Before Prostate BiopsyNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT02186925
A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.No drug interventionsNot AvailableNot Availablerecruiting
NCT00251225
A Study of Imatinib and Docetaxel in Prostate Cancertreatment2completed
NCT02478125
Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancertreatment1terminated
NCT00416325
Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate CancerNo drug interventionsprevention1completed
NCT02825225
A Prospective Randomized Trial of Two Different Prostate Biopsy SchemesNo drug interventionsdiagnosticNot Availablecompleted
NCT01257425
Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mgtreatment2completed
NCT01497925
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancertreatment1completed
NCT02034825
Multi-site Decision Impact Study for DecipherNo drug interventionsNot AvailableNot Availablecompleted
NCT05184725
CARINAE for Stress Relief in Perioperative CareNo drug interventionstreatmentNot Availablecompleted
NCT03658525
Prostate Radiotherapy Integrated With Simultaneous MRI (The PRISM Study)No drug interventionstreatmentNot Availableunknown_status
NCT04317625
Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mLNo drug interventionsscreeningNot Availableunknown_status
NCT00129025
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate CancerNo drug interventionstreatment1 / 2completed
NCT02788825
STHLM3-MR: Comparing Standard With Targeted Prostate BiopsiesNo drug interventionsdiagnosticNot Availablecompleted
NCT02079025
Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT01005225
Genetic Investigation of Solid Tumors CohortNo drug interventionsNot AvailableNot Availablecompleted
NCT02995330
Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancertreatment1terminated
NCT00072930
MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancertreatment2completed
NCT00201630
Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing BrachytherapyNo drug interventionstreatment3unknown_status
NCT00625430
A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancertreatment1unknown_status
NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyNo drug interventionsdiagnostic3recruiting
NCT02865330
Spanish Urological Association Registry of Patients on Active SurveillanceNo drug interventionsNot AvailableNot Availablerecruiting
NCT01495130
Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic SurgeryNo drug interventionsdiagnosticNot Availablecompleted
NCT03256630
Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT03852030
Mind-Body Health in Uro-Oncology: Research StudyNo drug interventionssupportive_careNot Availablecompleted
NCT00629330
Dissemination of Prostate Cancer Screening to PCP's in African American CommunitiesNo drug interventionsscreening4terminated
NCT00719030
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before ProstatectomyNo drug interventionspreventionNot Availablecompleted
NCT02895230
Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04541030
Integrated Genomic Prostate Score With MRI Targeted Prostate BiopsiesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00126230
Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancertreatment2terminated
NCT00444730
Urology Database for Outcomes ResearchNo drug interventionsNot AvailableNot Availablecompleted
NCT06561230
Leveraging EA8191 to Assess AI-Augmented EHR AbstractionNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01020448
Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancerdiagnostic3completed
NCT02092948
Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic CancerNo drug interventionsdiagnostic1completed
NCT00681148
Botulinum Toxin Injection With Prostate Brachytherapytreatment2withdrawn
NCT02430948
Improving Compliance With Medical Testing GuidelinesNo drug interventionsscreeningNot Availablecompleted
NCT00770848
AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancertreatment1 / 2completed
NCT01979848
MRI Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal BalloonNo drug interventionsNot AvailableNot Availablecompleted
NCT00005848
R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT00140348
Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer VaccineNo drug interventionstreatment1 / 2completed
NCT03426748
LDR vs. HDR Brachytherapy for Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04627948
STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01816048
NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasistreatment2terminated
NCT00002848
Group Therapy Compared With Educational Materials in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01614548
Management of Prostate Cancer in Central ChinaNo drug interventionsNot AvailableNot Availablecompleted
NCT05501548
Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancertreatment2recruiting
NCT02499848
Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancertreatment2completed
NCT00769548
Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancertreatment3completed
NCT05847348
68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patientsdiagnostic3recruiting
NCT00626548
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancertreatment3terminated
NCT06317948
Improving the Quality of Radiotherapy by Multi-Institution Knowledge-Based Planning Optimization Models (Acronym: MIKAPOCo, Multi-Institutional Knowledge-based Approach in Plan Optimization for the Community)No drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02481648
Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00833248
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancertreatment3completed
NCT03035357
Neoadjuvant Listeria or Daratumumab in Prostate Cancertreatment2withdrawn
NCT04565457
A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image QualityNo drug interventionstreatmentNot Availablerecruiting
NCT03275857
Cisplatin in Castration Resistant Prostate Cancertreatment0completed
NCT00093457
Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancertreatment2completed
NCT04545957
Jump: MR Simulation For Radiation Therapy Master ProtocolNo drug interventionstreatmentNot Availablerecruiting
NCT00250757
Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic SecretionsNo drug interventionsNot AvailableNot Availableterminated
NCT03561857
Clinical Trial for a Robotic Endomicroscopy to Better Define Resection Strategies Applied to Urology SurgeryNo drug interventionsotherNot Availableunknown_status
NCT02957357
Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer SurvivorsNo drug interventionsNot AvailableNot Availablecompleted
NCT05189457
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancertreatment2active_not_recruiting
NCT06575257
Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancertreatment2recruiting
NCT00215657
Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patientstreatment2terminated
NCT02918357
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrencediagnostic2 / 3completed
NCT03734757
Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate CancerNo drug interventionsotherNot Availableunknown_status
NCT05212857
Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancertreatment2unknown_status
NCT06402357
High Intensity Focused Ultrasound in Prostate CancerNo drug interventionstreatment2not_yet_recruiting
NCT06022757
Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)treatment1 / 2recruiting
NCT03604757
68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic RisksNo drug interventionstreatment2completed
NCT05842057
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical ProstatectomyNo drug interventionssupportive_care2recruiting
NCT01496157
Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancerdiagnostic1 / 2completed
NCT00349557
Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancertreatment2completed
NCT00480857
Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomytreatment2terminated
NCT00005857
Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapytreatment2completed
NCT00084526
Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate CancerNo drug interventionsdiagnostic1 / 2completed
NCT01790126
The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancertreatment2completed
NCT04838626
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detectiondiagnostic2 / 3completed
NCT03077126
Feasibility Study of Ultrasound Elastography Detecting Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT06518226
Two-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00004026
CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapytreatment2terminated
NCT05822726
The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT03851926
Hypofractionated Radiotherapy for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03381326
CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02813226
Assessment of New Molecular Imaging Strategies for Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT03630926
Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.No drug interventionsNot AvailableNot Availableunknown_status
NCT01041326
Preoperative Radiation Therapy for High Risk Prostate CancerNo drug interventionstreatment1completed
NCT05187026
Electrical Patient Reported Outcome of Prostate Cancer RadioTherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02723526
Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT04553926
'OLAP' (OLAparib Regulatory Post-marketing Surveillance)No drug interventionsNot AvailableNot Availablerecruiting
NCT00136526
Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancertreatment2completed
NCT01215526
A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00061126
ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Bodytreatment2completed
NCT00338026
A Phase I Study of ECO-4601 in Patients With Advanced Cancertreatment1completed
NCT01830166
Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate BrachytherapyNo drug interventionshealth_services_researchNot Availableunknown_status
NCT00706966
MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate CancerdiagnosticNot Availablecompleted
NCT02086266
The Efficacy of Pilates in the Recovery of Post-prostatectomy Urinary IncontinenceNo drug interventionstreatmentNot Availablecompleted
NCT00528866
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomytreatment2completed
NCT00545766
Vinflunine in Hormone Refractory Prostate Cancer (HRPC)treatment2completed
NCT03769766
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillancetreatment3recruiting
NCT03938766
Upregulation of PSMA Receptors After Androgen Deprivation Therapy on PSMA PET/CT Imaging in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT02238366
Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate CancerNot AvailableNot Availablecompleted
NCT03238066
Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation TherapyNo drug interventionstreatmentNot Availableunknown_status
NCT03924466
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsNo drug interventionsdiagnostic2recruiting
NCT00589966
Coping in African American Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT00058266
Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical ProstatectomyNo drug interventionstreatment2terminated
NCT04812366
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancertreatment2recruiting
NCT02290366
Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate CancerNo drug interventionstreatmentNot Availablewithdrawn
NCT05576766
Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical ProstatectomyNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT03630666
Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer PatientstreatmentNot Availableactive_not_recruiting
NCT05801965
A Digital Therapeutic Solution for Cancer PatientsNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT01946165
Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamidetreatment2completed
NCT02511665
Metformin And Longevitybasic_science4unknown_status
NCT04503265
A Trial of AMXI-5001 for Treatment in Patients With Advanced MalignanciesNo drug interventionstreatment1 / 2active_not_recruiting
NCT02793765
Docetaxel Followed by Provenge in Metastatic Prostate Cancertreatment2withdrawn
NCT00084565
Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancertreatment2withdrawn
NCT01484665
Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer ScreeningNo drug interventionsscreeningNot Availablecompleted
NCT00122265
Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT01826565
Comparison of Two Insertion Technique of I-gelNo drug interventionstreatmentNot Availableunknown_status
NCT00258765
Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.prevention2terminated
NCT03706365
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancertreatment2 / 3active_not_recruiting
NCT05327465
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablerecruiting
NCT00421265
Active Surveillance for Prostate Cancer With Indolent FeaturesNo drug interventionsNot AvailableNot Availableunknown_status
NCT02757365
Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancerprevention4unknown_status
NCT04011865
Robot-assisted vs Laparoscopic Radical Prostatectomy for Prostate Cancer TreatmentNo drug interventionstreatmentNot Availableunknown_status
NCT00811265
Safety Evaluation of ExAblate MRgFUS for Prostate CancerNo drug interventionstreatment1completed
NCT01615965
Detection of Micrometastases in Lymph Nodes of Patients With Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT01177865
Study of Treatment Choice in Patients With Localized Prostate CancerNo drug interventionshealth_services_researchNot Availableunknown_status
NCT04340765
18F-fluorocholine and 18F-fluoride PET in Prostate CancerdiagnosticNot Availablecompleted
NCT02380274
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)No drug interventionsNot AvailableNot Availablecompleted
NCT00790374
BN83495 in Prostate Cancertreatment1completed
NCT00499174
Observation or Radical Treatment in Patients With Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT06536374
Folate Study in Men With Advanced Prostate Cancertreatment2not_yet_recruiting
NCT01704274
GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary TherapyNo drug interventionsother2completed
NCT04100174
Focal HDR Brachytherapy Boost to Stereotactic RadiotherapyNo drug interventionstreatment2recruiting
NCT02139774
Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT05183074
MR-linac Guided Ultra-hypofractionated RT for Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT00003674
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancertreatment3completed
NCT00405574
Study of ATN-224 in Patients With Prostate Cancertreatment2unknown_status
NCT00028574
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancersupportive_care3completed
NCT00482274
Docetaxel in Treating Patients With Relapsed Prostate Cancertreatment2terminated
NCT00796874
Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active SurveillanceNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00928174
Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancerdiagnostic1 / 2completed
NCT01617174
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00908674
Androcur Effects on Quality of LifeNot AvailableNot Availablecompleted
NCT03292874
High Resolution MRI Study for Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT06437574
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancerprevention2recruiting
NCT04087174
A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancertreatment1completed
NCT03396874
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrencediagnostic2completed
NCT02716974
A Study of Definitive Therapy to Treat Prostate Cancertreatment2completed
NCT05097274
The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.No drug interventionsNot AvailableNot Availablerecruiting
NCT05215574
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumorstreatment1recruiting
NCT02831920
CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT04339920
Spermine Measuring Device Evaluation ProtocolNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03459820
Prostate Cancer Patient Management With 18F-DCFPyL PET/CTNo drug interventionsdiagnostic2 / 3enrolling_by_invitation
NCT00525720
Brachytherapy for Prostatic Carcinoma PatientsNo drug interventionstreatment2active_not_recruiting
NCT01615120
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancertreatment2completed
NCT04105920
Evaluation of the Interest of Hyaluronic Acid in the Preservation of Sexual Function During Prostate CurietherapiesNo drug interventionsotherNot Availablerecruiting
NCT00005820
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyNo drug interventionstreatment2completed
NCT00225420
Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancertreatment1 / 2completed
NCT03254420
Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.No drug interventionstreatmentNot Availableactive_not_recruiting
NCT02165020
Hyaluronic Acid for Hypofractionated Prostate RadiotherapyNo drug interventionstreatment2unknown_status
NCT03561220
A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04593420
Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.No drug interventionsNot AvailableNot Availablecompleted
NCT01347320
Preoperative Magnetic Resonance (MR) Imaging of Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00753220
Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancertreatment1 / 2terminated
NCT03726320
Trial of Community Health Worker-led Decision CoachingNo drug interventionsscreeningNot Availablecompleted
NCT01487720
GEMOX in Docetaxel-Refractory Castration-Resistant Prostate CancerNo drug interventionstreatment2completed
NCT06543420
The Role of Levator Ani Muscle Reconstruction Technology in Urinary Incontinence RecoveryNo drug interventionstreatmentNot Availablerecruiting
NCT02512120
Volume Controlled Ventilation vs Autoflow-volume Controlled VentilationNo drug interventionssupportive_careNot Availablewithdrawn
NCT01583920
Focal Salvage HDR Brachytherapy for the Treatment of Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04284020
Educational Program Plus Physiotherapy After ProstatectomyNo drug interventionstreatmentNot Availableunknown_status
NCT00877682
Prostate Conformal CryotherapyNo drug interventionstreatmentNot Availablecompleted
NCT00973882
Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancerstreatment2completed
NCT00475982
Effect of Weight Loss on Prostate Cancer PathologyNo drug interventionsdiagnosticNot Availablecompleted
NCT05850182
Lifestyle Intervention in Patients With Metastatic Prostate CancerNo drug interventionsotherNot Availablerecruiting
NCT05707182
18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: A Pilot Studydiagnostic0recruiting
NCT05958082
Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate CancerNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT00634582
Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastasestreatment2terminated
NCT04348682
Expanded Access Protocol of 68Ga-PSMA-11 for PET ImagingNo drug interventionsNot AvailableNot Availableapproved_for_marketing
NCT00582582
Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancertreatment2terminated
NCT00851682
Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate CarcinomaNo drug interventionsdiagnosticNot Availableterminated
NCT05046782
Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With HistopathologyNo drug interventionsdiagnostic2not_yet_recruiting
NCT05354882
Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in OncologyNo drug interventionssupportive_careNot Availablerecruiting
NCT01599182
Metabolic Effects of Treatment in Intermediate and High-Risk Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04335682
Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamideother2recruiting
NCT02064582
Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancertreatment2completed
NCT01417182
Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancerscreening1completed
NCT00379782
Kukui Ahi Navigator Cancer Screening and Treatment Demonstration ProjectNo drug interventionshealth_services_researchNot Availablecompleted
NCT02224482
Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS)No drug interventionssupportive_careNot Availablecompleted
NCT00488982
Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)treatment2completed
NCT00323882
Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancertreatment1 / 2completed
NCT03777982
Conventional ADT w/ or w/Out Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADTtreatment3terminated
NCT04457882
Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage TubeNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02793882
Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00314782
Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPCtreatment1completed
NCT00003682
Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancertreatment3terminated
NCT00769431
Evaluating Symptom Management Educational Materials for Patients With Prostate CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT00176631
Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapytreatment2terminated
NCT00068731
Lycopene in Treating Patients With Metastatic Prostate CancerNo drug interventionstreatment2completed
NCT01098331
Implant Radiation Therapy or Surgery in Treating Patients With Prostate CancerNo drug interventionsotherNot Availableterminated
NCT01832831
Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical ProstatectomyNo drug interventionsNot AvailableNot Availableterminated
NCT03127631
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer PatientstreatmentNot Availablerecruiting
NCT02640131
A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility StudyNo drug interventionssupportive_careNot Availablecompleted
NCT00010231
Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapytreatment1completed
NCT00128531
Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancertreatment3completed
NCT00587431
Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancertreatment2completed
NCT00045331
Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT04393831
A Prospective Trial on Nerve Sparing Techniques Performed in Radical ProstatectomyNo drug interventionstreatmentNot Availableterminated
NCT01191931
Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)No drug interventionsNot AvailableNot Availablecompleted
NCT05423431
Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)No drug interventionsNot AvailableNot Availablecompleted
NCT01496131
Tecemotide (L-BLP25) in Prostate Cancertreatment2completed
NCT00033631
Radiation Therapy in Treating Patients With Stage II Prostate CancerNo drug interventionstreatment3completed
NCT05818631
Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00626431
A Study of Leuprolide to Treat Prostate Cancertreatment3completed
NCT03339531
Optimized 2D-RT for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT02322931
C-arm Cone-beam CT in Prostate BrachytherapyNo drug interventionssupportive_careNot Availableunknown_status
NCT03335631
Preference-Based Exercise RCT for Men With PC on ADTNo drug interventionssupportive_careNot Availablecompleted
NCT02974231
Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02108431
Prospective Randomized Trial Comparing Urinary Diversion After Robot-assisted Radical ProstatectomyNo drug interventionstreatmentNot Availablecompleted
NCT06034431
Increasing Access to Definitive Treatment for Prostate CancerNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT02812173
Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARPNo drug interventionstreatmentNot Availablecompleted
NCT02788773
Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancertreatment2active_not_recruiting
NCT03979573
Prospective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT00884273
Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patientstreatment3completed
NCT01140373
Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)treatment1active_not_recruiting
NCT00242073
The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT03014973
Castration-resistant Prostate Cancer and Intra-prostatic Hormonal StatusNo drug interventionsotherNot Availablewithdrawn
NCT05712473
An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01313273
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patientstreatment3terminated
NCT02064673
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomytreatment3recruiting
NCT05656573
CART-PSMA Cells for Advanced Prostate CancerNo drug interventionstreatment1recruiting
NCT05796973
Measuring Oncological Value of Exercise and Statintreatment3recruiting
NCT05146973
External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET)treatment2active_not_recruiting
NCT00622973
USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node MetastasesNo drug interventionsdiagnostic3completed
NCT00005073
Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptomstreatment3terminated
NCT02613273
CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate CancerNo drug interventionspreventionNot Availablecompleted
NCT04300673
Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer PatientsNo drug interventionsdiagnostic1 / 2unknown_status
NCT01704027
Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate CancerNo drug interventionstreatment2terminated
NCT05354427
Retrospective Evaluation of Commercial Spacers in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04240327
Marker Driven Selection of Patients for Prostate Biopsy and ManagementNo drug interventionsNot AvailableNot Availablerecruiting
NCT02303327
Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer PatientsNo drug interventionstreatment3recruiting
NCT04019327
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancertreatment1 / 2active_not_recruiting
NCT01558427
Non-systemic Treatment for Patients With Low-volume Metastatic Prostate CancerNo drug interventionstreatment2completed
NCT00082927
Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Painsupportive_care3completed
NCT00176527
Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapytreatment2terminated
NCT01138527
Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) ApproachNo drug interventionsNot AvailableNot Availablecompleted
NCT05819827
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision TherapeuticsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05311527
UroLift System With SAbR for Prostate Cancer and BPHNo drug interventionstreatment1recruiting
NCT02257827
Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated ScheduleNo drug interventionstreatment3completed
NCT06101927
Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413No drug interventionsdiagnostic1enrolling_by_invitation
NCT01658527
TAK-700 in Castration Resistant Prostate Cancertreatment2withdrawn
NCT02546427
Hypofractionated Whole Pelvic Radiotherapy of the ProstateNo drug interventionstreatmentNot Availablewithdrawn
NCT04144127
Soccer Intervention in Prostate Cancer SurvivorsNo drug interventionspreventionNot Availablecompleted
NCT01605227
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100treatment3completed
NCT00859027
Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancertreatment4completed
NCT03387527
Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer ScreeningNo drug interventionssupportive_careNot Availablecompleted
NCT00010127
Vaccine Therapy in Treating Patients With Metastatic Prostate CancerNo drug interventionstreatment1terminated
NCT05294627
Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss PopulationNo drug interventionsNot AvailableNot Availablecompleted
NCT01810627
Application of Megavoltage Imaging to Reduce Artifact After Seed ImplantsNo drug interventionsNot AvailableNot Availablecompleted
NCT02507427
Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study)No drug interventionstreatment1 / 2completed
NCT00673127
Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancertreatment2completed
NCT03934827
MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumourtreatment1unknown_status
NCT03423927
Benefits of an Intervention Combining Hypnosis and Self-care for Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT00005627
Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapytreatment1completed
NCT04642027
PSMA-PET Guided Hypofractionated Salvage Prostate Bed RadiotherapyNo drug interventionstreatment3recruiting
NCT00090376
Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomytreatment2completed
NCT03861676
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CTtreatment0recruiting
NCT00798876
Low-Fat Fish Oil Diet for Prostate Cancer PreventionNo drug interventionsdiagnosticNot Availablecompleted
NCT05582876
Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05698576
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00060476
Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)prevention3completed
NCT06355076
New Urethral Reconstruction in Robot-assisted Laparoscopic Radical ResectionNo drug interventionstreatmentNot Availablerecruiting
NCT00577876
Assessment of the Functional Significance of Accessory Pudendal ArteriesNo drug interventionstreatmentNot Availablecompleted
NCT01551576
Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05022576
Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate BiopsyNo drug interventionsdiagnosticNot Availablecompleted
NCT04122976
A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are DescribedNot AvailableNot Availableactive_not_recruiting
NCT00103376
Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancertreatment2terminated
NCT00017576
Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT00268476
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacytreatment2 / 3active_not_recruiting
NCT04399876
Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate CancerNo drug interventionsdiagnostic1enrolling_by_invitation
NCT00714376
Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer Patientstreatment2terminated
NCT03365076
Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox)No drug interventionstreatmentNot Availableterminated
NCT04130776
4Kscore Using Serum Stored UncentrifugedNo drug interventionsNot AvailableNot Availablecompleted
NCT00043576
ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxoteretreatment2 / 3unknown_status
NCT02445976
Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.treatment2completed
NCT03677076
Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03159676
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01409876
HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR BrachytherapyNo drug interventionstreatment2unknown_status
NCT06423976
Microbiome Molecular CharaterisationNo drug interventionsNot AvailableNot Availablerecruiting
NCT01729676
Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy InitiationNot AvailableNot Availablecompleted
NCT00999960
Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy SimulatorNo drug interventionsotherNot Availablesuspended
NCT04337060
Open Radical Prostatectomy and Erector Spinae Plane BlockNo drug interventionssupportive_careNot Availablecompleted
NCT03307460
uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor AggressivenessNo drug interventionsdiagnostic2unknown_status
NCT00977860
Hypofractionated SBRT For Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00151060
Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostatetreatment2completed
NCT02693860
Neoadjuvant J591 Treatment for Prostate CancerNo drug interventionstreatment1completed
NCT02247960
Antibiotic Prophylaxis for Urinary Catheter Removal After Radical ProstatectomytreatmentNot Availableterminated
NCT01415960
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancertreatment3completed
NCT04672460
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumorstreatment1completed
NCT06400160
Clinical Trial of TB511 in Advanced Solid Tumorstreatment1 / 2not_yet_recruiting
NCT03098160
Immunotherapy Study of Evofosfamide in Combination With Ipilimumabtreatment1unknown_status
NCT03397160
Pioneering Advances in Care and Education (PACE)No drug interventionssupportive_careNot Availablecompleted
NCT01584960
The Effect of Endurance Training in Patients With Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00489060
A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate CancerNo drug interventionstreatment3completed
NCT02379260
Development of a Therapeutic Education Program for Patients Operated for Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00002760
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancertreatment3completed
NCT03376360
Functional Medical Imaging Quantization in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01310894
Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.treatment3completed
NCT03990194
Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate CancerNot AvailableNot Availableunknown_status
NCT00027794
Radical Prostatectomy in Treating Patients With Locally Advanced Prostate CancerNo drug interventionstreatment2completed
NCT00643994
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose DistributionNo drug interventionstreatmentNot Availablecompleted
NCT02145494
The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using CyberknifeNo drug interventionstreatment2unknown_status
NCT03574194
Methionine-Restricted Diet to Potentiate The Effects of Radiation TherapyNo drug interventionstreatmentNot Availableterminated
NCT05478694
Outcomes of Focal Ablation for Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00003394
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancertreatment1 / 2completed
NCT04846894
Ga-68 PSMA-11 PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: Digital PET/CT Versus Analog PET/CTNo drug interventionsdiagnosticNot Availableunknown_status
NCT06239194
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsNo drug interventionstreatment1 / 2recruiting
NCT05192694
Evaluation of Fapi-pet in Prostate Cancer.No drug interventionsbasic_scienceNot Availableunknown_status
NCT02441894
Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancertreatment4completed
NCT00025194
Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancertreatment1 / 2completed
NCT00716794
A Phase I/II Study of HE3235 in Patients With Prostate Cancertreatment1 / 2completed
NCT01036594
Ketoconazole and Dexamethasone in Prostate Cancertreatment2completed
NCT00499694
Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With DocetaxeltreatmentNot Availablecompleted
NCT01839994
Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate CancerNo drug interventionstreatment3unknown_status
NCT00400894
Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT05815394
177Lu-labeled NY108 SPECT Imaging in Patientstreatment0recruiting
NCT03822494
CyberKnife Dose Escalation Prostate Cancer TrialNo drug interventionstreatmentNot Availablerecruiting
NCT00776594
Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapytreatment2completed
NCT00307294
Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)treatment2completed
NCT02552394
J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell CountsNo drug interventionstreatment1completed
NCT02366494
Micro RNAs to Predict Response to Androgen Deprivation TherapyNot AvailableNot Availableactive_not_recruiting
NCT00421694
Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With BicalutamideNot Available2 / 3completed
NCT00139191
Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT01155791
Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancertreatment1terminated
NCT00739791
Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT04312191
Using Meditation for Oncology AnxietyNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00616291
Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancertreatment1completed
NCT03328091
Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)No drug interventionssupportive_careNot Availablecompleted
NCT03914391
To Identify Potential New Urine Markers for the Screening of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00526591
Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancertreatment2terminated
NCT03887091
Personal Web Page In Clinical Trial Participant EducationNo drug interventionshealth_services_researchNot Availablecompleted
NCT03040791
Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial)treatment2unknown_status
NCT03524391
Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT01601691
Protection of Rectum From High Radiation DosesNo drug interventionssupportive_careNot Availablecompleted
NCT00978991
Duke Urology Database and Specimen BankNo drug interventionsNot AvailableNot Availablecompleted
NCT01809691
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancertreatment3active_not_recruiting
NCT01212991
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancertreatment3completed
NCT00667862
Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancertreatment2completed
NCT06507462
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3No drug interventionsNot AvailableNot Availablerecruiting
NCT04062162
Walking Football as a Supportive Medicine for Patients With Prostate CancerNo drug interventionspreventionNot Availableunknown_status
NCT04266262
High-Intensity Training for Men With Prostate Cancer on Active Surveillance: A Feasibility StudyNo drug interventionssupportive_careNot Availableterminated
NCT00214162
CHESS Caregivers Study: Web-based Support for Informal Caregivers in CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01739062
The ProCaRis Study: Prostate Cancer Risk Assessment in General PracticeNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT01056562
An Alternative to A Fixed Schedule In Management Of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02104362
Single Fraction Early Prostate Irradiation (SiFEPI)No drug interventionstreatmentNot Availablecompleted
NCT00110162
Androgen Deprivation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment3unknown_status
NCT00669162
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancertreatment1 / 2completed
NCT03006562
PREvention of VENous ThromboEmbolism Following Radical Prostatectomyprevention4terminated
NCT02225262
A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate TumorsNo drug interventionstreatmentNot Availableunknown_status
NCT04379362
MRI-guided Focal Laser AblationNo drug interventionstreatment2unknown_status
NCT04443062
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancertreatment2recruiting
NCT02840162
Pre-Prostatectomy Celecoxib or Placebotreatment2terminated
NCT00003162
Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate CancerNo drug interventionssupportive_care3completed
NCT01742962
Prevalence of Neglected Side Effects to Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT00561262
High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT04706962
TH1902 in Patients With Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT01277562
Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00385580
Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancertreatment2completed
NCT04390880
18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancerdiagnostic2unknown_status
NCT06244680
Super-fast 3T Prostate MRI Using High Gradient Strength and Deep LearningNo drug interventionsNot AvailableNot Availablecompleted
NCT04154280
Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT03967080
Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRINo drug interventionsNot AvailableNot Availableunknown_status
NCT04087980
Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT01676480
The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation TherapyNo drug interventionstreatmentNot Availablecompleted
NCT00323180
Investigation of Protein Biomarkers of Prostate CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT04191980
Deep Learning for Prostate SegmentationNo drug interventionsNot AvailableNot Availableunknown_status
NCT04206280
Use of Pedometer Following Radical ProstatectomyNo drug interventionsotherNot Availableunknown_status
NCT01087580
Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancertreatment2withdrawn
NCT03735680
A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancerdiagnostic2completed
NCT03950180
Assessing The Impact Of Incorporating Charlson Comorbidity Scores On Patient Anxiety And SatisfactionNo drug interventionsotherNot Availablecompleted
NCT04000880
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT02830880
FACBC Prostate Therapy Responsediagnostic2completed
NCT03787680
Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)treatment2active_not_recruiting
NCT03263780
High Resolution PET-MRI Before Prostate Cancer HIFUother2completed
NCT00676780
Green Tea Extract and Prostate Cancerbasic_science2completed
NCT00418080
Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapytreatment2completed
NCT04858880
Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.No drug interventionstreatment3recruiting
NCT05710380
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted BiopsyNo drug interventionsscreeningNot Availablerecruiting
NCT01308580
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancertreatment3completed
NCT04662580
ARX517 in Subjects With Metastatic Castration-Resistant Prostate CancerNo drug interventionstreatment1recruiting
NCT04500080
Feasibility and Safety of Physical Exercise in Men With Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00288080
Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancertreatment3completed
NCT05965180
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic ProbeNo drug interventionsNot AvailableNot Availablerecruiting
NCT01350180
Assessing DNA Changes in High Risk Prostate Cancer to Determine PrognosisNo drug interventionsNot AvailableNot Availableunknown_status
NCT00562380
AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphomatreatment1completed
NCT00658229
The Physical Exercise and Prostate Cancer StudyNo drug interventionssupportive_care3completed
NCT01013129
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06167629
Monocentric Observational Study on the Diagnostic and Prognostic Role of 18F-PSMA PET (PET/CT and PET/MR) in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02397629
Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer DiagnosisNo drug interventionsNot AvailableNot Availablecompleted
NCT02220829
Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapysupportive_care3unknown_status
NCT00712829
Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agentsdiagnostic1completed
NCT00023829
Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancertreatment3completed
NCT01240629
Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancertreatment1 / 2completed
NCT02941029
RADTOX: Measuring Radiation Toxicity Using Circulating DNANo drug interventionsNot AvailableNot Availablecompleted
NCT06085729
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)treatment1 / 2recruiting
NCT01715129
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancertreatment3completed
NCT03675529
The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.No drug interventionsbasic_scienceNot Availablecompleted
NCT03151629
International Registry for Men With Advanced Prostate Cancer (IRONMAN)No drug interventionsNot AvailableNot Availablerecruiting
NCT00004029
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancertreatment1completed
NCT00283829
Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancertreatment1 / 2completed
NCT04446429
Anti-Androgen Treatment for COVID-19treatmentNot Availablecompleted
NCT00559429
Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancertreatment1completed
NCT00554229
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastasestreatment3completed
NCT02844829
Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and BiomarkersNo drug interventionsdiagnosticNot Availableunknown_status
NCT00305929
Study of WST09 in Prostate Cancer After Radiation: Repeat Proceduretreatment2completed
NCT04104529
Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine DepartmentNo drug interventionsotherNot Availablerecruiting
NCT03482089
Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder InvasionNo drug interventionstreatmentNot Availablerecruiting
NCT01441089
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04060589
ReIMAGINE Prostate Cancer RiskNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02080689
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After SurgeryNo drug interventionsdiagnosticNot Availablecompleted
NCT01415089
Tailored Web-Based Intervention for Cancer Patients and Family CaregiversNo drug interventionssupportive_careNot Availablecompleted
NCT00967889
Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT02315989
Early-Phase Safety of Proton Therapy EquipmentNo drug interventionstreatmentNot Availablecompleted
NCT02954289
Cooking Class Intervention Project for Men With Prostate Cancer and Their PartnersNo drug interventionspreventionNot Availablecompleted
NCT00002889
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancertreatment2completed
NCT05343689
Pneumatic Compression and Post-induction HypotensionNo drug interventionspreventionNot Availablecompleted
NCT06482489
Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01377389
Ipilimumab + Androgen Depravation Therapy in Prostate Cancertreatment2terminated
NCT05996289
Inter-observer Variability in the Segmentation of Prostate Tumour Lesions Using Multiparametric MRI (VARIOP)No drug interventionsNot AvailableNot Availablerecruiting
NCT02300389
Comparing Hypofractionated Radiotherapy Boost to Conventionally FractionatedNo drug interventionstreatmentNot Availablecompleted
NCT06054789
Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT03543189
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapytreatment1 / 2active_not_recruiting
NCT05873192
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancertreatment2not_yet_recruiting
NCT04180592
Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate.No drug interventionsdiagnosticNot Availableunknown_status
NCT02425592
Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05276492
Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.treatment1active_not_recruiting
NCT06441292
Multi-Modal Image Fusion for Precision Prostate Biopsy NavigationNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT01558492
Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancertreatment2terminated
NCT05462392
Robot-assisted Urological Surgeries Using the MicroHand S RobotNo drug interventionsotherNot Availablerecruiting
NCT00268892
Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancertreatment2 / 3completed
NCT05722392
Safety and Efficacy of Two-step Radical ProstatectomyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00005992
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyNo drug interventionstreatment1unknown_status
NCT01766492
Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With RadiosurgeryNo drug interventionsNot AvailableNot Availablerecruiting
NCT05587192
Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic ModelNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT02177292
High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)No drug interventionstreatmentNot Availableactive_not_recruiting
NCT00006392
S0000 Selenium and Vitamin E in Preventing Prostate Cancerprevention3completed
NCT00757692
Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer.treatment2completed
NCT03215992
Optical Tomography in Prostate CancerNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT00851292
The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firingNo drug interventionsdiagnostic3unknown_status
NCT06274892
Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review ProcessNo drug interventionssupportive_careNot Availablerecruiting
NCT00844792
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate CancerNo drug interventionstreatment2completed
NCT05726292
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancertreatment2recruiting
NCT00583492
Randomized Trial of Suicide Gene Therapy and Prostate CancerNo drug interventionstreatment2completed
NCT03209492
Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"Not AvailableNot Availablecompleted
NCT00756392
Magnetic Resonance (MR) Spectroscopy in Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00834392
Exercise in Men With Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT03807492
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)No drug interventionsNot AvailableNot Availablecompleted
NCT01455792
Biopsy Study Comparing MRI and Ultrasound Soft Image Fusion Guided Biopsies and Gold Standard Prostate Biopsies.No drug interventionsdiagnosticNot Availablecompleted
NCT00924092
An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...treatment1completed
NCT00376792
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancertreatment3unknown_status
NCT00630344
RAD001 and Bicalutamide for Androgen Independent Prostate Cancertreatment2completed
NCT01763944
Carbohydrate Restriction and Prostate Cancer GrowthNo drug interventionstreatmentNot Availablecompleted
NCT00010244
Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate CancerNo drug interventionstreatment3completed
NCT04787744
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancertreatment2 / 3recruiting
NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT00019344
Flavopiridol in Treating Patients With Refractory Cancertreatment1completed
NCT00176644
Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancertreatment2terminated
NCT00954044
Exercising Together: An Intervention for Prostate Cancer Survivors and SpousesNo drug interventionssupportive_careNot Availablecompleted
NCT04731844
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancertreatment2recruiting
NCT02410044
Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00005044
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancertreatment3completed
NCT03356444
Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostatetreatment2unknown_status
NCT03444844
Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate CancerNo drug interventionsdiagnostic1 / 2active_not_recruiting
NCT03156244
Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00006044
Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapytreatment1completed
NCT03135444
PSA TOOL for Prostate Cancer Screening DiscussionsNo drug interventionssupportive_careNot Availablecompleted
NCT01571544
The Use of Thermal Suits as Preventing Hypothermia During SurgeryNo drug interventionsprevention4completed
NCT00456144
Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01193244
Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancertreatment3completed
NCT05745844
Evaluation of Neuromuscular ElectroStimulation in Addition to a Physical Activity ProgramNo drug interventionssupportive_careNot Availablerecruiting
NCT03253744
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapytreatment1active_not_recruiting
NCT05065944
Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer CenterNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00327340
Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPCtreatment2completed
NCT05354440
Post Marketing Clinical Follow Up of the BioProtect Balloon Implant SystemNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05332340
Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administeredsupportive_care1completed
NCT00887640
Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancertreatment2terminated
NCT00318240
Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound (HIFU)No drug interventionstreatmentNot Availablecompleted
NCT00372840
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerNo drug interventionsotherNot Availablecompleted
NCT03425240
Intra-operative Neuromodulation of the Pelvic PlexusNo drug interventionsdevice_feasibilityNot Availableunknown_status
NCT02816840
PET-CT/MRI in the Radiotherapy for Prostate CancerNo drug interventionstreatment1 / 2unknown_status
NCT01418040
PROstate Cancer Imaging, Treatment and Toxicity (PROCITT)No drug interventionsNot AvailableNot Availablecompleted
NCT00007540
Study of Prostate Cancer in Black and White U.S. VeteransNo drug interventionsNot AvailableNot Availablecompleted
NCT00578240
Molecular Studies and Clinical Correlations in Human Prostatic DiseaseNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01752140
A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy SchemeNo drug interventionsdiagnosticNot Availablecompleted
NCT01535040
Memantine Hydrochloride in Helping Cancer Survivors Stop Smokingsupportive_care2completed
NCT02773940
ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic ProstatectomyNo drug interventionsotherNot Availableunknown_status
NCT00582140
Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancertreatment1completed
NCT05133440
A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the BonesNo drug interventionstreatment2active_not_recruiting
NCT04571840
Prostate Imaging Using MRI +/- Contrast EnhancementNo drug interventionsdiagnosticNot Availableunknown_status
NCT01289067
Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Catreatment2completed
NCT02685267
Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancertreatment2terminated
NCT05810467
The Active Surveillance StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06184867
Choices About Genetic Testing And Learning Your Risk With Smart TechnologyNo drug interventionshealth_services_research0recruiting
NCT00003367
Diet and PSA Levels in Patients With Prostate CancerNo drug interventionstreatment3completed
NCT06218667
A Study of Copanlisib in Combination With Degarelix in People With Prostate Cancertreatment1 / 2recruiting
NCT00024167
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancertreatment3terminated
NCT01308567
Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancertreatment3completed
NCT00061867
Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancertreatment1completed
NCT00242567
Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancertreatment3completed
NCT04506567
Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPCNo drug interventionstreatment1 / 2suspended
NCT01972867
Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk PatientsNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02643667
Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancertreatment2completed
NCT06546267
Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)No drug interventionsNot AvailableNot Availablerecruiting
NCT06508567
Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan EraNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03331367
Investigating and Characterizing the Immune Response to Prostate CancerNo drug interventionsbasic_scienceNot Availablecompleted
NCT04580667
Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From PlasmaNo drug interventionsNot AvailableNot Availablerecruiting
NCT00041301
Assessing Quality of Life of Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00432601
Testing the Helpfulness of 2 Decision Aids for Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01572701
Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissectiondiagnostic1completed
NCT06517901
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate CancerNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT01780701
Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02588001
Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - EnzalutamidetreatmentNot Availablecompleted
NCT04751201
Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study)No drug interventionssupportive_careNot Availablecompleted
NCT05155501
Clinical Trial of Approaches to Prostate Cancer SurgeryNo drug interventionstreatmentNot Availablerecruiting
NCT06446401
The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate CancerNot AvailableNot Availablenot_yet_recruiting
NCT01018901
Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer TreatmentNo drug interventionsotherNot Availablecompleted
NCT02339701
Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate CancerNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT05033301
Evaluating the Effectiveness of the Nurse Ned ClinicNo drug interventionssupportive_careNot Availablerecruiting
NCT02450201
MRI With C13 Pilot Study Prostate CancerNo drug interventionsdiagnostic0terminated
NCT00805701
Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantationtreatment4completed
NCT00004001
S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapytreatment3completed
NCT00006101
Eflornithine in Treating Patients At High Risk of Developing Prostate Cancerprevention2completed
NCT05220501
Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRINo drug interventionsdiagnosticNot Availablerecruiting
NCT00446901
Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene ExpressionNo drug interventionspreventionNot Availablecompleted
NCT00030901
S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostateprevention3completed
NCT02432001
Radiologically Guided Biopsies of mCRPCNo drug interventionsNot AvailableNot Availablecompleted
NCT00081601
Study of CEP-701 in Treatment of Prostate Cancertreatment2completed
NCT02542501
Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) AnaloguesNo drug interventionsNot AvailableNot Availablecompleted
NCT00425204
Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatmenttreatment2completed
NCT01275404
Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation ProgramNo drug interventionstreatmentNot Availablecompleted
NCT00139204
Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT02367404
Prospective RCT on Post Prostatectomy Urine Leaktreatment3unknown_status
NCT04704804
Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT01020604
PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01954004
Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT01434004
Eating, Activity, and Stress EducationNo drug interventionsotherNot Availablecompleted
NCT01300104
Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT04017104
Dynamic Whole Body Positron Emission Tomography/Computed Tomography ImagingNo drug interventionsNot AvailableNot Availableunknown_status
NCT00003104
Computer Planned Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT03692104
US-CT Fusion for Post Implant DosimetryNo drug interventionsNot AvailableNot Availablecompleted
NCT05453604
Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology ApplicationsNo drug interventionsotherNot Availableactive_not_recruiting
NCT06307704
Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy PatientsNo drug interventionssupportive_careNot Availablerecruiting
NCT02107404
Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT06011304
Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate CancerNo drug interventionsdiagnostic3recruiting
NCT05557604
Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcersupportive_care2recruiting
NCT04032704
A Study of Ladiratuzumab Vedotin in Advanced Solid Tumorstreatment2terminated
NCT06284304
A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRLNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05041504
A Web-based Peer Navigation Program for Men With Prostate CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00388804
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancertreatment3terminated
NCT03478904
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancerother1terminated
NCT01335204
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancertreatment1 / 2terminated
NCT03816904
Involvement of SK3 Calcium Channel in Taxane NeuropathyNo drug interventionsNot AvailableNot Availablecompleted
NCT02225704
Radium-223 in Combination With Enzalutamidetreatment2completed
NCT00932672
Atkins Diet and Prostate Cancer Clinical TrialNo drug interventionsprevention2terminated
NCT01699672
Group-based or Individual Information About Disease and Treatment PlanNo drug interventionssupportive_careNot Availableterminated
NCT02594072
Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT)treatmentNot Availableactive_not_recruiting
NCT00558272
Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Diseasetreatment2completed
NCT04742972
Prostate PMSABR StudyNo drug interventionstreatmentNot Availablewithdrawn
NCT03199872
RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid TumoursNo drug interventionstreatment1 / 2completed
NCT03093272
A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancertreatment2terminated
NCT00579072
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and OlderNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05396872
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate CancerNo drug interventionshealth_services_researchNot Availablerecruiting
NCT01238172
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceNo drug interventionstreatment3completed
NCT03233672
Hypo-fractionated Postoperative IMRT in Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT03860272
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancertreatment1recruiting
NCT05100472
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT02044172
Prostate Testing for Cancer and TreatmentNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05040672
Evaluation of Knowledge and Practice About Prostate Cancer in Male EmployeesNo drug interventionsNot AvailableNot Availablecompleted
NCT02232672
Choline PET/CT vs. MeAIB PET/CT in Prostate CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT01296672
3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancerscreening4completed
NCT05169372
Retrospective Analysis of 68Ga-PSMA-PET in Patients With Prostate Cancer: Experience From BrazilNo drug interventionsNot AvailableNot Availableterminated
NCT04488068
Transpelvic Magnetic Stimulation to Improve Urogenital FunctionNo drug interventionspreventionNot Availablecompleted
NCT01244568
Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2No drug interventionstreatmentNot Availablecompleted
NCT02396368
A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancertreatment1withdrawn
NCT03943368
Using Virtual Reality (VR) Models for Robotic ProstatectomyNo drug interventionstreatmentNot Availablecompleted
NCT01685268
A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetatetreatment1 / 2completed
NCT04163068
The Improving Cancer Aftercare Study.No drug interventionsNot AvailableNot Availablecompleted
NCT04589468
Researching the Effect of Exercise on CancerNo drug interventionspreventionNot Availablerecruiting
NCT02903368
Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomytreatment2active_not_recruiting
NCT02981368
Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancerdiagnostic2 / 3completed
NCT00868868
Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04644068
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignanciestreatment1 / 2recruiting
NCT02339168
Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancertreatment1active_not_recruiting
NCT00002668
Pain Control in Patients With Recurrent or Metastatic Breast or Prostate CancerNo drug interventionsotherNot Availableterminated
NCT04800068
Expanded Access [Ga-68] PSMA-11 PET ImagingNo drug interventionsNot AvailableNot Availableno_longer_available
NCT02124668
A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapytreatment2completed
NCT00779168
White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local TherapyNo drug interventionstreatment1completed
NCT05546268
Study of Oral MRT-2359 in Selected Cancer Patientstreatment1 / 2recruiting
NCT01087268
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic CancerNo drug interventionssupportive_care3unknown_status
NCT04179968
The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate CancerNo drug interventionsdiagnostic2completed
NCT00667069
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancertreatment3active_not_recruiting
NCT03870269
Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNCNo drug interventionstreatmentNot Availablecompleted
NCT00001469
Genetic Analysis of Hereditary Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02156869
Impact of a Printed Decision Aid on Patients' Intent to Undertake Prostate Cancer ScreeningNo drug interventionsscreeningNot Availablecompleted
NCT06281769
Prostate Cancer Detection Rate of Targeted Biopsies With PCaVisionNo drug interventionsdiagnosticNot Availablerecruiting
NCT01008969
Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer PatientsNo drug interventionsdiagnosticNot Availablecompleted
NCT05469269
Cleveland African American Prostate Cancer ProjectNo drug interventionsscreeningNot Availablerecruiting
NCT05224869
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04693169
[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer PatientsdiagnosticNot Availableactive_not_recruiting
NCT01428869
Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03105869
Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammoniumNo drug interventionsdiagnosticNot Availablecompleted
NCT03406169
Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomytreatment3unknown_status
NCT00617669
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancertreatment3completed
NCT04687969
Multimodal Machine Learning Characterization of Solid TumorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT03001869
68Ga-PSMA PET/CT in Prostate Cancerdiagnostic3completed
NCT01766869
Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRSNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00028769
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT01220869
A Study of Degarelix in Taiwanese Patients With Prostate Cancertreatment3completed
NCT06435546
Adherence to Oral Therapies in Advanced Breast and Prostate CancersNo drug interventionspreventionNot Availablerecruiting
NCT02102646
MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadismtreatment4completed
NCT00520546
Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate CancerNo drug interventionsdiagnostic3completed
NCT06055946
Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical ProstatectomyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00321646
Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomytreatment2completed
NCT04319146
Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04486846
Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)No drug interventionshealth_services_researchNot Availablewithdrawn
NCT05114746
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in JapanNo drug interventionstreatment2recruiting
NCT01205646
PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate CancerscreeningNot Availablecompleted
NCT06582446
Artificial Intelligence to Personalize Prostate Cancer Treatment (the HypoElect Trial)treatment2recruiting
NCT05162846
Methods for Increasing Genetic Testing Uptake in MichiganNo drug interventionshealth_services_researchNot Availablerecruiting
NCT03388346
68Ga PSMA in Preprostatectomy Patientsdiagnostic2 / 3completed
NCT02588846
Multi-target Tracking in Prostate Radiotherapy Using MLC and KIMNo drug interventionstreatmentNot Availablewithdrawn
NCT04827446
Lighting Intervention for Cancer-related FatigueNo drug interventionssupportive_careNot Availablecompleted
NCT04251546
Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPVNo drug interventionsNot AvailableNot Availableunknown_status
NCT03682146
Laparoscopic vs Robotic-Assisted Radical ProstatectomyNo drug interventionstreatmentNot Availablecompleted
NCT05880446
PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)No drug interventionsdiagnosticNot Availablecompleted
NCT03650946
Clinical Application of 68Ga-PSMA PET in Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT06219746
99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT01812746
A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate CancerNo drug interventionstreatment2completed
NCT00494546
High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate CancerNo drug interventionstreatment3completed
NCT02558946
Physical Therapy for Men Undergoing ProstatectomyNo drug interventionssupportive_careNot Availablerecruiting
NCT02137746
Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate CancerNo drug interventionstreatment2completed
NCT00016146
Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancertreatment1completed
NCT00031746
Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen LevelsNo drug interventionsprevention2completed
NCT00038246
Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinomatreatment1 / 2completed
NCT00237146
Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomytreatment4completed
NCT01173146
Imaging of Residual Tumor During ProstatectomyNo drug interventionsNot AvailableNot Availablewithdrawn
NCT05019846
SRT Versus SRT+ADT in Prostate Cancertreatment3recruiting
NCT00242112
Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRINo drug interventionsdiagnosticNot Availablecompleted
NCT06306612
CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00147212
ET 743 (Yondelis) in Men With Advanced Prostate Cancertreatment2completed
NCT05249712
Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancertreatment2recruiting
NCT03960112
Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as ReferenceNo drug interventionsdiagnosticNot Availableunknown_status
NCT05443412
Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer DetectionNo drug interventionsNot AvailableNot Availablerecruiting
NCT03151512
UNDISTORT Correction of Distortions in Diffusion MRI V1.0No drug interventionsNot AvailableNot Availablecompleted
NCT00598312
Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancertreatment3completed
NCT01565512
Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomforttreatment1 / 2withdrawn
NCT01761812
Multiparametric MRI for Prostate Cancer Localization and Characterization: New MethodsNo drug interventionsdiagnosticNot Availableterminated
NCT00899912
Changes in DNA After Radiation Therapy in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02478112
Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI)No drug interventionstreatmentNot Availablesuspended
NCT00515112
Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancertreatment2terminated
NCT05761912
Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate BiopsyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02034812
Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation OncologistsNo drug interventionsNot AvailableNot Availablecompleted
NCT00043212
Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective.treatment3withdrawn
NCT03741712
A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPCtreatment1 / 2terminated
NCT00003312
Brachytherapy in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT05574712
A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancertreatment2withdrawn
NCT05521412
EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&TNo drug interventionstreatment1 / 2active_not_recruiting
NCT00117312
Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patientstreatment2terminated
NCT05169112
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomytreatment3recruiting
NCT03876912
The Effect of ADT on PSMA Expression in Metastatic Prostate CancertreatmentNot Availableunknown_status
NCT04823910
Personalizing Docetaxel Dosing in Advanced Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06521710
Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical ProstatectomyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02480010
A Study of Pertuzumab in Participants With Prostate Cancertreatment2terminated
NCT04985110
Administration of Antibiotic Prophylaxis for Transperineal Prostate Biopsy in Cipto Mangunkusumo Hospitaltreatment2unknown_status
NCT00459810
Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancertreatment2terminated
NCT00550810
Sutent Maintenance After Response to Taxoteretreatment2unknown_status
NCT04645810
A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only RecurrenceNo drug interventionstreatmentNot Availablerecruiting
NCT00652210
Use of Multiphoton Microscopy in the Diagnosis of CancerNo drug interventionsdiagnostic1completed
NCT00233610
Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancerprevention3completed
NCT00939510
Lenalidomide and GM-CSF in Treating Patients With Prostate Cancertreatment1 / 2completed
NCT01204710
A Study of Olaratumab (IMC-3G3) in Prostate Cancertreatment2completed
NCT03228810
Genetic Biomarker Discovery for Metastatic Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01620710
Safety Study of a Shorter (Hypofractionated) Radiotherapy for the Prostate Bed With or Without the Pelvic Lymph NodesNo drug interventionstreatment2completed
NCT01867710
Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapytreatment2completed
NCT04506710
Improvement of Communicational Skills Between Health Workers and Oncological Patients During Medical Consultative ConversationsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01057810
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancertreatment3completed
NCT03911310
[18F]PSMA-11 PET/CT Phase 3 Clinical StudyNo drug interventionsdiagnostic3completed
NCT00078910
Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancertreatment2completed
NCT03128710
Prostate Cancer SurveyNo drug interventionsNot AvailableNot Availablecompleted
NCT00394810
Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancertreatment2completed
NCT02262910
Study of ES414 in Metastatic Castration-Resistant Prostate CancerNo drug interventionstreatment1completed
NCT03179410
PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancertreatment2completed
NCT03275181
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00052481
Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05893381
Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)treatment2recruiting
NCT06111781
The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancertreatment2recruiting
NCT03392181
PET/MRI for the Staging of Newly Diagnosed Prostate Cancerdiagnostic0unknown_status
NCT00859781
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancertreatment2active_not_recruiting
NCT03009981
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancertreatment3active_not_recruiting
NCT00398281
Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancerdiagnostic3completed
NCT03701581
4-aminopyridine Treatment for Nerve Injurytreatment2 / 3suspended
NCT02678481
MR-targeted vs. Random TRUS-guided Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT01960881
Evaluation of Diet and Exercise in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00002881
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancertreatment3completed
NCT03081481
Intraprostatic PRX302 Injection to Treat Localised Prostate Cancertreatment2completed
NCT01734681
Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancertreatment2withdrawn
NCT03377881
Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion BiopsiesNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT05613881
Symptom Management, Education and Telephone Follow-up, Quality of Life,No drug interventionssupportive_careNot Availablecompleted
NCT00027781
MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapytreatment2completed
NCT03202381
Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelixother4unknown_status
NCT05903781
Value of Ultra-fast Prostate MRI in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01499381
EMBRACE1: Prostate BiorepositoryNo drug interventionsNot AvailableNot Availablecompleted
NCT03589781
Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the ProstateNo drug interventionspreventionNot Availablewithdrawn
NCT01089881
The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00769795
Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancertreatment2completed
NCT00790595
Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomytreatment1completed
NCT03650595
MRI Guided Focal Laser Ablation of Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03085095
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancertreatment3completed
NCT06389695
Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in PatientsNo drug interventionsdiagnostic1recruiting
NCT00448695
MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate CancerNo drug interventionstreatment1completed
NCT00966095
PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate BiopsyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03790995
Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARPNo drug interventionsNot AvailableNot Availablecompleted
NCT00150995
Tetrathiomolybdate in Hormone Refractory Prostate Cancertreatment2completed
NCT05014295
Patient Recall of Cancer Screening and DiagnosisNo drug interventionssupportive_careNot Availablerecruiting
NCT02454595
Registry to Measure the Impact of Adding Genomic TestingNo drug interventionsNot AvailableNot Availableterminated
NCT02516995
Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03073395
Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal CancerNo drug interventionsdiagnostic1active_not_recruiting
NCT06392295
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate CancerNo drug interventionstreatment2recruiting
NCT00861614
Study of Immunotherapy to Treat Advanced Prostate Cancertreatment3completed
NCT02292914
Prospective Analysis of Robot-Assisted SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT04301414
Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancertreatment0active_not_recruiting
NCT00303914
Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00870714
Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot StudytreatmentNot Availableunknown_status
NCT03111914
Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate CancerNo drug interventionsdiagnosticNot Availableterminated
NCT00322114
Lycopene in Preventing Prostate Cancer in Healthy ParticipantsNo drug interventionspreventionNot Availableunknown_status
NCT02874014
Prospective Evaluation of Hypofractionation Proton Beam Therapy With Concurrent Treatment of the Prostate and Pelvic Nodes for Clinically Localized, High Risk or Unfavorable Intermediate Risk Prostate CancerNo drug interventionstreatment2active_not_recruiting
NCT04729114
Open-label, Multicenter Study of Intramuscular PRL-02 Depot in Patients With Advanced Prostate Cancertreatment1 / 2recruiting
NCT06451614
SpaceIT Hydrogel System for Perirectal SpacingNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02601014
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7treatment2completed
NCT00006214
Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostateprevention2completed
NCT05961514
the Beijing Randomized Study Of Prostate Cancer ScreeningNo drug interventionsscreeningNot Availablerecruiting
NCT04890314
Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for TreatmentNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00024414
DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancertreatment2unknown_status
NCT04197414
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNANo drug interventionsNot AvailableNot Availablerecruiting
NCT00428714
Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapytreatment2completed
NCT02013414
Fusion Targeted Biopsy of the ProstateNo drug interventionsdiagnosticNot Availablecompleted
NCT02536014
Effect of Dexmedetomidine on Heart-rate Corrected QT(QTc) Interval Prolongation During Robotic-assisted Laparoscopic Radical Prostatectomy -Randomized Blind Clinical Trial-preventionNot Availablecompleted
NCT04465214
Mobile Sensor Technologies to Assess General Symptomology of People With CancerNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT01278914
Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate CancerNo drug interventionsNot Available1 / 2completed
NCT01688414
Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney CancerNo drug interventionsdiagnosticNot Availablewithdrawn
NCT01436214
Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancertreatment1 / 2unknown_status
NCT04158414
Applying PET/MR in Oncology - a Prospective ProjectNo drug interventionsdiagnosticNot Availableunknown_status
NCT00003614
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT06237114
Novel Robotic Prostatectomy Technique for Early Urinary ContinenceNo drug interventionsNot AvailableNot Availablerecruiting
NCT00380055
Reducing Cancer Disparities for American Indians in the Rural Intermountain WestNo drug interventionsscreeningNot Availablecompleted
NCT03385655
Prostate Cancer Biomarker Enrichment and Treatment Selectiontreatment2active_not_recruiting
NCT04207255
Addition of Opaganib to Androgen Antagonists in Patients With mCRPCtreatment2active_not_recruiting
NCT06041555
MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)No drug interventionsNot AvailableNot Availablerecruiting
NCT03618355
Trial of eRapa in Prostate Cancer Patientstreatment1completed
NCT03632655
A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy ApproachesNo drug interventionsdiagnosticNot Availableterminated
NCT03459755
Evaluating Race Specific AGE Accumulation as a Behavioral Biomarker Prostate Cancer SurvivorsNo drug interventionspreventionNot Availablewithdrawn
NCT01400555
A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)No drug interventionstreatment1completed
NCT01084655
Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancertreatment1 / 2completed
NCT06062355
Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate CancerNo drug interventionstreatment1not_yet_recruiting
NCT06014255
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancertreatment2recruiting
NCT05530655
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancersupportive_care0recruiting
NCT00976755
Everolimus as First-Line Therapy in Treating Patients With Prostate Cancertreatment2completed
NCT02933255
PROSTVAC in Combination With Nivolumab in Men With Prostate Cancertreatment1 / 2completed
NCT01953055
SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)No drug interventionstreatment1 / 2unknown_status
NCT03311555
A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)treatment2completed
NCT00269555
Effects of GCP on Prostate Cancer.treatmentNot Availablecompleted
NCT03619655
Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapydiagnostic1terminated
NCT02034955
Prostatectomy Adaptive Radiation Therapy (ART)No drug interventionstreatmentNot Availablecompleted
NCT05616650
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumortreatment2recruiting
NCT01650350
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancertreatment2terminated
NCT03600350
pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancertreatment2active_not_recruiting
NCT06355050
Ultrahypofractionated, Adaptive Radiation Therapy of Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02080650
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)No drug interventionsdevice_feasibilityNot Availablecompleted
NCT03400150
ProSpace™ Balloon System Pivotal Study BP-007No drug interventionssupportive_careNot Availablecompleted
NCT01842750
The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00815750
Decision Making in Unaffected First-Degree Relatives of Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT02783950
Genomics in Michigan Impacting Observation or RadiationNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT02248350
An Exercise Intervention for Prostate Cancer Patients Receiving Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT05127850
MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT03424850
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate BrachytherapyNo drug interventionstreatment1 / 2recruiting
NCT00009750
Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapytreatment1unknown_status
NCT01272050
Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After SurgeryNo drug interventionstreatment3completed
NCT01875250
Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancertreatment2completed
NCT00021450
Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancertreatment3completed
NCT00295750
The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancertreatment3completed
NCT00578123
Clinical and Quality of Life Outcomes After Open or Robotic-Assisted Laparoscopic Radical ProstatectomyNo drug interventionssupportive_careNot Availablecompleted
NCT05613023
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRTNo drug interventionstreatment3recruiting
NCT00078923
Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the ProstateNo drug interventionsprevention2completed
NCT00002723
Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancertreatment3completed
NCT00045123
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrencetreatment2unknown_status
NCT02313623
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer ResearchNo drug interventionsNot AvailableNot Availablerecruiting
NCT01624623
Daily Target Guided Radiation Therapy Using the Calypso 4D Localization System in Patients Who Have Had a Prostatectomy for Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00480623
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrencetreatment1terminated
NCT01562223
Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT00702923
CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancertreatment1terminated
NCT02274623
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acidsupportive_care1completed
NCT01902823
Effect of Cancer Nurse Navigators on Patient OutcomesNo drug interventionssupportive_care2 / 3terminated
NCT00831623
Study of Hypofractionated Proton Beam Radiation Therapy for Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT00005623
Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancersupportive_care3completed
NCT04535908
Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.No drug interventionstreatmentNot Availableterminated
NCT00065208
Reiki/Energy Healing in Prostate CancerNo drug interventionstreatment1 / 2completed
NCT05262608
The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutationtreatment2unknown_status
NCT05871008
Integrated Actionable Aging Assessment for Cancer Patients PilotNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04369508
PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent BrachytherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT04264208
HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancertreatment2terminated
NCT06215508
Geriatric Assessment and Technology Evaluation in Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02142608
A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate CancerNo drug interventionsdiagnostic1 / 2completed
NCT00186108
A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate CancerNo drug interventionstreatment1completed
NCT03706508
Pentafecta Outcomes After Robot-assisted Laparoscopic Radical ProstatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03507608
Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppressiontreatment0active_not_recruiting
NCT00422708
Local Anesthesia for Prostate BiopsyNo drug interventionstreatment4completed
NCT03657108
CivaSheet With Radical Prostatectomy & Adjuvant External Beam RadiationNo drug interventionstreatmentNot Availableterminated
NCT03824808
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgerytreatment4terminated
NCT04396808
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate CancerNo drug interventionsotherNot Availablerecruiting
NCT06462508
Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and MetastasisNo drug interventionsdiagnostic0recruiting
NCT01607008
MRI for Assessing Prostate Cancer ResponseNo drug interventionsdiagnosticNot Availablerecruiting
NCT02946008
Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate CancerNo drug interventionstreatment1completed
NCT00138008
Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical ProstatectomyNo drug interventionstreatment3completed
NCT00373308
Quality of Life Following Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT02452008
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancertreatment2active_not_recruiting
NCT01611038
Methylselenocysteine Effects on Circadian RhythmNo drug interventionsbasic_scienceNot Availablecompleted
NCT00985738
Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancertreatment2terminated
NCT00326638
3D-Conformal Radiation vs Helical Tomotherapy in Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT01826838
Study of Dasatinib, Androgen Deprivation Therapy and Radiationtreatment1withdrawn
NCT01964638
Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis.No drug interventionsdiagnosticNot Availablecompleted
NCT00659438
Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancertreatment2completed
NCT00703638
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT01842438
A Couple Support Intervention for Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT04654338
2 Ablative RadioTherapy Treatments for Prostate CancerNo drug interventionstreatment2 / 3recruiting
NCT01105338
Lycopene or Green Tea for Men at Risk of Prostate CancerNo drug interventionstreatment2 / 3completed
NCT05096338
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01751438
Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)No drug interventionstreatment2completed
NCT02654938
Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancertreatment1completed
NCT00949338
Comparing Two Sets of Bladder-Filling Instructions in Treating Patients Undergoing Radiation Therapy For Prostate Cancer. ICORG 05-04No drug interventionstreatmentNot Availablecompleted
NCT05331638
Prostate Cancer Genius App Education and Home-based PSA Screening for African American MenNo drug interventionspreventionNot Availableactive_not_recruiting
NCT00003038
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT00179738
A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.treatment2terminated
NCT01756638
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancertreatment2completed
NCT04030338
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06119438
Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate BiopsyNo drug interventionssupportive_careNot Availablecompleted
NCT03056638
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancertreatment3terminated
NCT04705038
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone TreatmentsNo drug interventionsotherNot Availablerecruiting
NCT00046943
Atrasentan in Treating Patients With Prostate Cancertreatment3completed
NCT00329043
Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomytreatment2active_not_recruiting
NCT00379743
Partnership for Healthy SeniorsNo drug interventionsscreeningNot Availablecompleted
NCT05513443
Prostate Cancer IRE Study (PRIS)No drug interventionstreatmentNot Availablerecruiting
NCT01391143
Safety Study of MGA271 in Refractory Cancertreatment1completed
NCT06355843
Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.No drug interventionsdiagnosticNot Availablesuspended
NCT00253643
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate CancerNo drug interventionspreventionNot Availablecompleted
NCT00100243
Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapytreatment2completed
NCT05669443
Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic ProstatectomyNo drug interventionsotherNot Availablerecruiting
NCT03503643
Hemi-Gland Cryoablation for Prostate Cancer at UCLANo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04936243
TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)No drug interventionshealth_services_researchNot Availablecompleted
NCT02454543
Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone MetastasesNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03793543
Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancerdiagnostic1completed
NCT00732043
Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate CancerNo drug interventionsprevention2unknown_status
NCT04060043
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancertreatment0completed
NCT03529643
Effect of Anesthetic Method on Optic Nerve Sheath Diameter in Patients Undergoing RALPotherNot Availablecompleted
NCT05209243
START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPCNo drug interventionstreatmentNot Availablerecruiting
NCT04555343
Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retentiontreatment1 / 2completed
NCT01059643
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Necktreatment2completed
NCT06270043
Focal Therapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04278443
Fertility After Prostate BrachytherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00036543
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancertreatment3completed
NCT01499043
Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)treatment2terminated
NCT01950143
Effect of Sulforaphane on Prostate CAncer PrEventionNo drug interventionspreventionNot Availablecompleted
NCT01961843
Abiraterone Acetate for Castrate Resistant Prostate CancertreatmentNot Availableactive_not_recruiting
NCT03976843
Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancerdiagnostic2recruiting
NCT05317143
Evaluation of Prostate Cancer MarginsNo drug interventionsNot AvailableNot Availablecompleted
NCT00004043
Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate CancerNo drug interventionstreatment2completed
NCT01921803
Hypofractionated Radiotherapy as Primary Therapy for Prostate CancerNo drug interventionstreatment2completed
NCT05946603
IS-002 in Prostate CancerNo drug interventionsother2recruiting
NCT00001503
Follow-up Protocol for Patients With Cancer/AIDS/Skin DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01742403
Continuous Monitoring of Prostate Position During RadiotherapyNo drug interventionstreatmentNot Availablerecruiting
NCT03262103
Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancertreatment1completed
NCT00485303
An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapytreatment2completed
NCT04428203
Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancertreatment1completed
NCT00970203
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancertreatment2completed
NCT03087903
A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSANo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02799303
MRI Versus PSA in Prostate Cancer ScreeningNo drug interventionsscreeningNot Availableunknown_status
NCT03832803
Less to Hold - A Comparison of Bladder Toxicities (Side Effects) in Patients Undergoing Prostate Radiotherapy Between Patients Treated With Empty Bladder and Those on a Drinking Protocol.No drug interventionsotherNot Availablecompleted
NCT03644303
Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.No drug interventionstreatmentNot Availableunknown_status
NCT05700903
Contributions to Hypertension With Androgen Deprivation Therapybasic_science4recruiting
NCT00002703
Radiation Therapy in Treating Patients With Stage I or Stage II Prostate CancerNo drug interventionstreatment3completed
NCT06027203
Transperineal Versus Transrectal Prostate BiopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT01794403
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00003103
Chemotherapy in Treating Patients With Solid Tumorstreatment1 / 2completed
NCT05381103
PSMA-PET to Guide ProstatectomyNo drug interventionsdiagnostic2 / 3recruiting
NCT00928603
Investigative Study of the Role of Focal Therapy for Prostate Cancer TreatmentNo drug interventionstreatment1unknown_status
NCT01803503
Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumorstreatment2unknown_status
NCT06397703
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancertreatment3recruiting
NCT05223803
TERPS Trial for de Novo Oligometastic Prostate CancerNo drug interventionstreatment2recruiting
NCT01795703
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxeltreatment2completed
NCT00003290
Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment3completed
NCT01685190
A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate CancerNo drug interventionstreatment2unknown_status
NCT00623090
Internet-Based Education for Prostate Cancer ScreeningNo drug interventionsscreening3completed
NCT03187990
Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSANo drug interventionsdiagnosticNot Availablecompleted
NCT01917890
Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT04159090
Head- to Head Comparison of [68Ga]Ga-PSMA-11 With [18F]PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-StandardNo drug interventionsdiagnosticNot Availableunknown_status
NCT01994590
Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)treatment2terminated
NCT00391690
Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancertreatment4completed
NCT01630590
Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancertreatment2completed
NCT01748890
A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate BiopsyNo drug interventionsdiagnosticNot Availableterminated
NCT00769990
Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone MetastasesNo drug interventionstreatment1 / 2withdrawn
NCT01434290
Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment2completed
NCT02255890
Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife DeviceNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05403190
The Performance of da Vinci SP System on Extraperitoneal Approach Radical ProstatectomyNo drug interventionstreatmentNot Availableunknown_status
NCT00416390
Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic HyperplasiaNo drug interventionstreatmentNot Availablecompleted
NCT02093390
A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjectstreatment1completed
NCT00003690
Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumorstreatment1completed
NCT02141490
Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancersdiagnostic2completed
NCT05252390
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT05755490
PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care InterventionNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00480090
A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancertreatment2completed
NCT06101290
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)No drug interventionstreatmentNot Availablerecruiting
NCT03511664
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancertreatment3completed
NCT00587964
Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesNo drug interventionstreatment2completed
NCT00997464
An Exploration of Genetic Testing for Prostate Cancer SusceptibilityNo drug interventionsNot AvailableNot Availableunknown_status
NCT00853164
A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)No drug interventionstreatmentNot Availablecompleted
NCT00741364
Vitamin D Effects on Prostate PathologyNo drug interventionstreatment2unknown_status
NCT03232164
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancerdiagnostic0recruiting
NCT02037464
CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate CancerNo drug interventionsbasic_science2unknown_status
NCT01852864
Degarelix Before Radical Prostatectomybasic_science0unknown_status
NCT02114164
Study of Carbon Dioxide Exchange Patterns During Robotic ProstatectomiesNo drug interventionssupportive_careNot Availablecompleted
NCT00217464
Fulvestrant in Treating Patients With Recurrent Prostate Cancertreatment2terminated
NCT05605964
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetatetreatment3active_not_recruiting
NCT02362464
Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139No drug interventionstreatment2completed
NCT02088164
Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese MenNo drug interventionsNot AvailableNot Availablecompleted
NCT02485964
A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer VaccineNo drug interventionsotherNot Availablecompleted
NCT05647564
PET/CT Characterization of Treatment ResistanceNo drug interventionsdiagnosticNot Availablerecruiting
NCT03321864
Capture of Prostatic Trans-rectal Ultrasound Scans for ResearchNo drug interventionsbasic_scienceNot Availablesuspended
NCT06449664
Training for Men Undergoing Androgen Deprivation Therapy.No drug interventionssupportive_careNot Availablerecruiting
NCT04019964
Nivolumab in Biochemically Recurrent dMMR Prostate Cancertreatment2recruiting
NCT04698564
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance ImagingNo drug interventionstreatment2recruiting
NCT00339664
Analyses of Human Samples Collected in Clinical TrialsNo drug interventionsNot AvailableNot Availablecompleted
NCT06168864
Development of Artificial Intelligence Models for Segmentation and Characterization of Prostate Cancer: a Single-center Retrospective Observational Study.No drug interventionsNot AvailableNot Availablecompleted
NCT01006564
Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT01715064
Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer PatientsNo drug interventionssupportive_care2 / 3completed
NCT01344564
Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by LeuprolidetreatmentNot Availablecompleted
NCT06359964
Infective Complications in TP Biopsy Without Antibiotic ProphylaxisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00084864
Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostatetreatment2terminated
NCT01254864
Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapiestreatment2completed
NCT01262664
A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and ObesityNo drug interventionstreatment1terminated
NCT03223064
Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRINo drug interventionsdiagnosticNot Availableunknown_status
NCT04773821
Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal TherapyNo drug interventionsdiagnosticNot Availablerecruiting
NCT03031821
Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndromeprevention3terminated
NCT01990521
Prostate Screening Study Using MRI in BRCA CarriersNo drug interventionstreatmentNot Availablerecruiting
NCT05644821
Influence of Electronic Patient Reported Outcomes (ePROMs) in Surgical Therapy for Prostate Cancer on Postoperative OutcomeNo drug interventionsotherNot Availablerecruiting
NCT02494921
LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPCtreatment1 / 2completed
NCT00984321
A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00849121
Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancertreatment2completed
NCT01542021
Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate CancertreatmentNot Availableactive_not_recruiting
NCT00923221
Collection of Blood From Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04535921
Fear of Cancer Recurrence in Genitourinary CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06353321
Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03271502
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic ProstatectomyNo drug interventionsotherNot Availablecompleted
NCT04575402
Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer PatientsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05926102
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)No drug interventionsscreeningNot Availablerecruiting
NCT01812902
Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical ProstatectomyNo drug interventionshealth_services_researchNot Availablecompleted
NCT06165302
Exercise in Prostate CancerNo drug interventionsotherNot Availablenot_yet_recruiting
NCT01716702
A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT00824902
Evaluation Ultrasound Elasticity/Tissue Strain-Hardening Imaging for Prostate Cancer Patients Undergoing Radical ProstatectomyNo drug interventionstreatmentNot Availableterminated
NCT00126802
The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate CancerNo drug interventionstreatment1 / 2unknown_status
NCT01594502
Validation of Digital Morphometry for Cancer Risk in Benign Prostate BiopsiesNot AvailableNot Availablecompleted
NCT00295802
Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate CancerNo drug interventionstreatment2 / 3unknown_status
NCT00421902
Acupuncture Treatment for Hot Flashes StudyNo drug interventionstreatmentNot Availablecompleted
NCT00964002
Efavirenz in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT00433602
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsNo drug interventionsNot AvailableNot Availablecompleted
NCT04420702
Diffusion Basis Spectrum Imaging of the ProstateNo drug interventionsdiagnosticNot Availablerecruiting
NCT05389202
Study of Prostate Perfusion Before Embolization in Patients With Symptomatic Prostate AdenomaNo drug interventionstreatmentNot Availableunknown_status
NCT03853902
Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the ProstateNo drug interventionssupportive_careNot Availablecompleted
NCT02594202
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer TissueNo drug interventionsNot AvailableNot Availablerecruiting
NCT00077402
Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancertreatment2completed
NCT04825002
Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker SensorNo drug interventionsdiagnosticNot Availableunknown_status
NCT02440802
Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00856102
Exercise and Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion TherapyNo drug interventionstreatmentNot Availablecompleted
NCT04015102
A Registry for Hereditary Cancer Risk Assessment and Genetic TestingNo drug interventionsNot AvailableNot Availablecompleted
NCT00241384
Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate CancerNo drug interventionstreatment3completed
NCT01694784
Understanding and Discouraging Overuse of Potentially Harmful Screening TestsNo drug interventionspreventionNot Availablecompleted
NCT05923684
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision MakingNo drug interventionshealth_services_researchNot Availablerecruiting
NCT04809584
18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate CancerNot AvailableNot Availabletemporarily_not_available
NCT05109884
Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00342784
Identification of Prostate Cancer GenesNo drug interventionsNot AvailableNot Availablecompleted
NCT00258284
Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancertreatment2completed
NCT03284684
Kinetics of Perioperative Circulating DNA in Cancer SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT00303784
Prostate Adenocarcinoma TransCutaneous Hormonestreatment3unknown_status
NCT06122584
Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate CancerNo drug interventionsdiagnostic3recruiting
NCT00899184
DNA Changes in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT06274684
Feasibility of Virtual Reality Assistance in Prostate Biopsy Under Local Anesthesia.No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT03028584
Survivorship Care Plans in a Community Oncology PracticeNo drug interventionsNot AvailableNot Availablecompleted
NCT02721784
Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapyNo drug interventionsdiagnostic1 / 2unknown_status
NCT02621684
Physical Activity Intervention in African American Men After Radical ProstatectomyNo drug interventionssupportive_careNot Availablewithdrawn
NCT00523484
Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNtsNo drug interventionsNot AvailableNot Availablecompleted
NCT05840484
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active SurveillanceNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03739684
Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancerdiagnostic3completed
NCT01673984
GP Extended Action Triptorelintreatment4terminated
NCT02483884
PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancerdiagnostic1 / 2terminated
NCT02968784
Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT00765479
Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate CancerNo drug interventionstreatment2 / 3completed
NCT02274779
Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancertreatment2active_not_recruiting
NCT05383079
Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men With Metastatic Castration-Resistant Prostate Cancertreatment1 / 2recruiting
NCT00004879
Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancertreatment1completed
NCT06238479
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsNo drug interventionstreatment1recruiting
NCT04271579
Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s)No drug interventionstreatmentNot Availablerecruiting
NCT04478279
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumorstreatment1 / 2active_not_recruiting
NCT03634579
MRI Guided Prostate Cancer Focal Laser AblationNo drug interventionstreatmentNot Availableterminated
NCT06237179
Behavioral Exercise Training to Reduce Cardiovascular Disease RiskNo drug interventionssupportive_care1 / 2recruiting
NCT05099679
Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart StudyNo drug interventionssupportive_careNot Availablerecruiting
NCT01607879
Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablationsupportive_care2completed
NCT00911079
Pilot Study of a Catheter-based Ultrasound Hyperthermia SystemNo drug interventionsdevice_feasibilityNot Availableterminated
NCT03602079
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneNo drug interventionstreatment1 / 2completed
NCT02190279
18F-DCFBC PET/CT in Prostate Cancerdiagnostic0completed
NCT01025479
Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen AgentNo drug interventionsNot AvailableNot Availablecompleted
NCT02584179
Biparametric MRI for Detection of Significant Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT04304079
A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted SurgeryNo drug interventionstreatmentNot Availablewithdrawn
NCT02278679
Digital Rectal Exam Proficiency ToolNo drug interventionsNot AvailableNot Availableunknown_status
NCT06584279
Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men at Risk of Prostate Cancer: a Prospective, Multicenter, Paired, Non-inferiority TrialNo drug interventionsNot AvailableNot Availablerecruiting
NCT03411486
Safety and Tolerability of a Modified Vaccinia Ankara (MVA) Priming Followed by Fowlpox Booster Vaccines Modified to Express Brachyury and T-Cell Costimulatory Molecules (MVA-BN-Brachyury/FPV-Brachyury)treatment1not_yet_recruiting
NCT00413530
Effects of Pomegranate Juice or Extract on Rising PSA Levels in Men Following Primary Therapy for Prostate CancertreatmentNot Availablecompleted
NCT00632983
Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancertreatment3unknown_status
NCT00003915
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancertreatment2active_not_recruiting
NCT02349347
A Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles in Patients With Castration-resistant Prostate Cancer (CRPC)treatment2recruiting
NCT01303003
Evaluation of Addition of Dexamethasone to Transversus Abdominis Plane (TAP) Peripheral Nerve BlocktreatmentNot Availablecompleted
NCT01998685
Prothrombotic Factors and Anaesthesia in Prostate CancerpreventionNot Availablecompleted
NCT04043637
Early Urinary Continence After Radical Prostatectomy: Surgical Procedure and Anatomic LandmarksNo drug interventionsNot AvailableNot Availablecompleted
NCT04495959
Dynamic Whole Body PET/ MRINo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00417274
Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancertreatment2completed
NCT05754580
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT03606889
Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-prostatectomy AnalgesiatreatmentNot Availableterminated
NCT04484701
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate CancerNot AvailableNot Availablerecruiting
NCT03893123
Prostate Cancer Risk in FirefightersNo drug interventionsNot AvailableNot Availableunknown_status
NCT01284608
Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)No drug interventionsNot AvailableNot Availablecompleted
NCT02687308
Open Anterograde Radical Prostatectomy Compared to Open Retrograde TechniqueNo drug interventionstreatmentNot Availablecompleted
NCT05184790
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New TechnologyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05851521
To Evaluate LUTS and Complications Between Indwelling Catheter and Temporary Prostatic Stent in Patients Undergoing Minimally Invasive Procedures for the Treatment of Localized Prostate Cancer or Benign Prostatic Hyperplasia (HERMES)No drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06439784
Contribution of the VERITON-CT Camera in Prostate Bone RadiostereotaxyNo drug interventionsotherNot Availablenot_yet_recruiting
NCT05623878
68Ga-labeled NY108 PET Imaging in PatientsNo drug interventionsdiagnostic0recruiting
NCT01086956
Effect of Adding Sufentanil to Epidural Ropivacaine on Perioperative Metabolic and Stress Responses in Combined General/Epidural Anaesthesia for Geriatric Radical Retropubic ProstatectomydiagnosticNot Availablecompleted
NCT05740956
A Study of Hansoh (HS)-10502 in Patients With Advanced Solid TumorsNo drug interventionstreatment1recruiting
NCT02909049
Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsytreatment4completed
NCT03481816
Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccinestreatment1completed
NCT04434963
Safety and Feasibility of Reversible Induction StrategyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01787630
To Evaluate the Technique and Effects of Separating the Prostate and Rectum With Hyaluronic Acid During RadiotherapyNo drug interventionstreatment2 / 3unknown_status
NCT01171729
Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate CancerNo drug interventionstreatment1 / 2completed
NCT05969704
Fusion Versus Cognitive MRI Targeted Prostatic BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT04421781
Salvage HIFU for Local Recurrence in the Prostatic Bed After Prostatectomy and External Beam Radiation Therapy : Preliminary ResultsNo drug interventionsNot AvailableNot Availablecompleted
NCT03866785
Physical Activity Experiment on Male Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT06359717
Prospective Validation of PSMA-RADSNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05154474
Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic MalignancyNo drug interventionsNot AvailableNot Availableunknown_status
NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT04074460
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Studyother4completed
NCT06583395
Quest to Analyze One Thousand Humans MeditatingNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04836221
Comorbidities And Reducing inEquitieSNo drug interventionshealth_services_researchNot Availablecompleted
NCT05410002
Diet Effect on Cancer Treatment OutcomeNo drug interventionssupportive_care1active_not_recruiting
NCT03157856
Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate ResectionNo drug interventionsNot AvailableNot Availableterminated
NCT06152419
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National ProjectNo drug interventionsotherNot Availablerecruiting
NCT06035731
Evaluation of the Medical Service by Socio-aesthetics in OncologyNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT00172055
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapytreatment3completed
NCT06574880
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancertreatment1 / 2not_yet_recruiting
NCT04534075
Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized TrialNo drug interventionsprevention3recruiting
NCT06437496
68Ga-AAZTA-093 PET/CT: First-in-human Studydiagnostic0recruiting
NCT04696263
Single-Port Versus Multi-Port Robotic Radical ProstatectomyNo drug interventionstreatmentNot Availablesuspended
NCT01764646
Hypofractionated Radiation Therapy in Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04765423
Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic DiseaseNo drug interventionsdiagnosticNot Availablewithdrawn
NCT02810886
Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient ManagementNo drug interventionsdiagnostic2withdrawn
NCT00917865
FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate CancerNo drug interventionsdiagnostic2terminated
NCT03450109
A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancerother1completed
NCT03444532
Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With InsomniaNo drug interventionssupportive_careNot Availablecompleted
NCT04633252
M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancertreatment1 / 2recruiting
NCT01639859
Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer FociNo drug interventionsdiagnosticNot Availablecompleted
NCT02614859
Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patientstreatment2completed
NCT06318559
Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D InterventionNo drug interventionsdiagnosticNot Availablerecruiting
NCT03442075
Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic BiopsyNo drug interventionsNot AvailableNot Availablecompleted
NCT04258813
Onco-primary Care Networking to Support TEAM-based CareNo drug interventionspreventionNot Availablerecruiting
NCT03031418
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)No drug interventionsNot AvailableNot Availablecompleted
NCT03133286
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)No drug interventionsNot AvailableNot Availablecompleted
NCT00220194
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancertreatment4completed
NCT03579680
De-implementation of Low Value Castration for Men With Prostate CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT03919214
Hypertension Management in Cancer PatientsNo drug interventionssupportive_careNot Availableterminated
NCT06554587
Investigation of Three Biomarkers for the Detection of Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03899077
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RPtreatment2recruiting
NCT05361798
T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapytreatment2recruiting
NCT04319783
Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMAtreatment2recruiting
NCT05844761
Real-time Motion Management During Prostate and Lung RadiotherapyNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT05214937
A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availablerecruiting
NCT02235142
Prostatic Cancer Versus Androgen DeficiencyNo drug interventionsotherNot Availablecompleted
NCT05224024
Retzius-sparing Technique in Robotic-assisted Radical ProstatectomyNo drug interventionsotherNot Availableunknown_status
NCT04304196
Tailored, wEb-based, Psychosocial and Physical Activity Self-Management PrOgrammeNo drug interventionsotherNot Availablecompleted
NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)No drug interventionsNot AvailableNot Availableunknown_status
NCT05653063
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03632980
Dynamic Focusing Evaluation for Prostate Cancer TreatmentNo drug interventionstreatmentNot Availableunknown_status
NCT06406803
The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT03235687
Decision Impact Trial of the ExoDx Prostate (IntelliScore)No drug interventionsscreeningNot Availableunknown_status
NCT02355054
Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access StudyNot AvailableNot Availableapproved_for_marketing
NCT00992251
Eligard Observational Registry for Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01897207
Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate CancerNo drug interventionstreatment1 / 2completed
NCT04057859
PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness TrainingNo drug interventionsNot AvailableNot Availablecompleted
NCT03564275
Proton Boost in Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT02212548
Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal DoseNo drug interventionstreatmentNot Availablecompleted
NCT02578940
Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcerdiagnostic3completed
NCT03191968
Prostate Cancer Survivors and Exercise and Behavioral CounselingNo drug interventionssupportive_care2completed
NCT02381990
MRI/Ultrasound Fusion Guided Prostate CryotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02958787
Vessel Sparing Prostate Radiation TherapyNo drug interventionstreatment2completed
NCT03124433
Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancertreatment2completed
NCT02879851
Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound Obtained in Vivo by the Koelis™ SystemNo drug interventionsNot AvailableNot Availableunknown_status
NCT03392428
A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancertreatment2completed
NCT03960788
Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancerdiagnostic0unknown_status
NCT02939456
Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot StudyNo drug interventionsdiagnosticNot Availablecompleted
NCT03238170
MR-simulation in Radiotherapy for Prostate CancerNo drug interventionstreatmentNot Availableunknown_status
NCT05241236
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03653819
High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower LimbsNo drug interventionssupportive_careNot Availablecompleted
NCT02349386
Maintaining Suppression of Testosterone With Transdermal Estradiol Geltreatment2terminated
NCT04017325
European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-upNo drug interventionsNot AvailableNot Availablecompleted
NCT03285048
Cognitive Remediation Therapy (CRT) for Adults Treated for CancerNo drug interventionstreatmentNot Availablecompleted
NCT06363266
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their CaregiversNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT03939689
Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abirateronetreatment2active_not_recruiting
NCT02632669
Hemi-Ablative Prostate BrachytherapyNo drug interventionstreatmentNot Availablecompleted
NCT02274350
The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side EffectsNo drug interventionsNot AvailableNot Availablecompleted
NCT00502723
Multicentric Study Comparing Carcinological and Functional Results of SurgeryNo drug interventionstreatment3unknown_status